See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · InformexUSA 2012 · New Orleans, Louisiana · February 14-17, 2012 · Booth 2514

Research Area · Neuroscience

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
10976 10-HDA New 14113-05-4 ≥98% 2011-10-13 2.886165015296 10-hda fatty acids royal jelly lifespan MMP RA, rheumatoid arthritis VEGF angiogenesis antitumor neurogenesis collagen 2.886165015296
33400 (±)10-HDoHE 90780-50-0 ≥98% 12.843563535912 -10-hdohe 10-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)10-HDoHEs (+/-)HDoHEs neurochemistry 12.843563535912
10008598 (±)11(12)-EET Ethanolamide - ≥98% 2007-01-16 20.371491712707 -11-12-eet-ethanolamide (±)11(12)-EpETrE Ethanolamide AEA endocannabinoids Arachidonoyl ethanolamides CYP450 cytochromes metabolism neurochemistry anxiety depression 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide anandamides lipids neurotransmitters cannabinergic cannabinoids CBs FAAH inhibitor fatty acids hydrolases cbs synthetic 20.371491712707
10010101 11-cis Vaccenyl Acetate Exclusive 6186-98-7 >98% 2007-08-06 40.569631675874 11-cis-vaccenyl-acetate d. melanogaster pheromones olfactory receptors mating male female specific insects flys fruit flies Or67d odorant hydrocarbon 865721-11-5 40.569631675874
33450 (±)11-HDoHE 87018-59-5 ≥98% 11.408922651933 -11-hdohe 11-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)11-HDoHEs (+/-)HDoHEs neurochemistry 11.408922651933
10009897 (−)-11-nor-9-carboxy-Δ9-THC (solution) 56354-06-4 ≥98% 2010-11-11 6.639502762431 -11-nor-9-carboxy-9-thc-solution THC metabolites Delta9-THC Δ9-THC tetrahydrocannabinols marijuana cannabinoids cbs synthetic 10915 6.639502762431
10009473 1,2-dipalmitoyl-sn-glycero-3-PC 63-89-8 >98% 2007-01-19 7.301464088397 1-2-dipalmitoyl-sn-glycero-3-pc L-dipalmitoyl Lecithin; L-DPPC; 1,2-dipalmitoyl-sn-glycero-3-Phosphatidylcholine antigens phosphatidylcholines zwitterionic phosphoglycerides proteoliposomes liposomal enzymes g-glutamyl gamma-glutamyl .gamma.-glutamyl transpeptidase erythrocytes immunotherapy immunotherapies GSLs glycosphingolipids phospholipids polyenylphosphatidylcholine 7.301464088397
90377 13-Docosenamide 112-84-5 ≥98% 2.151104972375 13-docosenamide Erucamide; Armoslip E CSF sleep fatty acids neurochemistry neuroscience 2.151104972375
33500 (±)13-HDoHE 90780-53-3 ≥98% 11.307265193370 -13-hdohe 13-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)13-HDoHEs (+/-)HDoHEs neurochemistry 11.307265193370
10008599 (±)14(15)-EET Ethanolamide - ≥95% 2006-08-07 14.656841620625 -14-15-eet-ethanolamide (±)14(15)-Epoxy Eicosatrienoyl Ethanolamide; (±)14(15)-EpETrE Ethanolamide CYP450 cytochrome P450 metabolites AEA arachidonoyl ethanolamides anandamide lipids neurotransmitter cannibinergic cannabinoid CB1 CB2 receptors enzymatic metabolism FAAH fatty acid amide hydrolases endocannabinoid neurochemistry anxiety depression neuroscience 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide cbs synthetic cannabinoids 14.656841620625
33550 (±)14-HDoHE 87042-40-8 ≥98% 12.088759876324 -14-hdohe 14-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)14-HDoHEs (+/-)HDoHEs neurochemistry 12.088759876324
10010132 15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester - ≥98% (isomer mixture) 2008-06-09 26.555457335788 15-deoxy-12-14-prostaglandin-j2-2-glycerol-ester 15-deoxy-Δ12,14-PGJ2-2-glycerol ester PPARgamma PPAR.gamma. PPARg PGD2 PGJ2 lipolysis prostaglandins adipocyte endocannabinoid metabolism diabetes obesity nuclear receptors COX-2 COX2 2-AG 2AG cannabinoids cbs synthetic 26.555457335788
10169 15(S)-HETE Ethanolamide 161744-53-2 ≥98% 19.968830570902 15-s-hete-ethanolamide 15(S)-HAEA neurotransmitters ethanolamides fatty acids endocannabinoids CB receptors amide hydrolases FAAH neurochemistry neuroscience ethanolamines 15HETE cannabinoids cbs synthetic 19.968830570902
10174 16(17)-EpDPE - ≥90% 2004-01-14 24.917596685082 16-17-epdpe 16,17-epoxy Docosapentaenoic Acid; 16,17 EDP epoxides epoxygenases cytochrome P450 (±)16,17-EpDPEs (+/-)16,17-EpDPEs fatty acids (+/-)16(17)EpDPEs 16(17)EETs eicosatrienoic neurochemistry 16,17-EDP 16,17EDP 24.917596685082
33600 (±)16-HDoHE 90780-51-1 ≥98% 10.762974217311 -16-hdohe 16-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)16-HDoHEs (+/-)HDoHEs neurochemistry 10.762974217311
33650 (±)17-HDoHE 90780-52-2 ≥98% 13.732331066723 -17-hdohe 17-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)17-HDoHEs (+/-)HDoHEs neurochemistry 13.732331066723
14810 17-phenyl trinor Prostaglandin E2 38315-43-4 >98% 56.688241252302 17-phenyl-trinor-prostaglandin-e2 17-phenyl trinor PGE2 agonists EP1 EP3 prostaglandins receptors 17-phenyl-trinor-PGE2 56.688241252302
10004238 17-phenyl trinor Prostaglandin E2 serinol amide - ≥95% 2004-05-13 117.110243093922 17-phenyl-trinor-prostaglandin-e2-serinol-amide 17-phenyl trinor PGE2-SA agonists EP1 EP3 prostaglandins receptors 17-phenyl-trinor-PGE2 analogs 17-phenyl-PGE2SA 17-phenyl-PGE2-SA amides cannabinoids Cbs sythetic 117.110243093922
10004237 17-phenyl trinor Prostaglandin F serinol amide - >98% 2004-03-15 7.416194751381 17-phenyl-trinor-prostaglandin-f2-serinol-amide 17-phenyl trinor PGF2α-SA; 17-phenyl trinor PGF2α serinol amide; Bimatoprost serinol amide analogs agonists receptors 17-phenyl-PGF2.alpha.SA 17-phenyl-PGF2alphaSA 17-phenyl-PGF2a-SA prostaglandins cannabinoids CBs synthetic 7.416194751381
10005099 17(R)-HDoHE Exclusive 155976-53-7 ≥98% 2005-01-05 24.270205209155 17-r-hdohe 17(R)-hydroxy Docosahexaenoic Acid resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry 24.270205209155
10009799 17(S)-HDoHE - ≥98% 2007-03-12 10.232854511970 17-s-hdohe 17(S)-hydroxy Docosahexaenoic Acid resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry 17(s)-hdohe 10.232854511970
10175 19(20)-EpDPE - ≥98% 2004-01-14 34.789093922651 19-20-epdpe 19,20-epoxy Docosapentaenoic Acid; 19,20 EDP metabolites epoxides epoxygenases cytochrome P450 (±)19,20-EpDPEs (+/-)19,20-EpDPEs fatty acids (+/-)19(20)EpDPEs 19(20)EETs eicosatetraenoic 19,20-EETs neurochemistry 19,20-EDP 19,20EDP 34.789093922651
62150 1-Arachidonoyl Glycerol Exclusive 35474-99-8 >95% (as a 9:1 mixture of the 1-AG and 2-AG) 9.433922651934 1-arachidonoyl-glycerol 1-AG cannabinoids glycerol anandamides fatty acids neurochemistry neuroscience 9.433922651934
362152 1-Arachidonoyl Glycerol-d5 - ≥99% deuterated product 29.892113259668 1-arachidonoyl-glycerol-d5 1-AG-d5 deuterium isotopes GC/MS endocannabinoids anandamides 1AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 1-AG-d5 internal fatty acids cannabinoids cbs synthetic 29.892113259668
33750 (±)20-HDoHE 90906-41-5 ≥98% 12.469972375690 -20-hdohe 20-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)20-HDoHEs (+/-)HDoHEs neurochemistry 12.469972375690
10008602 20-HETE Ethanolamide - ≥98% 2006-09-26 32.682062615101 20-hete-ethanolamide 20-hydroxy AEA; 20-hydroxy Arachidonoyl Ethanolamide hydroxy fatty acids omega-oxidation .omega.-oxidation w-oxidation cytochrome P450 CYP450 arachidonic HETEs metabolites P-450 vasoconstrictors vasoconstriction ethanolamides cannabinoids cbs synthetic 32.682062615101
10009501 20-hydroxy N-Arachidonoyl Taurine - >95% 2008-04-23 10.447243707796 20-hydroxy-n-arachidonoyl-taurine metabolism metabolites CYP450 20-HETE taurines vasoconstrictors TRPV1 TRPV4 FAAH 10.447243707796
10009962 2-(14,15-Epoxyeicosatrienoyl) Glycerol 848667-56-1 ≥95% 2008-04-03 28.374088397789 2-14-15-epoxyeicosatrienoyl-glycerol 2-14,15-EG 2-AG CYP450 metabolism mitogens cancers kidneys endocannabinoids cannabinoids cbs synthetic 28.374088397789
9001133 2,3-Methylenedioxymethcathinone (hydrochloride) New - ≥98% 2012-01-26 188.724570602383 2-3-methylenedioxymethcathinone-hydrochloride 2,3-MDMC forensics phenethylamines cathinones designer drugs amphetamines bath salts party pills plants food hydrochloride HCl 188.724570602383
9000683 25-hydroxy Vitamin D3 New 19356-17-3 ≥98% 2012-01-12 69.944444444444 25-hydroxy-vitamin-d3 RO 8-8892; Rovimix Hy-D; U 32070E; 25-hydroxy Cholecalciferol 25631-40-7 calcidiol calcifediol calderol dedrogyl didrogyl hidroferol Hy-D Ro 8-8892 Rovimix Hy-D U 32070E U-32070E U32070E 25-OH cholecalciferol 25-OH vitamin D3 25-hydroxyvitamin D3 phosphorus metabolism neuromuscular inflammatory intermediates receptors livers kidneys plasma serum 69.944444444444
9001128 25I-NMBOMe New 1043868-97-8 ≥98% 2012-02-06 232.472329749104 25i-nmbome 919797-19-6 serotonin 5-HT2A hallucinogenic frontal cortex agonists forensic sciences phenethylamines neuroscience receptors brains memory schizophrenia hallucinogenic drugs 232.472329749104
64970 2-APB 524-95-8 >98% 65.262099447514 2-apb receptors inositol-1,4,5-triphosphates calcium signalling ins(1,4,5)IP3 blocked inositols antagonists Ca2+ neurochemistry neuroscience 65.262099447514
62160 2-Arachidonoyl Glycerol 53847-30-6 >95% (as a 9:1 mixture of the 2-AG and 1-AG) 41.965750591949 2-arachidonoyl-glycerol 2-AG endocannabinoids anandamides 2AG fatty acids CB1 neuroscience neurochemistry endocrinology cannabinoids cbs synthetic 41.965750591949
362162 2-Arachidonoyl Glycerol-d5 - ≥99% deuterated product 46.147099447513 2-arachidonoyl-glycerol-d5 2-AG-d5 deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 2-AG-d5 internal fatty acids lipids neurochemistry neuroscience endocrinology cannabinoids cbs synthetic 46.147099447513
362160 2-Arachidonoyl Glycerol-d8 - ≥99% deuterated product 71.042030386740 2-arachidonoyl-glycerol-d8 2-AG-d8 deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d8 GC-MS mass spectrometry LC/MS LC-MS deuterated standards internal neurochemistry neuroscience endocrinology cannabinoids cbs synthetic 71.042030386740
62165 2-Arachidonyl Glycerol ether 222723-55-9 >98% 27.766740331492 2-arachidonyl-glycerol-ether Noladin; 2-AG ether endocannabinoids 2AG anandamides CB1 receptor selective selectivity agonists stable 2-AG-ether analogs fatty acids neurochemistry neuroscience lipids cannabinoids cbs synthetic 27.766740331492
10395 2C-E New 71539-34-9 ≥95% 2012-01-11 134.150318586106 2c-e 2,5-Dimethoxy-4-ethylphenethylamine forensics designer drugs phenethylamines serotonin norepinephrine dopamine monoamines oxidase inhibitors 2Cs psychoactive metabolism 4-ethyl-2,5-dimethoxy-phenethylamine 4-ethyl-2,5-dimethoxy-β-phenethylamine 134.150318586106
9000787 2-chloro Adenosine 40656-71-1 ≥98% 2011-06-29 0.741560773480 2-chloro-adenosine 2-CADO; NSC 158900; 6-Amino-2-chloropurine riboside adenosine receptors analogs agonists seizures neuroscience NSC158900 NSC-158900 neurotransmission A1 A2A A2B A3 G protein-coupled 2-chloroadenosine 2CA 2-CA 2 CA CADO 0.741560773480
11113 2C-I (hydrochloride) New 64584-32-3 ≥98% 2012-01-17 204.681218637992 2c-i-hydrochloride forensics designer drugs phenethylamines serotonin norepinephrine dopamine monoamine oxidase inhibitors hydrochloride HCl psychoactive metabolism 2CI 2C I 204.681218637992
11199 2-Ethylethcathinone (hydrochloride) New - ≥98% 2012-02-10 48.152438155136 2-ethylethcathinone-hydrochloride 2-EEC forensics phenethylamines amphetamines cathinones designer drugs ethcathinones hydrochloride HCl 2EEC 2 EEC 48.152438155136
11419 2-Fluoroamphetamine (hydrochloride) New 1626-69-3 ≥98% 2012-02-07 168.532669142288 2-fluoroamphetamine-hydrochloride 2-FA 1716-60-5 designer drugs amphetamines phenethylamines bath salts monoamine neurotransmitters isomers 4-FA 4 FA 2 FA forensics hydrochloride HCl 168.532669142288
11229 2-Fluoroethcathinone (hydrochloride) Exclusive New - ≥98% 2012-01-27 134.362783009654 2-fluoroethcathinone-hydrochloride 2-FEC forensics phenethylamine cathinones designer drugs amphetamines hydrochloride HCl bath salts plants food pills 134.362783009654
11420 2-Fluoromethamphetamine (hydrochloride) Exclusive New - ≥98% 2012-02-09 127.104559268987 2-fluoromethamphetamine-hydrochloride 2-FMA methamphetamines forensic science stimulant 4-fluoromethamphetamine 4-FMA MDMA amphetamines 4FMA FMAs 127.104559268987
62260 2-Linoleoyl Glycerol Exclusive 3443-82-1 >98% 14.702549329124 2-linoleoyl-glycerol 2-LG CB1 glycerols 2LG cannabinoids 2-Linoleoyl-Glycerol reuptake endocannabinoids receptors congeners fatty acids neurochemistry neuroscience lipids cannabinoids cbs synthetic 14.702549329124
9001186 2-Methoxymethcathinone (hydrochloride) New - ≥98% 2012-02-06 263.450466910299 2-methoxymethcathinone-hydrochloride 2-MMC forensics phenethylamines amphetamines cathinones designer drugs isomers methedrone party pills bath salts hydrochloride HCl bronchodilator receptors agonists methoxyphenamine 2MMC 2 MMC 263.450466910299
90055 (±)-2-Methyl Arachidonoyl-2'-Fluoroethylamide 166100-39-6 >95% 18.838038674033 -2-methyl-arachidonoyl-2-fluoroethylamide O-689; 2-Methyl-2'-fluoro Anandamide; 2-methyl-2'-fluoro AEA anandamides ethanolamides AEA cannabinoids receptors CB1 binding affinity faah fatty acid hydrolases .DELTA.9-THC .DELTA.9THC DELTA9-THC DELTA9THC D9-THC D9THC tetrahydrocannabidiol selective analogs neurochemistry neuroscience fluoromethanandamide 18.838038674033
11223 2-Methylmethcathinone (hydrochloride) New 1246815-51-9 ≥98% 2012-02-09 140.295513958342 2-methylmethcathinone-hydrochloride 2-MMC forensics science phenethylamines cathinones designer drugs amphetamines bath salts mephedrone 3MMC 4MMC MMCs 4-MMC 1246911-71-6 HCl cathinones 140.295513958342
10007980 3,4-DAA - ≥95% 2006-08-09 3.768259668508 3-4-daa Trp tryptophan Multiple Sclerosis MS T helper-1 TH1 cytokines EAE encephalomyelitis inflammation immunity autoimmune autoimmunity cells cytokines 3.768259668508
11228 3,4-Dimethylethcathinone (hydrochloride) New - ≥95% 2012-01-23 126.364948789933 3-4-dimethylethcathinone-hydrochloride 3,4-DMEC hydrochloride HCl forensics phenethylamines cathinones designer drugs amphetamines psychoactive 126.364948789933
9001098 3,4-Dimethylmethcathinone (hydrochloride) New 1081772-06-6 ≥98% 2012-01-19 177.839535004769 3-4-dimethylmethcathinone-hydrochloride 3,4-DMMC 1082110-00-6 forensics phenethylamines cathinones designer drugs amphetamines hydrochloride HCl 4-methylmethcathinone 4-MMC 4 MMC 4MMC psychoactive bath salts plants food research 3,4 DMMC 3,4DMMC 177.839535004769
10397 3-amino Benzamide New 3544-24-9 ≥98% 2011-10-07 2.289024419063 3-amino-benzamide 3-(Aminocarbonyl) Aniline; 3-Carboxamidoaniline poly(ADP-ribose) polymerases PARPs DNA repairs DNA strands breaks apoptosis inflammation atherosclerosis neruogenesis cancers angiogenesis signaling cellular responses inhibits inhibitor inhibition telomere shortening shortens stimulates mediated mediates PARP-mediated 2.289024419063
10918 (±)3-epi CP 47,497-C8-homolog - ≥98% 2011-05-06 12.267457068203 -3-epi-cp-47-497-c8-homolog (±)-trans-CAY10596 (±)-3-epi CP 47,497-C8 analogs trans-CAY10596 cannabinoids analogs receptors by-product standards (+)-CP 47,497-C8 CB2 CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 13802 12.267457068203
13802 (±)3-epi CP 47,497-C8-homolog (solution) Exclusive - ≥98% 2010-08-04 11.371533840622 -3-epi-cp-47-497-c8-homolog-solution (±)-trans-CAY10596 (±)-3-epi CP 47,497-C8 analogs trans-CAY10596 cannabinoids analogs receptors by-product standards (+)-CP 47,497-C8 CB2 CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 10918 11.371533840622
11198 3-Ethylethcathinone (hydrochloride) New - ≥98% 2012-01-24 156.618991201291 3-ethylethcathinone-hydrochloride 3-EEC 3EEC EECs forensics phenethylamines amphetamines cathinones designer drugs ethcathinones psychoactive 156.618991201291
9001082 3-Ethylmethcathinone (hydrochloride) New - ≥98% 2012-01-27 164.896184086192 3-ethylmethcathinone-hydrochloride 3-EMC designer drugs forensics hydrochloride HCl stimulants entactogen amphetamines phenethylamines cathinones mephedrone bath salts plants food tablets 164.896184086192
9001191 3-Fluoroamphetamine (hydrochloride) New 1716-59-2 ≥98% 2012-02-07 210.199335808955 3-fluoroamphetamine-hydrochloride 3-FA 1626-71-7 designer drugs amphetamines phenethylamines bath salts isomers 3 FA 4-FA 4 FA monoamine neurotransmitters hydrochloride HCl 210.199335808955
11230 3-Fluoroethcathinone (hydrochloride) New - ≥98% 2012-02-03 157.530908009654 3-fluoroethcathinone-hydrochloride 3-FEC forensics phenethylamine cathinones designer drugs amphetamines bath salts plants food pills hydrochloride HCl 157.530908009654
9001185 3-Fluoromethamphetamine (hydrochloride) New - ≥98% 2012-02-10 11.798895027624 3-fluoromethamphetamine-hydrochloride 3-FMA designer drugs amphetamines phenethylamines bath salts 4 FMA 4FMA stimulants methamphetamines powders isomers hydrochloride HCl forensics 3FMA 3 FMA 11.798895027624
10730 3-Fluoromethcathinone (hydrochloride) - ≥98% 2011-04-26 100.924141257072 3-fluoromethcathinone-hydrochloride 3-FMC flephedrones cathinones analogs designer drugs plant feeders forensic analysis CMF-3 1049677-77-1 100.924141257072
11222 3-Methylethcathinone (hydrochloride) New - ≥98% 2012-02-06 155.204106125184 3-methylethcathinone-hydrochloride 3-MEC forensics phenethylamines cathinones designer drugs amphetamines 3MEC 3 MEC hydrochloride HCl 155.204106125184
11224 3-Methylmethcathinone (hydrochloride) New 1246816-62-5 ≥97% 2012-02-03 200.664023225790 3-methylmethcathinone-hydrochloride 3-MMC 1246911-86-3 forensics phenethylamines cathinones designer drugs amphetamines synthetic bath salts powders mephedrone 3 MMC 4-MMC 4 MMC 4-methylmethcathinone 200.664023225790
90312 4,5-dehydro Docosahexaenoic Acid - ≥98% 20.457495395948 4-5-dehydro-docosahexaenoic-acid 4,5-dehydro Cervonic Acid; 4,5-dehydro DHA w-3 fatty acids omega-3 .omega.-3 n-3 analogs acetylene 5-LO 5-lipoxygenases inhibits inhibitors 20.457495395948
90314 4(5)-EpDPE methyl ester 121818-29-9 ≥98% 24.003793738489 4-5-epdpe-methyl-ester 4,5-epoxy Docosapentaenoic Acid methyl ester cytochrome P450 metabolites epoxide epoxygenase neurochemistry 24.003793738489
11231 4-Fluoroethcathinone (hydrochloride) New - ≥98% 2012-01-16 130.117004166755 4-fluoroethcathinone-hydrochloride 4-FEC forensics phenethylamine cathinones designer drugs amphetamines psychoactive plants feeder capsules analogs ehtyl groups methyl amino flephedrone 4 FMC 4 FEC 130.117004166755
9001070 4-Fluoromethamphetamine (hydrochloride) 52063-62-4 ≥98% 2011-08-08 68.252000772342 4-fluoromethamphetamine-hydrochloride 4-FMA methamphetamines forensic sciences stimulants 4 fluoromethamphetamine 4FMA FMA MDMA amphetamines 4-fluoroamphetamine 351-03-1 68.252000772342
10859 4-Fluoromethcathinone (hydrochloride) 7589-35-7 ≥98% 2011-05-31 102.008874562155 4-fluoromethcathinone-hydrochloride 4-FMC; Flephedrone flephedrones 4-FMC cathionones analogs 4 FMC 4FMC derivatives drugs plants feeders forensics 447-40-5 102.008874562155
33200 (±)4-HDoHE 90906-40-4 ≥98% 12.785344703339 -4-hdohe 4-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)4-HDoHEs (+/-)HDoHEs neurochemistry 12.785344703339
13265 4-hydroxy Nonenal Alkyne Exclusive 1011268-23-7 ≥98% 2010-06-16 121.635972989564 4-hydroxy-nonenal-alkyne Click Tag™ 4-HNE alkyne lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT 121.635972989564
9000895 4-methoxy DMT New 3965-97-7 ≥98% 2011-11-21 96.998213852581 4-methoxy-dmt 4-MeO DMT; 4-methoxy-N,N-Dimethyltryptamine hallucinogen DMT dimethyltryptamine 5-HT receptors agonists 5-hydroxytryptamine behavior neuroscience forensics 4-OMe DMT 4 OMe DMT 4OMe DMT tryptamine 96.998213852581
9001069 4-Methylethcathinone (hydrochloride) Exclusive 1266688-86-1 ≥98% 2011-07-18 83.281241722824 4-methylethcathinone-hydrochloride 4-MEC; 4-methyl-N-ethyl Cathinone forensic sciences designer drugs methamphetamines 4methylethcathinone 4 methylethcathinones mephedrones cathinones analogs MDMA amphetamines plant feeders 1225617-18-4 83.281241722824
10801 4-Methylmethcathinone (hydrochloride) 1189726-22-4 ≥98% 2011-06-17 83.647718190009 4-methylmethcathinone-hydrochloride 4-MMC; 4-Methylephedrone; Mephedrone designer drugs methcathinone cathinones methamphetamine bath salts plants food feeder forensics psychoactive analysis hallucinogen meow bounce bubbles mad cow 4MMC MMC methylephedrone 1189805-46-6 4-methyl-methcathinone 83.647718190009
10448 4'-Methyl-α-pyrrolidinohexanophenone (hydrochloride) New - ≥98% 2011-10-21 21.055398696870 4-methyl-pyrrolidinohexanophenone-hydrochloride MPHP 34138-58-4 designer drugs forensics pyrovalerone bath salts MPPP PPP α-PPP α PPP psychostimulant toxic liver damage rabdomyloysis 21.055398696870
13140 4-(n-nonyl) Benzeneboronic Acid 256383-45-6 ≥98% 2009-11-04 6.668687845304 4-n-nonyl-benzeneboronic-acid fatty acids amide hydrolase FAAH endocannabinoids arachidonoyl ethanolamides AEA inhibitors inhibit monoacylglycerol lipase MAGL 2-arachidonoyl glycerol 2-AG 2AG 2 AG inhibition cannabinoids cbs synthetic 6.668687845304
11093 4-Quinolone-3-Carboxamide Derivative New 1314230-69-7 ≥98% 2012-01-30 128.388330263966 4-quinolone-3-carboxamide-derivative CB1 CB2 cannabinoid CBs central peripheral receptors inverse agonists antinociception AM630 analgesic pain osteoporosis synthetic ligands mice analgesic AM 630 AM-630 128.388330263966
10008596 (±)5(6)-EET Ethanolamide - ≥95% 2006-10-20 8.898524072612 -5-6-eet-ethanolamide (±)5(6)-EpETrE Ethanolamide epoxides epoxygenases 5,6-EETs cytochrome P450 (+/-)5(6)-EpETrEs (+/-)5,6-EpETrEs fatty acids esters ethanolamides metabolites AEA anandamides arachidonoyl neurotransmitters cannabinergic endocannabinoids CB1 CB2 receptors central peripheral FAAH hydrolases metabolism lipoxygenases inhibition (±)5(6)-Epoxy eicosatrienoyl 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide cannabinoids cbs synthetic 8.898524072612
11134 5-APB (hydrochloride) New 286834-80-8 ≥95% 2012-01-13 82.780268199234 5-apb-hydrochloride 5-(2-aminopropyl)benzofuran 6-APB benzofurans amphetamines phenethylamines MDA 5-APDB forensics designer drugs analogs stimulants entactogens 1-benzofuran-5yl-propan-2-amine 82.780268199234
13803 (±)5-epi CP 55,940 - ≥98% 2010-08-04 7.455193370166 -5-epi-cp-55-940 (±)-5-trans-CP 55,940 (±)-CP 55,940 cannabinoids analogs receptors pains analgesics by-products standards Δ9-THC delta-tetrahydrocannabidiol CP 55940 CP44950 CP-55940 CP55,940 7.455193370166
11035 5-IAI (hydrochloride) New - ≥98% 2011-12-09 115.824291554659 5-iai-hydrochloride 5-iodo-2-Aminoindan 132367-76-1 phenethylamines phenylethylamines forensics indans indanes analogs MDMA rats serotonin hi hydrochloride hcl AI 5IAI psychoactive alkaloids 3,4-methylenedioxymethamphetamine 115.824291554659
10729 5-methoxy DALT Exclusive 928822-98-4 ≥95% 2011-04-05 97.452586634441 5-methoxy-dalt N,N-Diallyl-5-Methoxytryptamine tryptamines neuroscience forensics designer drugs 5-MeO-DALT MeO TRYPTAMINE, n,n-DIALLYL-5-METHOXY N,N-DIALLYL-5-METHOXYTRYPTAMINE INDOLE, 3-[2-(DIALLYLAMINO)ETHYL]-5-METHOXY 3-[2-(DIALLYLAMINO)ETHYL]-5-METHOXYINDOLE 5-Methoxy-DALT 5-MeO-DALT DALT 97.452586634441
90195 5(Z),8(Z),11(Z)-Eicosatrienoic Acid Ethanolamide 169232-04-6 ≥98% 9.294045898852 5-z-8-z-11-z-eicosatrienoic-acid-ethanolamide Mead Acid Ethanolamide cannabinoids neurotransmitter CB1 CB2 receptors ligands acids ethanolamides eicosatrienoyl fatty acids neurochemistry neuroscience ethanolamines 9.294045898852
10009315 6-Aminonicotinamide 329-89-5 ≥98% 2008-11-21 2.086464088398 6-aminonicotinamide 6-AN; NSC 21206; SR 4388 inhibitors inhibits inhibition 6-phosphoguconate dehydrogenase cancers ATPs oxidative injury neurodegeneration cardiovascular 2.086464088398
10010670 7-Aminoclonazepam-d4 - ≥99% deuterated product 2009-04-17 5.674033149171 7-aminoclonazepam-d4 seizures myotonic atonic epilepsy receptors acids deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 5.674033149171
33300 (±)7-HDoHE 90780-55-5 ≥98% 12.675405156537 -7-hdohe 7-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)7-HDoHEs (+/-)HDoHEs neurochemistry 12.675405156537
81340 7-Nitroindazole 2942-42-9 >98% 7.590122774708 7-nitroindazole nitric oxide synthases inhibitors nNOS eNOS iNOS inhibits anti-nociceptive antinociceptive neurochemistry 7.590122774708
10006878 8,12-iso-iPF-VI-d11 Exclusive - ≥99% deuterated product 2005-09-01 7.075386740332 8-12-iso-ipf2-vi-d11 8,12-epi-iPF2α-VI-d11 GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry analogs internal standards isoprostanes prostaglandins free-radical lipid peroxidation stero- regioisomers arachidonic acids 8-isoprostane 8-epi-PGF2.alpha. iPF2.alpha.-III oxidative stress Type VI class internal lactones facilitates extraction and purification neurochemistry neuroscience 7.075386740332
10008597 (±)8(9)-EET Ethanolamide - ≥98% 2007-07-05 15.558743093922 -8-9-eet-ethanolamide (±)8(9)-EpETrE Ethanolamide AEA endocannabinoids arachidonoyl ethanolamide CYP450 cytochrome P450 metabolism ethanolamides hypertension cannabinoids cbs synthetic 15.558743093922
10010109 8-DY547-cGMP - ≥98% 2008-10-23 736.127458563536 8-dy547-cgmp CNGA2 channels activators fluorescences cyclic nucleotides 736.127458563536
33350 (±)8-HDoHE 90780-54-4 ≥98% 10.762974217311 -8-hdohe 8-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)8-HDoHEs (+/-)HDoHEs neurochemistry 10.762974217311
316350 8-iso Prostaglandin F-d4 211105-40-7 ≥99% deuterated product 50.421588397790 8-iso-prostaglandin-f2-d4 15-F2t-Isoprostane-d4; iPF2α-III-d4; 8-epi PGF2α-d4; 8-Isoprostane-d4 GC/MS deuterium isotopes 8-isoprostanes 8-epi-PGF2.alpha.-d4 8-epi-PGF2alpha-d4 8-iso-PGF2.alpha.-d4 8-iso-PGF2alpha-d4 internal standards prostaglandins mass spectrometry LC/MS GC-MS LC-MS deuterated 8-iso-PGF2a-d4 8-epi-PGF2a-d4 ipf2a neurochemistry 316351 50.421588397790
10005764 8-iso Prostaglandin F Ethanolamide - >98% 2004-09-24 17.166390423573 8-iso-prostaglandin-f2-ethanolamide 8-Isoprostane Ethanolamide; 8-epi PGF2α Ethanolamide; 8-iso PGF2α Ethanolamide; iPF2α-III Ethanolamide ethanolamides prostaglandins anandamides AEA COX-2 cox2 cyclooxygenases synthases isoprostanes 8-epi-PGF2alpha 8-iso-PGF2alpha arachidonoyl prostamides congeners decomposition standards non-enzymatic iPF2a-III PGHS2 PGHS-2 ethanolamines 714966-38-8 cannabinoids cbs sythetic 17.166390423573
516351 8-Isoprostane EIA Kit - 898.138721844454 8-isoprostane-eia-kit iPF2α-III EIA Kit; 8-epi Prostaglandin F2α EIA Kit; 8-iso Prostaglandin F2α EIA Kit; 8-Isoprostane ELISA Kit solid plates oxidative injury stress reactive oxygen species 8-isoprostanes 8-epi-PGF2.alpha. 8-epi-PGF2alpha 8-iso-PGF2.alpha. 8-iso-PGF2alpha prostaglandins free radicals ROS peroxidation lipids measures kits eias enzyme immunoassays ELISAs assays 898.138721844454
516360 8-Isoprostane Express EIA Kit - 2009-10-26 177.831516825716 8-isoprostane-express-eia-kit 8-epi Prostaglandin F2α Express EIA Kit; iPF2α-III Express EIA Kit; 8-Isoprostane Express ELISA Kit; 8-iso Prostaglandin F2α Express EIA Kit solid plates oxidative injury stress reactive oxygen species 8-isoprostanes 8-epi-PGF2.alpha. 8-epi-PGF2alpha 8-iso-PGF2.alpha. 8-iso-PGF2alpha prostaglandins free radicals ROS peroxidation lipids measures kits eias enzyme immunoassays ELISAs 177.831516825716
90375 9-Octadecenamide 301-02-0 >98% 4.123281767955 9-octadecenamide Oleamide; cis-9-octadecenamide CSF sleep 9Z-octadecenamide fatty acids neurochemistry neuroscience 4.123281767955
10012588 A-803467 944261-79-4 ≥98% 2009-02-14 0.216574585635 a-803467 Nav1.8 sodium channels neuropathic pain inflammatory blockers inhibitors inhibits inhibition TTX-resistance TTX-R 0.216574585635
10092 Adenosine Receptor A2A Blocking Peptide - 2009-04-03 152.562306629834 adenosine-receptor-a2a-blocking-peptide A2AR blocking peptides Western blots immunoblotting ARA2A 152.562306629834
10005254 AFMK 52450-38-1 >98% 2004-10-28 2.185055248618 afmk melatonin metabolites metabolism radicals scavengers neurotransmitters eukaryotes circadean rhythms antioxidants plasma synthesis endocrinology neurochemistry 2.185055248618
13203 Agomelatine 138112-76-2 ≥98% 2009-11-06 3.236961325967 agomelatine Valdoxan® melatonin circadian rhythm MT1 MT2 serotonin 5-HT noradrenaline dopamine antidepressant anti-depressant S20098 S-20098 S 20098 3.236961325967
10011546 AL 34662 210580-75-9 ≥98% 2008-11-12 22.488281767955 al-34662 AL 34497 serotonins 5-HTs 5HT 5-hydroxy trptamine IOPs intraocular pressure glaucoma ophthalmology lower 5-hydroxytrptamine 22.488281767955
10005223 AM1172 251908-92-6 >98% 2004-09-01 25.692268262737 am1172 cannabinoids neurotransmitters inhibitors AEA lipids CB1 CB2 receptors anandamide hydrolysis fatty acids inhibits arachidonoyl ethanolamides reuptake FAAH-resistant amide hydrolases neuroscience neurochemistry cannabinoids cbs synthetic 25.692268262737
9001055 AM1220 Exclusive New 137642-54-7 ≥98% 2011-10-11 118.380461040369 am1220 [1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]-1-naphthalenyl-methanone AM-2201 AM 2201 AM-1220 AM 1220 cannabinoids CB1 CB2 CBs receptors pains forensic science forensics 118.380461040369
10010118 AM1241 444912-48-5 >97% 2007-08-29 104.824301021262 am1241 CB1 CB2 cannabinoids receptors agonists antagonists antinociception AM630 AM251 AM-1241 AM 1241 cannabinoids cbs synthetic 104.824301021262
11282 AM1248 Exclusive New 335160-66-2 ≥98% 2012-02-06 128.785932020974 am1248 CBs cannabinoids synthetic agonist AM-1248 AMs 1248 forensic sciences receptors CB1 CB2 1-pentyl-3-(1-adamantoyl)indole AM679 AM-679 679 128.785932020974
11193 AM2201 7-hydroxyindole metabolite New - ≥98% 2012-01-16 119.790823986937 am2201-7-hydroxyindole-metabolite forensics sciences AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 metabolites urinary urine metabolism synthetic central peripheral 119.790823986937
9001031 AM2201 N-(2-fluoropentyl) isomer New - ≥95% 2011-12-15 125.960721783419 am2201-n-2-fluoropentyl-isomer forensics AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 synthetic isomers fluorine pentyl chains synthetic central peripheral 125.960721783419
9001029 AM2201 N-(4-fluoropentyl) isomer Exclusive - ≥98% 2011-08-11 65.690699556963 am2201-n-4-fluoropentyl-isomer forensics sciences AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 central peripheral 65.690699556963
10203 AM2201 N-(4-hydroxypentyl) metabolite Exclusive New - ≥98% 2011-10-11 105.795305348014 am2201-n-4-hydroxypentyl-metabolite AM-2201 AM 2201 cannabinoids cannabimimetic metabolites CB1 CB2 CBS receptors forensics synthetics smoking urinary urine potent synthetic 105.795305348014
11008 AM2233 New 444912-55-4 ≥98% 2011-10-24 100.230828316970 am2233 769958-75-0 forensic science cannabinoid receptors CB1 agonists WIN 55,212-2 WIN 55212-2 radioligands neuroscience 100.230828316970
71670 AM251 183232-66-8 >98% 76.381213014119 am251 cannabinoids receptors antagonists CB1 analogs selective SR-141716-A AM-251 SR141716A neuroscience neurochemistry endocrinology 76.381213014119
13452 AM3102 Exclusive 213182-22-0 ≥98% 2009-08-11 45.108392879067 am3102 KDS-5104 OEA PPARs PPARα KDS5104 antiobesity anti-obesity CB1 CB2 endocannabinoids obesity cannabinoids inhibitors agonists receptors cbs synthetic 45.108392879067
90060 AM404 183718-77-6 >98% 37.788228974830 am404 N-(4-hydroxyphenyl)-Arachidonoyl Amide; 4-HPA cannabinoids neurotransmitter inhibitors AEA lipids CB1 CB2 receptors anandamide hydrolysis fatty acids neuroscience neurochemistry 37.788228974830
10006974 AM630 164178-33-0 ≥98% 2009-02-09 47.163132289748 am630 Iodopravadoline neurochemistry neuroscience cannabinoids CB1 CB2 antagonist inverse agonist antinociception pain receptors 47.163132289748
10567 AM694 Exclusive 335161-03-0 ≥95% 2011-01-31 55.781724575096 am694 cannabinoids CB1 CB2 receptors pain JWH neuroscience AM-694 AM 694 55.781724575096
10869 AM694 4-iodo isomer Exclusive - ≥97% 2011-06-21 29.220392980301 am694-4-iodo-isomer cannabinoids CBs cannabimimetics CB1 CB2 pain spices forensics synthetic receptors agonists AM-694 AM 694 analogs neuroscience 29.220392980301
10005098 AMC Arachidonoyl Amide - >98% 2004-08-31 12.158132596685 amc-arachidonoyl-amide 7-amino-4-methyl Coumarin-Arachidonamide; AMC-AA fatty acid amides hydrolases FAAH anandamides fluorescence coumarin 12.158132596685
11001 Anatabine New 2743-90-0 ≥95% 2011-11-10 0.311827956989 anatabine alkaloids solanaceae tobacco Alzheimer’s diseases amyloid beta Aβ β-secretase BACE-1 NF-κB inflammation urine nicotine transcription proteins SHSY-5Y cells 0.311827956989
13523 Apelin-13 217082-58-1 ≥95% 2010-06-29 51.080481452249 apelin-13 ligands APJ receptors central nervous system cardiovascular functions fluid homeostasis neurosciences hypertension diabetes metabolic syndrome insulin HIV aids Peptide Factors Paracrine Paracrine Protein Factors Paracrine Peptide Factors Growth Factors 51.080481452249
13524 Apelin-36 252642-12-9 ≥95% 2011-04-04 55.485883977900 apelin-36 agonists receptors APJ cardiovascular functions fluids homeostasis hypertension insulin sensitivity apelin-17 apelins 17 13 36 apelin-13 HIV infections peptides mature G protein-coupled GPCR c-protein coupled 55.485883977900
10008617 Arachidonic Acid Leelamide - ≥95% 2006-09-27 13.333687845304 arachidonic-acid-leelamide AA cannabinoids central peripheral CB1 CB2 CP55940 PDK pyruvates dehydrogenases kinases anti-inflammatory inflammation phospholipases PLA2 inhibits inhibitors inhibition cannabinoids cbs sythetic 13.333687845304
10007904 Arachidonoyl-1-thio-Glycerol Exclusive - >98% 2006-01-24 18.352375690608 arachidonoyl-1-thio-glycerol 1-S-Arachidonoyl-1-mercapto-2,3-propanediol cannabinoids monoacylglycerols monoglycerol monoglyceride anandamides fatty acids neurochemistry neuroscience chromogenic substrates lipases 2-arachidonoyls 2-AG agonists central CB1 nervous system CNS rat brains MGL hydrolyzes arachidonic acids thioesters analogs thiols DTNB Ellman's reagents yellow cannabinoids cbs synthetic 18.352375690608
91054 Arachidonoyl 2'-Chloroethylamide 220556-69-4 >96% 22.960930018415 arachidonoyl-2-chloroethylamide 2'-chloro-AEA; ACEA agonists selective CB1 receptors AEA arachidonoyl ethanolamides cannabinoids selectivity hypothermia FAAH fatty acid amide hydrolases neurochemistry neuroscience thc tetrahydrocannabinoids ethanolamines 22.960930018415
90054 Arachidonoyl-2'-Fluoroethylamide 166100-37-4 >98% 5.036048269845 arachidonoyl-2-fluoroethylamide 2'-fluoro Anandamide; 2'-fluoro AEA anandamides cannabinoids neurotransmitters ligands AEA lipids CB1 CB2 receptors neurochemistry neuroscience 5.036048269845
10007295 Arachidonoyl amide 85146-53-8 >98% 2006-01-18 7.823456985003 arachidonoyl-amide Arachidonamide; Arachidonic Acid amide anandamides arachidonoyl ethanolamides AEA endogenous endocannabinoids CB1 CB2 receptors cellular uptake hydrolysis bonds enzymes fatty acids hydrolases FAAH N,N-dimethyl analogs human inhibits inhibition rat glial gap junction cell-cells communications neurochemistry hydroxyethyl moiety transporter astrocytoma neuroscience cannabinoids inhibitors 7.823456985003
91053 Arachidonoyl Cyclopropylamide 229021-64-1 >98% 19.122202052091 arachidonoyl-cyclopropylamide ACPA cannabinoids receptors CB1 agonists AEA FAAH fatty acid hydrolases substrates selective analogs anandamide arachiodonyl ethanolamides neurochemistry neuroscience thc tetrahydrocannabinoids ethanolamines 19.122202052091
90050 Arachidonoyl Ethanolamide 94421-68-8 ≥98% 35.180919814842 arachidonoyl-ethanolamide Anandamide; AEA cannabinoids neurotransmitter ligands lipids CB1 CB2 receptors AEA fatty acids neuroscience neurochemistry ethanolamines ethanolamides endocrinology 35.180919814842
10011178 Arachidonoyl Ethanolamide-d4 946524-40-9 ≥99% deuterated product 2008-03-04 35.926298342541 arachidonoyl-ethanolamide-d4 AEA-d4; Anandamide-d4 deuterium GC/MS internal isotopes standards ethanolamides LC/MS mass spectrometry cannabinoids fatty acids deuterated neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic 35.926298342541
390050 Arachidonoyl Ethanolamide-d8 - ≥99% deuterated product 35.021906077348 arachidonoyl-ethanolamide-d8 Anandamide-d8; AEA-d8 deuterium GC/MS internal isotopes standards ethanolamides GC-MS LC/MS LC-MS mass spectrometry cannabinoids deuterated fatty acids neurochemistry neuroscience ethanolamines endocrinology 35.021906077348
10007270 Arachidonoyl Ethanolamide Lipid Maps MS Standard 94421-68-8 ≥98% 2009-02-18 6.314611134721 arachidonoyl-ethanolamide-lipid-maps-ms-standard AEA; Anandamide cannabinoids neurotransmitter ligands lipids CB1 CB2 receptors AEA fatty acids neuroscience neurochemistry ethanolamines ethanolamides endocrinology MS mass spectrometry standards 6.314611134721
10180 Arachidonoyl Ethanolamide Phosphate 183323-26-4 >98% 2004-08-19 15.640524861879 arachidonoyl-ethanolamide-phosphate AEA-P; Anandamide Phosphate endocannabinoids neurotransmitters ligands lipids CB1 CB2 receptors fatty acids phosphates anandamides LPA lysophosphatidic ethanolamines ethanolamides cannabinoids cbs synthetic 15.640524861879
90051 Arachidonoyl Glycine 179113-91-8 >98% 22.298044198895 arachidonoyl-glycine NAGly; N-Arachidonyl Glycine cannabinoids ligands lipids CB1 receptors AEA anandamides ethanolamides fatty acids neurochemistry neuroscience 22.298044198895
10007531 Arachidonoyl Glycine-d8 - ≥99% deuterated product 2005-09-13 17.672720994475 arachidonoyl-glycine-d8 N-Arachidonyl Glycine-d8; NAGly-d8 deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated cannabinoids ligands lipids CB1 receptors AEA anandamides ethanolamides fatty acids neurochemistry neuroscience 17.672720994475
90059 Arachidonoyl m-Nitroaniline Exclusive - >98% 5.256883977900 arachidonoyl-m-nitroaniline AmNA FAAH substrates anandamides hydrolases colorimetric cannabinoids fatty acids meta-nitroaniline aea nitroanilines nitroanalines neurochemistry neuroscience 5.256883977900
10007294 Arachidonoyl-N-methyl amide 156910-29-1 >98% 2006-01-18 7.114112075769 arachidonoyl-n-methyl-amide acids anandamides arachidonoyl ethanolamides AEA endogenous endocannabinoids CB1 CB2 receptors cellular uptake hydrolysis bonds enzymes fatty acids hydrolases FAAH N,N-dimethyl analogs human inhibits inhibition rat glial gap junction cell-cells comunications neurochemistry neuroscience inhibitors 7.114112075769
10007293 Arachidonoyl-N,N-dimethyl amide 45280-17-9 >98% 2006-01-11 7.195374901341 arachidonoyl-n-n-dimethyl-amide Arachidonic Acid-N,N-dimethyl amide anandamides arachidonoyl ethanolamides AEA endogenous endocannabinoids CB1 CB2 receptors cellular uptake hydrolysis bonds enzymes fatty acids hydrolases FAAH N,N-dimethyl analogs human inhibits inhibition rat glial gap junction cell-cells comunications neurochemistry neuroscience cannabinoids cbs synthetic 7.195374901341
10168 Arachidonoyl p-Nitroaniline 119520-58-0 >98% 2004-12-01 8.814443567482 arachidonoyl-p-nitroaniline ApNA FAAH substrates anandamides hydrolases colorimetric cannabinoids fatty acids para-nitroaniline aea nitroanilines arachidonoyl ethanolamides neurochemistry neuroscience 8.814443567482
62170 Arachidonoyl Serinol 183718-70-9 >98% 32.943646408840 arachidonoyl-serinol endocannabinoids anandamides 2AG CB1 receptors neurochemistry neuroscience cannabinoids cbs synthetic 32.943646408840
70665 Arachidonoyl Serotonin 187947-37-1 >98% 12.063613761929 arachidonoyl-serotonin AA-5HT inhibitors fatty acids amides hydrolase FAAH inactivation cannabinoids AA-5HT neurochemistry neuroscience 12.063613761929
62120 Arachidonyl Trifluoromethyl Ketone 149301-79-1 >98% 30.507655003069 arachidonyl-trifluoromethyl-ketone ATK; AATFMK ATK AACOCF3 inhibitors PLA2 analogs fatty acids lipoxygenases inhibition inhibits LOs neurochemistry neuroscience 30.507655003069
10005765 Arachidoyl Ethanolamide Exclusive 94421-69-9 >98% 2005-06-22 11.432394106814 arachidoyl-ethanolamide N-Arachidoylethanolamine arachidoyls ethanolamides N-acyls saturated anandamides analogs enocannabinoids CB1 CB2 memory weight loss appetite neurodegeneration tumors arachidoylethanolamide surveillance analgesia inflammations fatty hydrolytic enzymes FAAH acid amides hydrolases AEA neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic 11.432394106814
9000325 Arachidoyl glycine 617703-96-5 ≥98% 2008-12-02 1.094232044199 arachidoyl-glycine arachidic acid glycine fatty acids PUFAs polyunsaturated fatty acids 1.094232044199
13662 Arecoline (hydrobromide) 300-08-3 ≥95% 2010-08-19 0.299079189687 arecoline-hydrobromide 63-75-2 alkaloids betel nuts Areca agonists muscarinic acetylcholine receptors M1 M2 M3 M4 M5 smooth muscles contractions learning memory dementia Alzheimer’s diseases Methylarecaidin Arecholine Arecoline Arecholin Arecaline Arecolin 0.299079189687
90052 Arvanil 128007-31-8 >98% 10.947914364641 arvanil N-Vanillylarachidonamide capsaicin capsicum vanilloids receptors agonists cannabinoids analgesia anandamides analgesic vanillylamines amides neurochemistry neuroscience 10.947914364641
13644 Aspalatone Exclusive 147249-33-0 ≥98% 2010-02-19 3.789786898184 aspalatone Acetylsalicylic Acid Matol ester antioxidants platelet aggregation thrombosis epilepsy kainic acid thromboembolism anti-platelets antiplateles 2-(Acetyloxy)benzoic Acid Acid, Acetylsalicylic Acetylsalicylic Acid Aloxiprimum Polopiryna Polopirin Micristin Endosprin Acylpyrin Solupsan Magnecyl Colfarit Acetysal Zorprin Solprin Ecotrin Easprin Dispril Aspirin 3.789786898184
13160 AT-56 Exclusive 162640-98-4 ≥95% 2010-06-22 14.424548802946 at-56 Prostaglandins D synthases L-PGDS PGD2 lipocalin-type inflammation inhibition inhibitors inhibits PGs eosinophils LPGDs bronchoalveolar lavage fluid Lysosomal Proton Translocating ATPases Vacuolar Proton-Translocating ATPases Vacuolar Membrane H(+)-ATPase Proteins Membrane-Associated Membrane-Associated Proteins Membrane Associated Proteins Tacrolimus Binding Proteins Proteins Rapamycin-Binding Proteins Integral Membrane Membrane Proteins Integral Binding Proteins Rapamycin Rapamycin-Binding Proteins Rapamycin Binding Proteins Protein Integral Membrane Integral Membrane Proteins Vacuolar F(1)F(0) ATPasesLysosomal F(1)F(0) ATPase Integral Membrane Protein Vacuolar F(1)F(0) ATPase Proteins Cell Membrane Protein FK-506-Binding Proteins Cell Surface Protein FK506-Binding FK-506-Binding ProteinFK506 Binding Proteins FK 506 Binding Protein Cell Membrane Proteins FK506-Binding ProteinFK506 Binding Protein Cell Surface Proteins H+-ATPase, Vacuolar Vacuolar H+-ATPase Vacuolar H+ ATPase Proteins Membrane Proteins Vacuolar ATPase Rotamase FKBP V Type ATPase FKBP Rotamase Membrane FKBP 14.424548802946
10009410 ATF2 (Phospho-Ser490,498) Polyclonal Antibody - 2006-11-28 0.870165745856 atf2-phospho-ser490-498-polyclonal-antibody Activating Transcription Factor 2 wb western blotting blots ihc immunohistochemistry antibodies activating transcriptional factors CRE-BP1 AP-1 DNA response elements ATF/CREB leucine zipper proteins regulating regulation genes cytokines cells cycles controls apoptosis death cellular stress inflammatory UV irradiation activity phosphorylation serines brains substrates neuronal neurons growth differentiation human depression phospho-specific immunoblotting 0.870165745856
10009021 AVE-1625 Exclusive 358970-97-5 >98% 2008-04-03 121.810082872928 ave-1625 cannabinoids CB1 receptors schizophrenia parkinsons disease alzheimers disease metabolism obesity SR-141716 lipolysis glycogenolysis antagonist endocrinology neurochemistry 121.810082872928
13823 AX 048 Exclusive 873079-69-7 ≥98% 2010-09-15 9.193425414365 ax-048 Inflammation antihyperalgesia cPLA2 phospholipases inhibitors inhibition inhibits AX048 AX-048 signaling signalling group IVA PLA2 cannabinoids cbs synthetic Acids Octanoic Octanoic Acids 9.193425414365
10227 BACE (human recombinant) - ≥95% 2009-03-09 18.321469613259 bace-human-recombinant Membrane-bound Aspartic Protease; BACE-1; ASP-2; β-Secretase; Memapsin-2 proteins amyloids peptides C-terminus terminal alzheimers neurochemistry 18.321469613259
600070 BACE Inhibitor Screening Assay Kit - 2009-03-26 29.692872928176 bace-inhibitor-screening-assay-kit β-Secretase Inhibitor Screening Assay Kit inhibitors inhibition inhibits assays kits β-sites .beta.-sites b-sites APP cleaving enzymes β-amyloids .beta.-amyloids b-amyloids peptides Ab A.beta. brain neurodegeneration Alzheimer's Diseases AD proteolytic cleavages precursors β-secretases b-secretases γ-secretases .gamma.-secretases g-secretases membranes aspartic C-terminal C-terminus fragments proteolysis therapeutics therapy cascade pathogenesis mice mouse murine transgenics cholinergic dysfunctions HIV humans fluorescents fluorescences fluorometer assays 29.692872928176
10011135 BAY-60-7550 439083-90-6 ≥95% 2009-03-13 62.156844151329 bay-60-7550 inhibitors inhibits inhibition cyclic nucleotides cGMP cAMP cells signalling signaling PDE2 memory memories phosphodiesterase 62.156844151329
10506 Bio-active Lipid I Screening Library (96-Well) - 2010-06-15 44.241464088397 bio-active-lipid-i-screening-library-96-well vasoconstriction bronchoconstriction prostaglandins endocrinology prostaglandins HTS high thoroughput screening cannabinoids cbs synthetic 44.241464088397
10005836 bis(7)-Tacrine 224445-12-9 >98% 2005-04-15 4.350110497238 bis-7-tacrine 1,7-N-heptylene-bis-9,9'-amino-1,2,3,4-tetrahydro-acridine dimeric congeners amino acridines inhibits inhibitors inhibition acetylcholinesterases Alzheimer's disease hydrogen peroxides apoptosis pheochromocytoma cells neurochemistry neuroscience 4.350110497238
11283 Buphedrone (hydrochloride) New 166593-10-8 ≥98% 2012-01-23 147.413092335708 buphedrone-hydrochloride MABP; α-methylamino-Butyrophenone forensics phenethylamines amphetamines cathinones designer drugs ethcathinones psychoactive hydrochloride HCl stimulants 408332-79-6 147.413092335708
10488 Bupropion (hydrochloride) 31677-93-7 ≥98% 2010-08-16 24.251151406400 bupropion-hydrochloride NSC 315851 34841-36-6 Zyban Wellbatrin inhibitors inhibits inhibition reuptake dopamine norepinephrine Voxra Aplenzin Amfebutamone antagonists neuronal acetylcholine nicotinic receptors nAChR antidepressant depression neurosciences Wellbutrin 1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone GlaxoSmithKline Brand 2 of Bupropion Hydrochloride GlaxoSmithKline Brand 1 of Bupropion Hydrochloride Glaxo Wellcome Brand 3 of Bupropion Hydrochloride Glaxo Wellcome Brand 2 of Bupropion Hydrochloride Glaxo Wellcome Brand 1 of Bupropion Hydrochloride Esteve Brand of Bupropion Hydrochloride Bupropion Hydrochloride Bupropion Hydrochloride Zyban (Anti-Smoking) Amfebutamone Wellbutrin Bupropion Bupropion Zyntabac Quomen Isomer 24.251151406400
70090 BW 723C86 160521-72-2 >98% 22.502430939226 bw-723c86 bw-723c86 bw723-c86 5-ht2b agonist anxiolytic serotonin 5-hydroxy-tryptamine 5-OH-tryptamine bw723c86 receptors selective endocrinology neurochemistry neuroscience 22.502430939226
10011437 CaMKII Monoclonal Antibody (Clone 6G9) - 2008-05-20 20.143646408839 camkii-monoclonal-antibody-clone-6g9 Calcium/Calmodulin-dependent Protein Kinase II calcium calmodulin signalling signaling WB IHC IP EIA IF western blots immunohistochemistry immunoprecipitation immunofluorescence antibodies antiserum kinases neurochemistry enzyme immunoassays immunoblotting PPI PKA blotting 20.143646408839
10011438 CaMKII (Phospho-Thr286/Thr287) Monoclonal Antibody (Clone 22B1) - 2008-05-20 20.143646408839 camkii-phospho-thr286-thr287-monoclonal-antibody-clone-22b1 Calcium/Calmodulin-dependent Protein Kinase II calcium calmodulin signalling signaling WB IHC IP EIA IF western blots immunohistochemistry immunoprecipitation immunofluorescence antibodies antiserum kinases neurochemistry immunoblotting enzyme immunoassays PPI PKa blotting 20.143646408839
10489 Candesartan cilexetil 145040-37-5 ≥98% 2011-04-08 7.204143646409 candesartan-cilexetil TCV-116 angiotensin II receptors antagonists hypertension diabetes AT1 type 1 stress diastolic blood pressure anti-hypertensive antihypertensive 7.204143646409
90080 Cannabidiol 13956-29-1 >99% 26.647332280978 cannabidiol CBD delta9-THC .DELTA.9-THC delta9THC .DELTA.9THC marijuana neuroprotective tetrahydrocannabidiol d9-THC d9THC neurochemistry neuroscience synthetic cbs cannabinoids 26.647332280978
13285 Cannabidiol dimethyl ether 1242-67-7 ≥98% 2009-05-19 12.557320441989 cannabidiol-dimethyl-ether Cannabidiol-2',6'-dimethyl ether; CBDD 15-lipoxygenases 15-LOs dioxygenase fatty acids inflammation thrombosis cancer LDL oxidation inhibitions inhibition inhibiting cannabinoids cbs synthetic 12.557320441989
90081 Cannabidiol (solution) 13956-29-1 ≥99% 2011-03-03 33.602882973380 cannabidiol-solution CBD delta9-THC .DELTA.9-THC delta9THC .DELTA.9THC marijuana neuroprotective tetrahydrocannabidiol d9-THC d9THC neurochemistry neuroscience synthetic cbs cannabinoids 33.602882973380
92350 Capsaicin 404-86-4 >95% 2004-04-01 7.223272127169 capsaicin Capsicum peppers VR1 vanilloid receptors pain heat hot extracts nociceptive burning neurochemistry neuroscience lipid-soluble extracts calcium ca+ ion channels pathways desensitization non-myelinatedpolymomdal c-type nerve fibers 7.223272127169
10010743 Capsaicin (technical grade) 404-86-4 >60% 2007-11-27 5.491588397789 capsaicin-technical-grade Capsicum peppers VR1 vanilloid receptors pain heat hot extracts nociceptive burning neurochemistry neuroscience lipid-soluble extracts calcium ca+ ion channels pathways desensitization non-myelinatedpolymomdal c-type nerve fibers 5.491588397789
10007518 Capsazepine 138977-28-3 >98% 2006-03-29 10.181482504603 capsazepine vanilloid receptors 1 VR1 transient potential TRP endogenous stimuli tissues injury inflammation pain antagonists capsaicin Ca2+ neonatal rats dorsal root ganglias Chinese hamsters ovary ovaries cells 10.181482504603
13702 Cav1.2 Calcium Channel Monoclonal Antibody (Clone S57-46) - 2009-11-05 1.922651933701 cav1-2-calcium-channel-monoclonal-antibody-clone-s57-46 antibodies western blotting blots immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC channels ions fusion proteins gated voltage-gated ligand-gated voltage ligand 1.922651933701
13703 Cav1.3 Calcium Channel Monoclonal Antibody (Clone S38-8) - 2009-11-05 0.640883977900 cav1-3-calcium-channel-monoclonal-antibody-clone-s38-8 antibodies channels ions fusion proteins CACNAID western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC gated voltage-gated ligand-gated voltage ligand 0.640883977900
13706 Cav1.3 Calcium Channel Monoclonal Antibody (Clone S48A-9) - 2009-11-12 0.640883977900 cav1-3-calcium-channel-monoclonal-antibody-clone-s48a-9 antibodies channels ions fusion proteins CACNAID western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC gated voltage-gated ligand-gated voltage ligand 0.640883977900
13704 Cav3.2 Calcium Channel Monoclonal Antibody (Clone S55-10) - 2009-11-12 1.922651933701 cav3-2-calcium-channel-monoclonal-antibody-clone-s55-10 antibodies CACNA1H genes epilepsy up-regulations up regulations upregulations prostate cancers androgen-independent androgen independent western blotting blots WB fusion protein immunohistochemistry IHC immunocytochemistry ICC 1.922651933701
13701 Cavβ4 Calcium Channel Monoclonal Antibody (Clone S10-7) - 2009-11-05 0.640883977900 cav-4-calcium-channel-monoclonal-antibody-clone-s10-7 western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels antibodies epilepsy IGE JME subunits gated voltage-gated ligand-gated ligand voltage 0.640883977900
71652 CAY10401 288862-89-5 >98% 2005-02-02 8.948825046040 cay10401 FAAH inhibitors analgesics fatty acids amides hydrolases inhibits inhibition hydrolysis hydrolyze CAY-10401 inactivation anandamides AEA arachidonoyl ethanolamides neuroscience neurochemistry cannabinoids cbs synthetic 8.948825046040
72620 CAY10412 Exclusive 390824-17-6 >98% 12.422866022099 cay10412 endocannabinoids neurotransmitters ligands lipids CB1 CB2 receptors AEA fatty acids neurochemistry neuroscience cannabinoids inhibitors 12.422866022099
10004259 CAY10429 22972-55-0 >98% 2005-02-09 24.387769964841 cay10429 Abnormal Cannabidiol; Abn-CBD endocannabinoids cannabidiols abnormal abn-cbd non-CB1 non-CB2 receptors agonists BV-2 microglials hypotensives GPCR neurochemistry neuroscience 24.387769964841
10009523 CAY10429-d3 - ≥99% deuterated product 2007-10-02 1.414364640884 cay10429-d3 Abnormal Cannabidiol-d3; Abn-CBD-d3 endocannabinoids cannabidiols abnormal abn-cbd non-CB1 non-CB2 receptors agonists BV-2 microglials hypotensives GPCR neurochemistry neurosciences cannabindoids CB1 CB2 deuterated deuterium mass spectrometry LC-MS GC-MS AbnCBD LC/MS GC/MS cannabinoids cbs synthetic 1.414364640884
10005102 CAY10435 288862-73-7 >98% 2004-07-06 8.888496009822 cay10435 fatty acid amide inhibitors FAAH hydrolases inhibition inhibits hydrolysis hydrolyze CAY-10435 1-(Oxazolo[4,5-b]pyridin-2-yl)-1-oxo-dodecane neurochemistry neuroscience 8.888496009822
10005186 CAY10441 Exclusive 221529-58-4 >98% 2004-09-16 119.233397790055 cay10441 RO1138452 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma cyclic AMP cAMP adenylate cyclase 4,5-dihydro-1H-imidazol-2-yl-4-4-isopropoxy benzyl phenylamine atherosclerosis 119.233397790055
10005633 CAY10448 - >98% 2004-10-01 4.013453038673 cay10448 capsaicin capsicum vanilloids receptors antagonists cannabinoids analgesia anandamides analgesic vanillylamines amides analogs transient potential VR1 pain TRPV1 neurochemistry neuroscience 4.013453038673
10005913 CAY10449 Exclusive - >98% 2004-10-26 93.114659300184 cay10449 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma adenylate cyclase cyclic AMP cAMP iloprost athersclerosis CAY 10449 93.114659300184
10005072 CAY10455 290374-09-3 >98% 2004-11-09 5.969205801104 cay10455 SKM 4-45-1 anandamides AEAs neurons fatty acid amide hydrolase FAAH analogs arachidonyl ethanolamides transporters acyl fluorescent fluorescence substrates cellular trafficking neurochemistry neuroscience 5.969205801104
10007955 CAY10498 863202-33-9 >98% 2006-08-02 31.301583793738 cay10498 2-phenyl-amino-N6-endo-norbornyladenine adenosine receptor antagonist A1 A2A A2B A3 AR G-protein stroke inflammation glaucoma neurodegenerative disease reversine dedifferentiation neurochemistry ophthalmology 31.301583793738
10008669 CAY10508 878533-35-8 >98% 2006-08-04 27.353314917127 cay10508 1,3-bis(4-bromophenyl)-5-phenyl-Imidazolidine-2,4-dione central peripheral cannabinoids receptors inverse agonists antagonists therapeutic therapy obesity drug dependence CB1 CB2 CP-55,940 cannabinoids cbs synthetic 27.353314917127
10010740 CAY10550 34320-83-7 ≥98% 2008-07-14 5.031674723756 cay10550 3-(4-Nitrophenyl)-1-phenyl-2-pyrazolin-5-one prion PrPc PrPsc PrPres mad cow disease scrapie creutzfeldt-jakob disease spongigorm encephalopathy radical scavenger inhibitors inhibits inhibition 5.031674723756
10012565 CAY10568 22913-17-3 ≥98% 2008-05-28 4.645377532228 cay10568 Santinamide TRPV1 QX314 cationic lidocaine capsaicin pain ion channel anesthetics analgesia nociception CAY10568 4.645377532228
10010032 CAY10570 Exclusive 875014-22-5 >98% 2008-06-03 16.145870165746 cay10570 FAAH fatty acids amides AEA anandamides CB1 inhibitors inhibits inhibition endocannabinoids hydrolases cannabinoids 16.145870165746
13281 CAY10598 Exclusive 346673-06-1 ≥98% 2010-05-07 73.670928176795 cay10598 Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection 73.670928176795
13358 CAY10608 Exclusive 457897-92-6 ≥98% 2010-04-29 0.652624309392 cay10608 N-Methyl-D-aspartate NMDA receptors antagonists glutamate glycine propanolamine NR2B subunit AMPA kainate neuroprotection neurochemistry antagonizes potently selectively non-competitively 0.652624309392
10743 CAY10650 Exclusive 1233706-88-1 ≥98% 2011-06-14 23.657458563536 cay10650 cPLA2α cPLA2 inhibitors inflammation anti-inflammatory dermatitis metabolite phospholipase cytosolic prostaglandins PGs leukotrienes synthesis 10662 CAY-10650 CAY10641 CAY-10641 23.657458563536
10820 CAY10651 Exclusive - ≥98% 2011-06-15 0.911602209945 cay10651 Glutamate neurotransmitters receptors mGlu5 pain anxiety antagonists gastresophageal reflux diseases dyskinesia fragile X syndromes drug addictions cortical astrocytes functional binding assays mobilization calcium CNS 0.911602209945
10010398 CB-13 432047-72-8 ≥98% 2009-06-30 30.332404939876 cb-13 CRA-13 cannabinoids CB1 CB2 central peripheral receptors agonists pains hyperalgesia blocks blocking CB13 CB 13 CRA13 CRA 13 30.332404939876
10006590 CB1 Receptor (C-Term) Polyclonal Antibody - 2005-05-10 58.365460405156 cb1-receptor-c-term-polyclonal-antibody Cannabinoid Receptor 1 cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC western blots blotting antisera antiserum WB IHC immunohistochemistry neuroscience neurochemistry endocrinology immunoblotting cannabinoids cbs synthetic 58.365460405156
101500 CB1 Receptor Polyclonal Antibody - 31.096256906077 cb1-receptor-polyclonal-antibody Cannabinoid Receptor 1 Polyclonal Antibody cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC western blots blotting antisera antiserum WB neuroscience neurochemistry endocrinology immunoblotting 31.096256906077
10010116 CB-25 Exclusive 869376-63-6 >98% 2007-10-25 16.706774861878 cb-25 cannabinoids ligands receptors CB1 CB2 THC anandamides AEA inverse agonists cannabinoids cbs synthetic 16.706774861878
101550 CB2 Receptor Polyclonal Antibody - 50.664741336012 cb2-receptor-polyclonal-antibody Cannabinoid Receptor 2 cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC antisera antiserum western blots blotting WB neuroscience neurochemistry endocrinology immunoblotting IHC immunohistochemistry 50.664741336012
10010712 CB2 Receptor Polyclonal FITC Antibody - 2008-01-15 33.902596685083 cb2-receptor-polyclonal-fitc-antibody Cannabinoid Receptor 2 cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC antisera antiserum western blots blotting WB neuroscience neurochemistry GPCRs FC flow cytometry immunoblotting IF immunofluorescence 33.902596685083
10010117 CB-52 Exclusive 869376-90-9 ≥98% 2007-10-25 16.798142265193 cb-52 cannabinoids ligands receptors CB1 CB2 THCs anandamides AEAs partial agonists neutral antagonists cannabinoids cbs synthetic 16.798142265193
13289 CB-86 Exclusive 1150586-64-3 ≥98% 2010-05-03 17.649021310181 cb-86 cannabinoids receptors CB1 CB2 antinociception agonists resorcinol anandamides hybrids CB86 CB 86 partial agonist neural antagonist antinociceptive effects 2-beta-D-Ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione 6-Azauridine 6 Azauridine Azauridine cannabinoids cbs synthetic 17.649021310181
589101 CGRP (human) EIA Kit - 279.802209944751 cgrp-human-eia-kit Calcitonin Gene-Related Peptide (human) EIA Kit; CGRP (human) ELISA Kit calcitonin peptides measures kits eias enzyme immunoassays ELISAs spi-bio neurochemistry neuroscience spibio A05481 endocrinology assays 279.802209944751
589001 CGRP (rat) EIA Kit - 400.126519337016 cgrp-rat-eia-kit Calcitonin Gene-Related Peptide (rat) EIA Kit; CGRP (rat) ELISA Kit calcitonin peptides measures kits eias enzyme immunoassays ELISAs spi-bio neurochemistry neuroscience spibio A05482 endocrinology assays 400.126519337016
700610 Chloride Colorimetric Assay Kit New - 2011-11-18 99.084969590039 chloride-colorimetric-assay-kit chlorides Cl assays kits measures measurements plasma serums urine saliva cells cultures lysates Hg2+ Fe2+ mercury iron mercury-thiocyanate Hg-thiocyanate thiocyanates mercuric mineral humans anions hydration osmotic pressure cation-anion balance vascular intestinal fluids compartments hypochloremia hyperchloremia vomiting renal diseases metabolic acidosis burns dehydration diarrhea congestive heart failure hyperventilation kidneys Lightwood syndromes parathyroid glands pathological ions channels Cystic Fibrosis myotonia congenita Barter's Syndrome 2002 bestrophins proteins hbest1 retinal progressive vision loss vitelliform macular dystrophy Best 99.084969590039
10011126 Clobenpropit (hydrobromide) 145231-35-2 >98% 2008-12-04 6.820027624309 clobenpropit-hydrobromide Carbamimidothioic Acid; VUF-9153 histamines receptors antagonist GABA neurons brains seizures 6.820027624309
580110 Clusterin (human) EIA Kit - 2011-08-02 2.154696132597 clusterin-human-eia-kit KUB-1; CLI; SGP-2; AAG4; pADHC-9; TRPM-2; Apo-J; Apolipoprotein J apolipoproteins Up-regulated in Azheimer's diseases brains Ku70-binding proteins 1 sulfated glycoproteins 2 aging-associated genes 4 complement lysis inhibitors testosterone-repressed prostate messages secreted disulfide-linked heterodimeric amyloid lipids bacteria leptin immunoglobulins endocytic receptors LDLs low-density lipoprotein-related LPR2 LPR8 8 endocytosis tissues mammals mammalian cells plasma serums semen cultures media medium developmental remodeling apoptotic neurodegeneration injury stress inhibits inhibition apoptosis carcinogenesis genes CLU ELISAs EIAs enzymes immunoassays kits measures measurements human supernatants 2.154696132597
10910 (+)-CP 47,497 134308-14-8 ≥98% 2011-05-05 13.627848173453 -cp-47-497 cannabinoid analgesia analgesic CB1 hypothermia motor depressant anticonvulsant Δ9-THC CBs analogs cbs synthetic cannabinoids 13.627848173453
10913 (±)-CP 47,497 70434-82-1 ≥98% 2011-05-05 29.260334883041 -cp-47-497 receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic 16851 29.260334883041
10908 (±)-CP 47,497-C8-homolog Exclusive 70434-92-3 ≥98% 2011-05-06 33.211843073581 -cp-47-497-c8-homolog CAY10596; Cannabicyclohexanol cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic 33.211843073581
10686 (±)-CP 47,497-C8-homolog-d7 (solution) Exclusive - ≥99% deuterated forms (d1-d7) 2011-03-14 21.771818898971 -cp-47-497-c8-homolog-d7-solution Cannabicyclohexanol-d7 cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS GC LC standards stds 10914 21.771818898971
13216 (±)-CP 47,497-C8-homolog (solution) Exclusive 70434-92-3 ≥98% 2009-04-23 43.502412536909 -cp-47-497-c8-homolog-solution CAY10596; Cannabicyclohexanol cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic 10908 43.502412536909
10687 (±)-CP 47,497-d11 (solution) Exclusive - ≥99% deuterated forms (d1-d11) 2011-02-16 23.337757971923 -cp-47-497-d11-solution receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 10907 23.337757971923
13219 (+)-CP 47,497 (solution) 134308-14-8 ≥98% 2009-04-13 17.680171898900 -cp-47-497-solution cannabinoid analgesia analgesic CB1 hypothermia motor depressant anticonvulsant Δ9-THC CBs analogs cbs synthetic cannabinoids 10910 17.680171898900
16851 (±)-CP 47,497 (solution) 70434-82-1 ≥98% 2008-12-10 40.643750448281 -cp-47-497-solution receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic 10913 40.643750448281
90084 (−)-CP 55,940 83002-04-4 ≥98% 2007-01-15 30.013067923302 -cp-55-940 CP 55940 CP-55940 CP-55,940 agonists cannabinoids CB1 CB2 THC receptors endocrinology cp55940 cp55,940 neurochemistry cbs synthetic 30.013067923302
13241 (±)-CP 55,940 Exclusive 83003-12-7 ≥98% 2009-05-20 24.597446286065 -cp-55-940 cannabinoids analgetic pain THC thermal mechanical chemicals receptors CB1 cannabimimetic potent non-selective CP55940 CP-55940 cbs synthetic 24.597446286065
10011388 Cu/Zn SOD (human) Polyclonal Antibody - 23 kDa 2008-04-03 147.019160220994 cu-zn-sod-human-polyclonal-antibody SOD1; Cu/Zn Superoxide Dimutase SOD1 SOD2 SOD3 EC-SOD oxidative stress ROS superoxide antibodies antiserum WB western blots immunoblotting IP EIA IHC immunohistochemistry neurochemistry immunoprecipitation enzyme immunoassays neurochemistry blotting 147.019160220994
581001 Cyclic AMP EIA Kit - 717.950782093348 cyclic-amp-eia-kit Adenosine 3',5'-cyclic monophosphate EIA Kit; cAMP EIA Kit; Adenosine 3',5'-cyclic mononucleotide EIA Kit; Cyclic AMP ELISA Kit solid plates cAMP adenosine measures kits eias enzyme immunoassays ELISAs second messengers neurochemistry neuroscience endocrinology assays 717.950782093348
581002 Cyclic AMP EIA Kit (without Acetic Anhydride) - 575.332361878453 cyclic-amp-eia-kit-without-acetic-anhydride cAMP EIA Kit (without Acetic Anhydride); Adenosine 3',5'-cyclic monophosphate EIA Kit (without Acetic Anhydride); Adenosine 3',5'-cyclic mononucleotide EIA Kit (without Acetic Anhydride); Cyclic AMP ELISA Kit (without Acetic Anhydride) solid plates cAMP adenosine measures kits eias enzyme immunoassays ELISAs second messengers neurochemistry neuroscience endocrinology assays 575.332361878453
581021 Cyclic GMP EIA Kit - 839.255819134486 cyclic-gmp-eia-kit Guanosine 3',5'-cyclic mononucleotide EIA Kit; Cyclic GMP ELISA Kit; cGMP EIA Kit; Guanosine 3',5'-cyclic monophosphate EIA Kit solid plates cGMP guanosine measures kits eias enzyme immunoassays ELISAs second messengers neurochemistry neuroscience endocrinology assays 839.255819134486
581022 Cyclic GMP EIA Kit (without Acetic Anhydride) - 450.207665745856 cyclic-gmp-eia-kit-without-acetic-anhydride Cyclic GMP ELISA Kit (without Acetic Anhydride); Guanosine 3',5'-cyclic monophosphate EIA Kit (without Acetic Anhydride); Guanosine 3',5'-cyclic mononucleotide EIA Kit (without Acetic Anhydride); cGMP EIA Kit (without Acetic Anhydride) solid plates cAMP adenosine measures kits eias enzyme immunoassays ELISAs second messengers assays 450.207665745856
13197 DAPT 208255-80-5 ≥95% 2010-09-16 16.385745856353 dapt GSI-IX amyloids precursors proteins APP Notch beta amyloid Aβ Alzheimer’s disease inhibitors inhibits inhibition γ-secretase Aβ42 cells signaling signals differentiation GSIIX GSI IX Dipeptides 16.385745856353
10603 DARPP-32 (Phospho-Thr34) Polyclonal Antibody - 2009-10-22 0.386740331491 darpp-32-phospho-thr34-polyclonal-antibody gamma inhibits inhibitors neurotransmitters WB western blots blotting receptors dopamine cAMP inhibition immunoblotting DARPs DARP32 DARP 32 0.386740331491
90349 Decanoyl m-Nitroaniline Exclusive 72298-61-4 ≥98% 8.488437253354 decanoyl-m-nitroaniline DemNA FAAH substrates anandamides hydrolases colorimetric cannabinoids aea meta-nitroanilines fatty acids anandamide nitroanilines nitroanalines arachidonoyl ethanolamides ethanolamines neurochemistry neuroscience 8.488437253354
10007903 D-erythro-Sphingosine C-20 6918-49-6 ≥98% 2008-11-21 5.515801104972 d-erythro-sphingosine-c-20 sphingosines sphingolipids ceramides C-18 C18 C20 gangliosides brain development neurodegenerations 5.515801104972
10010575 Desmethyltrimebutine-d3 (hydrochloride) - ≥99% deuterated product 2008-04-14 0E-12 desmethyltrimebutine-d3-hydrochloride timebutine anesthetic SPI disorders spasmolytic gastrointestinal neurochemistry 0E-12
90235 Dihomo-γ-Linolenoyl Ethanolamide 150314-34-4 >98% 6.629359766006 dihomo-linolenoyl-ethanolamide endocannabinoids neurotransmitters dihomo-gamma-linolenoyl dihomo-g-linolenoyl dihomo-.gamma.-linolenoyl cannabinergic fatty acids neurochemistry neuroscience ethanolamines ethanolamides cannabinoids cbs synthetic 6.629359766006
92355 Dihydrocapsaicin 19408-84-5 ≥98% 4.867442778215 dihydrocapsaicin capsicum peppers VR1 receptors non-myelinated polymodal C-type nociceptive nerve fibers calcium ion channels pain pathways CA2+ vanilloid heat-activated neurochemistry hot extracts burning neuroscience lipid-souble desensitization patyways 4.867442778215
9000556 Dimebolin Exclusive 3613-73-8 ≥98% 2010-01-12 12.592592592592 dimebolin Dimebon™ neurodegeneration Alzheimer's diseases Huntington's neuroprotection cognition inhibitors inhibition β-amyloid calcium channels NMDA glutamate receptors mitochondria dimebone dimeboline preparation 84 Dimebolin 12687-54-6 20684-30-4 inhibited Indoles 12.592592592592
10011349 Dimebolin (hydrochloride) 97657-92-6 ≥98% 2010-02-19 10.793650793650 dimebolin-hydrochloride neurodegeneration Alzheimer's diseases Huntington's neuroprotection cognition inhibitors inhibits inhibition calcium channles β-amyloid β amyloid NMDA glutamate receptors mitochondria dimeboline dimebon neurochemistry neuroscience Indoles 10.793650793650
90310 Docosahexaenoic Acid 6217-54-5 ≥98% 78.465020257826 docosahexaenoic-acid DHA; Cervonic Acid polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 neurochemistry c22:6 22:6 78.465020257826
10005057 Docosahexaenoic Acid-d5 - ≥99% deuterated product 2005-03-16 202.916675874770 docosahexaenoic-acid-d5 DHA-d5; Cervonic Acid-d5 standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 retinol neuronal membranes neonatal deprivation hypertension 202.916675874770
10006865 Docosahexaenoic Acid methyl ester 2566-90-7 ≥98% 2005-09-06 77.203351749540 docosahexaenoic-acid-methyl-ester Cervonic Acid methyl ester; DHA methyl ester polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 esters diets dietary supplements hypertension neonatal photoreceptor degeneration retinitis pigmentosa depiration neural tissues retina 77.203351749540
10006829 Docosahexaenoic Acid Quant-PAK - 2005-08-08 45.867513812154 docosahexaenoic-acid-quant-pak DHA Quant-PAK; Cervonic Acid Quant-PAK Quant-PAKs polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated retinol neuronal membranes neonatal deprivation hypertension neurochemistry packs 45.867513812154
10007534 Docosahexaenoyl Ethanolamide Exclusive 162758-94-3 ≥98% 2006-02-17 22.962016574585 docosahexaenoyl-ethanolamide DHEA; DEA neurochemistry neuroscience endocannabinoids brain retina docosahexaenoic acids DHA fatty w-3 .omega.-3 neural tissues ethanolamines ethanolamides arachidonoyl AEA lipids extracts piglets diets rats CB1 receptors shaker-related voltage-gated potassium channels cannabinoids cbs synthetic DEA 22.962016574585
9000328 Docosahexaenoyl Glycine Exclusive 132850-40-9 ≥98% 2009-01-28 15.670000000000 docosahexaenoyl-glycine polunsaturated fatty acids PUFAs docosahexaenoic DHA glycines fish oils ALA brain retina neuron neuronal membrane ω-3 α-linolenic 15.670000000000
10005823 Docosanoyl Ethanolamide Exclusive 94109-05-4 ≥98% 2006-01-11 13.245211786371 docosanoyl-ethanolamide neurochemistry neuroscience N-acylethanolamides cannabinoids central CB1 peripheral CB2 non-CB receptor-mediated pharmacology memory weight loss appetite neurodegeneration tumor surveillance analgesia inflammation saturated ion channels ethanolamines cbs synthetic 13.245211786371
90385 Docosatetraenoyl Ethanolamide 150314-35-5 ≥98% 7.288651283718 docosatetraenoyl-ethanolamide DEA endocannabinoids neurotransmitters ethanolamides docosatetraenoic acid fatty acids neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic 7.288651283718
13245 Donepezil 120014-06-4 ≥95% 2010-03-08 3.829033149171 donepezil Aricept® acetylcholine neurotransmitters acetylcholinesterase inhibitors inhibits inhibition central nervous system Alzheimer's diseases cognition memory dementia Donezepil signaling signalling AchE CNS behavior (±)-E 2020 (+/-)-E 2020 E2020 3.829033149171
10009372 Dopamine Transporter (C-Term) Polyclonal Antibody - 2006-11-13 0E-12 dopamine-transporter-c-term-polyclonal-antibody DAT antibodies proteins diseases antibodies antisera antiserum IHC immunohistochemistry WB western blots blotting c-terminal keyhole limpet hemocyanin KLH accumulation catecholamine biosynthesis markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's dieseases drug abuse chronic administration immunoblotting 0E-12
10009373 Dopamine Transporter (Extracellular Loop 2) Polyclonal Antibody - 2006-11-13 0E-12 dopamine-transporter-extracellular-loop-2-polyclonal-antibody DAT (Extracellular Loop 2) antibodies proteins diseases antibodies antisera antiserum IHC immunohistochemistry WB western blots blotting c-terminal keyhole limpet hemocyanin KLH accumulation catecholamine biosynthesis markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's dieseases drug abuse chronic administration immunoblotting 0E-12
10009370 Dopamine β-hydroxylase (C-Term; human) Polyclonal Antibody - 2006-11-13 0E-12 dopamine-hydroxylase-c-term-human-polyclonal-antibody DBH antibodies proteins diseases antibodies antisera antiserum WB western blots blotting beta-hydroxylase neurons dopaminergic noradrenergic catecholamine biosynthesis markers depression schizophrenia parkinson's diseases drugs abuse immunoblotting 0E-12
10009371 Dopamine β-hydroxylase (N-Term; human) Polyclonal Antibody - 2006-11-13 0E-12 dopamine-hydroxylase-n-term-human-polyclonal-antibody DBH antibodies proteins diseases antibodies antisera antiserum WB western blots blotting beta-hydroxylase neurons dopaminergic noradrenergic catecholamine biosynthesis markers depression schizophrenia parkinson's diseases drugs abuse immunoblotting 0E-12
10005516 Doppel Blocking Peptide - 2004-10-01 1.075414364641 doppel-blocking-peptide antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides proteins diseases GPI glycosylphosphatidylinositol central nervous system male fertility sertoli CNS spermatozoa nonglycosylated oligosaccharides 1.075414364641
10005517 Doppel Polyclonal Antibody - 2004-09-24 6.339686924493 doppel-polyclonal-antibody proteins diseases antibodies antisera antiserum GPI glycosylphosphatidylinositol central nervous system male fertility sertoli CNS spermatozoa nonglycosylated oligosaccharides WB western blots blotting IHC immunohistochemistry immunoblotting 6.339686924493
10009785 Dynamin (Phospho-Ser774) Polyclonal Antibody - 2007-05-24 1.740331491713 dynamin-phospho-ser774-polyclonal-antibody phosphopeptide phospho-specific western blots WB antibodies proteins blotting dephosphins phosphorylation synaptic vesicle endocytosis protein kinase 5 immunoblotting 1.740331491713
10009786 Dynamin (Phospho-Ser778) Polyclonal Antibody - 2007-05-24 1.740331491713 dynamin-phospho-ser778-polyclonal-antibody phosphopeptide phospho-specific western blots WB antibodies proteins blotting dephosphins phosphorylation synaptic vesicle endocytosis protein kinase 5 immunoblotting 1.740331491713
10010571 Entacapone-d10 - ≥98% 2008-04-14 11.600773480663 entacapone-d10 Parkinsons dieseases inhibitors inhibits inhibition SPI nitrocatechols catechol-o-methyl blood-brain barrier neurochemistry 11.600773480663
101740 EP1 Receptor Polyclonal Antibody - 38.272182320441 ep1-receptor-polyclonal-antibody Prostaglandin E2 Receptor 1; PGE2 Receptor 1 PGE2 prostaglandins receptors antibodies antisera antiserum western blots blotting wb icc immunocytochemistry neurochemistry immunoblotting 38.272182320441
101760 EP3 Receptor Polyclonal Antibody - 33.555447513811 ep3-receptor-polyclonal-antibody Prostaglandin E2 Receptor 3; PGE2 Receptor 3 PGE2 prostaglandins receptors antibodies antisera antiserum western blots blotting wb C-terminus WB ICC immunocytochemistry neurochemistry immunoblotting 33.555447513811
10919 (±)-epi CP 47, 497 - ≥98% 2011-05-05 13.604473642789 -epi-cp-47-497 3-trans CP 47,497 (±)-trans-CP 47,497 cannabinoids analogs receptors CB1 standards (±)-CP47,497 analgesic potency epimer THC .delta.-THC (±)-iso Δ-tetrahydrocannabidiol CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 13801 13.604473642789
13801 (±)-epi CP 47,497 (solution) Exclusive - ≥98% 2010-08-04 11.620194114805 -epi-cp-47-497-solution 3-trans CP 47,497 (±)-trans-CP 47,497 cannabinoids analogs receptors CB1 standards (±)-CP47,497 analgesic potency epimer THC .delta.-THC (±)-iso Δ-tetrahydrocannabidiol CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 10919 11.620194114805
11241 Ethcathinone (hydrochloride) New 51553-17-4 ≥98% 2012-01-18 139.642585869217 ethcathinone-hydrochloride RMI 8201A; N-Ethylcathinone 71276-46-5 forensics phenethylamines cathinones designer drugs psychoactive recreational hydrochloride HCl amphetamines rats capsules tablets research N-monoethylcathinone RMI8201A RMI-8201A 139.642585869217
10012088 Ethyl-L-NIO (hydrochloride) 150403-97-7 ≥95% 2008-08-14 6.846657458563 ethyl-l-nio-hydrochloride L-N5-(1-Iminobutyl)ornithine hydrochloride nitric oxide synthase NOS iNOs nNOS selective inhibitors inhibits inhibition 6.846657458563
10007433 FABP5 (mouse recombinant) - >95% 2005-07-29 6.411692616775 fabp5-mouse-recombinant Epidermal-FABP; Fatty Acid Binding Protein 5; E-FABP protein-only proteins cytosolic acids lipophilic ligands uptake metabolism cellular membranes intracellular trafficking modulation enzymes lipids metabolic pathways cells growth differentiation antiparallel B .beta. strands barrel prostates bladder carcinomas atherosclerosis endocrinology neurochemistry 6.411692616775
301600 Fatty Acid Amide Hydrolase Blocking Peptide - 17.851381215469 fatty-acid-amide-hydrolase-blocking-peptide Oleamide Hydrolase; FAAH; Anandamide Amidohydrolase hydrolases peptides hydrolysis controls acids amides WB western blots blotting IHC immunohistochemistry immunoblotting antibodies neurochemistry neuroscience 17.851381215469
10010183 Fatty Acid Amide Hydrolase (human recombinant) - Whole-cell lysate 2008-11-05 29.586385161799 fatty-acid-amide-hydrolase-human-recombinant FAAH (human recombinant) FAAHs endocannabinoid AEA cannabinoids 2-AG 2AG proteins FAAH-1 acids amides hydrolases 29.586385161799
101600 Fatty Acid Amide Hydrolase Polyclonal Antibody - 24.641400947119 fatty-acid-amide-hydrolase-polyclonal-antibody Oleamide Hydrolase; FAAH; Anandamide Amidohydrolase WB western blots hydrolases antibodies antiserum antisera hydrolysis immunohistochemistry IHC immunoblotting neurochemistry neuroscience blotting 24.641400947119
10010182 Fatty Acid Amide Hydrolase Western Ready Control - 66 kDa (His-tagged), 63 kDa (native) 2007-07-06 5.770911602210 fatty-acid-amide-hydrolase-western-ready-control Oleamide Hydrolase; FAAH; Anandamide Aminohydrolase fatty acid amides sleep nociception cancers liver brain testes uterus small intestine ocular tissues western blots blotting WB inhibitors 5.770911602210
10004236 Fluprostenol serinol amide - ≥98% 2004-09-23 25.495878453039 fluprostenol-serinol-amide Flu-SA PGF2.alpha. PGF2alpha analogs agonists prostaglandins receptors amides cannabinoids CB1 CBs synthetic 25.495878453039
70250 (±)-Flurbiprofen 5104-49-4 ≥99% 83.073017188458 -flurbiprofen Ansaid cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases neurochemistry synthase-1 synthase-2 inhibits 51543-38-5 83.073017188458
10600 GABAA Receptor δ-subunit (N-Term) Polyclonal Antibody - 2009-10-22 0.386740331491 gabaa-receptor-subunit-n-term-polyclonal-antibody γ-Aminobutyric Acid A Receptor gamma inhibits inhibitors neurotransmitters WB western blots blotting IP IHC immunoprecipitation immunohistochemistry 0.386740331491
10008346 Gabapentin 60142-96-3 ≥98% 2006-04-20 25.639433701658 gabapentin Neurontin® antiepileptic drugs Gamma-aminobutyric acids GABA neurotransmitters receptors spinal cord analogs anticonvulsants analgeics neuropathics pain syndromes Complex Regional types CRPS1 multiple sclerosis dysesthesias cancers HIV infections CNS central nervous systems calcium channels .gamma.-aminobutyric g-aminobutyric neurochemistry 25.639433701658
10009400 Gap-43 (Phospho-Ser41) Polyclonal Antibody - 2006-12-18 1.160220994475 gap-43-phospho-ser41-polyclonal-antibody GAP43 development and plasticity neuronal growth cones axonal regeneration knockout animals amplify path finding signals mediate actin phosphorylation kinases C PKC modulates neurotransmitters LTP antibodies antisera antiserum WB western blots IHC immunohistochemistry frozen sections blotting proteins diseases phospho-specific immunoblotting 1.160220994475
10566 Garcinol New 78824-30-3 ≥95% 2011-10-25 11.209988941663 garcinol Camboginol inhibits inhibitors inhibition histones acetyltransferases HATs p300 PCAF GCN5 neurogenesis stem cells apoptosis cancers antiinflammatory anti-inflammatory inflammation neuroscience genes expressions regulations epigenetics 11.209988941663
10007621 GFAP (human) EIA Kit - 2006-07-11 0E-12 gfap-human-eia-kit Glial Fibrillary Acidic Protein (human) EIA Kit SPI-Bio spibio kits enzyme immunoassays A05188 assays 0E-12
10006306 Ghrelin (human acylated) EIA Kit - 2004-11-10 103.347343462246 ghrelin-human-acylated-eia-kit Ghrelin (human acylated) ELISA Kit spi-bio acylated immunoassays obesity growth hormones homeostasis ligands secretagogue A05106 receptors stomach hypothalmic spi-bio spibio A05106 adipokines endocrinology neurochemistry assays ghrelin assay 103.347343462246
10006307 Ghrelin (rat acylated) EIA Kit - 2004-11-10 156.573650355170 ghrelin-rat-acylated-eia-kit Ghrelin (rat acylated) ELISA Kit spi-bio acylated immunoassays obesity growth hormones homeostasis ligands secretagogue receptors stomach hypothalmic spibio A05117 adipokines endocrinology neurochemistry assays ghrelin assay 156.573650355170
10602 GluR1 (Phospho-Ser831) Polyclonal Antibody - 2009-10-22 0.386740331491 glur1-phospho-ser831-polyclonal-antibody Glutamate Receptor Subunit 1 gamma inhibits inhibitors neurotransmitters WB western blots blotting receptors NMDAR AMPAR kinase immunoblotting 0.386740331491
10601 GluR1 (Phospho-Ser845) Polyclonal Antibody - 2009-10-22 0.386740331491 glur1-phospho-ser845-polyclonal-antibody Glutamate Receptor Subunit 1 gamma inhibits inhibitors neurotransmitters WB western blots immunoblotting receptors NMDA AMPA kinases IHC immunohistochemistry 0.386740331491
10011347 Glycerophospho-N-Arachidonoyl Ethanolamine Exclusive 201738-25-2 ≥97% 2009-03-13 14.693112338857 glycerophospho-n-arachidonoyl-ethanolamine Glycerophospho-Arachidonoyl Ethanolamide; Glycerophosphoanandamide; GP-NArE anandamides arachidonoyl ethanolamide AEA NAE GDE1 cannabinoids neurotransmitters CB1 CB2 glycerophosphodiesterase 1 NAPE N-Acyl Phosphatidylethanolamide cbs synthetic 14.693112338857
10011357 Glycerophospho-N-Oleoyl Ethanolamine Exclusive 201738-24-1 ≥98% 2009-02-20 22.960773480663 glycerophospho-n-oleoyl-ethanolamine cannabinoids neurotransmitter PPARs neurochemistry neuroscience fatty acids amides hydrolase oleoyl ethanolamides methabolism obesity nutrition diet NAPE N-Acyl Phosphatidylethanolamide cannabinoids cbs synthetic 22.960773480663
10009399 Glycine Receptor Polyclonal Antibody - 2006-12-18 0.109122928176 glycine-receptor-polyclonal-antibody GLY inhibits inhibitors inhibition inhibitory transmitter brainstem spinal cord ligand-gated ion channels family LGICs chemical neurotransmission chloride conductance membranes hyperpolarization synapses cytoplasmic proteins gephyrin alcohol synaptic clustering NMDAR subunit antibodies antisera antiserum WB western blots blotting proteins diseases immunoblotting IHC immunohistochemistry 0.109122928176
10224 GPR55 Polyclonal Antibody - 2010-01-19 38.641258879242 gpr55-polyclonal-antibody G Protein-Coupled Receptor 55 proteins receptors antibodies western blots WB ICC signals signaling nucleotides THC amino acids blotting immunoblotting immunocytochemistry signalling cannabinoids cbs synthetic 38.641258879242
10851 Guanabenz (hydrochloride) New - ≥98% 2011-09-30 0.603038674033 guanabenz-hydrochloride Wytensin adrenergic receptors hypertension imidazoline adipose tissues neurosciences cardiovascular diseases agonists 5051-62-7 α2 alpha2 I2 hydrochloride HCl 0.603038674033
10010372 GW 842166X 666260-75-9 ≥98% 2008-05-23 35.737209944751 gw-842166x inflammatory pain arthritis neuropathic hyperalgesia CB2 cannabinoids agonists anandamide receptors neurochemistry cannabinoids cbs synthetic 35.737209944751
13205 Halopemide Exclusive 59831-65-1 ≥98% 2009-04-21 16.019558011050 halopemide R34301; NSC 354856 inhibitors phospholipases D PLD PLD1 PLD2 dopamine receptors inhibits inhibition potent cells DP nueraleptic 16.019558011050
10995 Harmaline New 304-21-2 ≥98% 2011-10-11 1.790779319947 harmaline inhibitors monoamine oxidases MAOI receptor agonists inverse agonists NMDA herbal mixtures forensics bath salts spices plants N-methyl-D-aspartate inhibits inhibition adulterant CBs cannabinoids hallucinogenic tryptamines 1.790779319947
13705 HCN1 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S70-28) - 2009-12-01 0E-12 hcn1-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s70-28 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-1 HCN 1 0E-12
13707 HCN2 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S71-37) - 2009-12-01 0E-12 hcn2-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s71-37 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC ions channels HCN-2 HCN 2 ICC immunocytochemistry immunoprecipitation IP 0E-12
13708 HCN3 Cyclic Neuclotide-gated Channel Monoclonal Antibody (Clone S141-28) - 2009-12-01 0E-12 hcn3-cyclic-neuclotide-gated-channel-monoclonal-antibody-clone-s141-28 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-3 HCN 3 0E-12
13709 HCN4 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S114-10) - 2009-12-02 0E-12 hcn4-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s114-10 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-4 HCN 4 hyperpolarization-activated cation gene family hyperpolarization activated activity activates 0E-12
10011038 Hemopressin - 2009-08-13 32.880710339384 hemopressin peptides antagonist inhibitors inhibits inhibition hypertension binding asoactive vasoactive cannabinoids cbs synthetic 32.880710339384
90342 Heptadecanoyl Ethanolamide - ≥98% 8.626643646409 heptadecanoyl-ethanolamide pea cannabinoids palmitoyl ethanolamides anandamides neurochemistry neuroscience ethanolamines 8.626643646409
90082 HU-210 112830-95-2 >98% 44.104514848065 hu-210 agonists analogs d9-THC marijuana CB1 CB2 receptors cannabinoids HU210 .DELTA.9-THC delta9-THC neuroscience neurochemistry endocrinology cannabinoids cbs synthetic 44.104514848065
90083 HU-210 (solution) 112830-95-2 ≥98% 2011-03-03 26.336929755327 hu-210-solution agonists analogs d9-THC marijuana CB1 CB2 receptors cannabinoids HU210 .DELTA.9-THC delta9-THC neuroscience neurochemistry endocrinology cannabinoids cbs synthetic Tetrahydrocannabinol, Trans-(+-)-Isomer Tetrahydrocannabinol, (6a-trans)-Isomer Tetrahydrocannabinol (6aS-cis)-Isomer Tetrahydrocannabinol (6aR-cis)-Isomer Solvay Brand of Tetrahydrocannabinol Tetrahydrocannabinol Trans-Isomer Tetrahydrocannabinol Trans Isomer delta(9)-Tetrahydrocannabinol delta(1)-Tetrahydrocannabinol 9-ene-Tetrahydrocannabinol 9 ene Tetrahydrocannabinol Tetrahydrocannabinol delta(9)-THC delta(1)-THC Dronabinol Marinol THC 26.336929755327
10006350 HU-211 112924-45-5 ≥98% 2005-03-30 58.790282381829 hu-211 Dexanabinol HU211 endocannabinoids cannabis CB2 pain inflammation NF-kB NF-.kappa.B inhibition antioxidants neurochemistry terpene-based psychomotor DELTA9-THC .DELTA.9-THC D9-THC neuroprotective cannabidiols CB1 inflammatory pharmacology neuroscience neurochemistry 58.790282381829
90086 HU-308 256934-39-1 >98% 2005-03-16 35.176025663875 hu-308 endocannabinoids CB2 pain inflammation G-protein coupled receptors agonists hypotensives analgesics anti-inflammatory phenolic .DELTA.9-THC D9-THC CB1 FAAH fatty acid hydrolases substrates selective neuroscience neurochemistry GPCRs HU308 HU 308 cannabinoids 35.176025663875
10005673 HU-331 137252-25-6 ≥95% 2005-09-09 28.665938203397 hu-331 cannabidiols analogs antiproliferative activity endocannabinoids central CB1 peripheral CB2 non-CB receptor-mediated pharmacology receptors memory weight loss appetite neurodegeneration tumor surveillance analgesia inflammation hydroxylquinone antineoplastic human cancer cells lines inhibits inhibitors inhibition growth Raji Jurkat lymphomas in vitro HT-29 colon carcinomas neuroscience neurochemistry cannabinoids cbs sythetic 28.665938203397
10010669 Hydroxy Bupropion-d9 - ≥99% deuterated product 2009-04-17 11.113259668508 hydroxy-bupropion-d9 aminoketone ketones antideppressant dopamine smoking cessation treatment deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 11.113259668508
70280 (±)-Ibuprofen 15687-27-1 ≥99% 26.545411574306 -ibuprofen Motrin PPAR cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits peroxisome proliferator-activated receptors neurochemistry 26.545411574306
10137 Icilin 36945-98-9 ≥98% 2004-04-27 12.468158379373 icilin AG 3-5 cooling agent cold receptors CMR1 neurons transient receptors potential VR1 vanilloid receptos TRPM8 neurochemistry neuroscience 12.468158379373
10215 IDFP 615250-02-7 ≥98% 2009-03-09 15.622209944751 idfp Isopropyl Dodecylfluorophosphonate CB1 agonist nerve agent serins organophophorus MAGL inhibitors inhibits inhibition FAAH 2-AG 2AG AEA arachidonic acids MGL inhibitors cannabinoids 15.622209944751
70275 IMMA - ≥98% 11.999785144260 imma Indomethacin Morpholinylamide; BML-190 cannabinoids receptors CB2 neuroscience neurochemistry endocrinology 11.999785144260
70270 Indomethacin 53-86-1 ≥99% 30.082153361624 indomethacin Indocin cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin synthases synthase-1 synthase-2 PPARs peroxisome proliferator-activated receptors inhibits neurochemistry 30.082153361624
10005518 IP Receptor (human) Polyclonal Antibody - 2004-10-21 24.633523634131 ip-receptor-human-polyclonal-antibody Prostaglandin I2 Receptor; Prostacyclin Receptor; PGI2 Receptor antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors immunoblotting atherosclerosis 24.633523634131
160070 IP Receptor (mouse) Polyclonal Antibody - 2004-05-25 23.623009208102 ip-receptor-mouse-polyclonal-antibody PGI2 Receptor; Prostacyclin Receptor; Prostaglandin I2 Receptor antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors atherosclerosis neurochemistry immunoblotting 23.623009208102
13325 Iso-Olomoucine 101622-50-8 ≥98% 2011-07-27 2.253867403315 iso-olomoucine cyclin dependent kinases Cdks cells cycles dopamine inhibitors inhibits inhibition inactive controls regulators iso olomoucine transporter diseases neurodegenerative signaling rats dorsal striatal synaptosomes cancers neuroscience 2.253867403315
10008661 JP104 Exclusive - ≥98% 2006-09-05 8.845590155700 jp104 click chemistry probes FAAH fatty acids amides hydrolases inhibits inhibitors inhibition URB598 acyl anandamide AEA esters unsaturated carbamates neurochemistry 8.845590155700
10008660 JP83 887264-44-0 ≥98% 2006-08-30 8.441088397790 jp83 FAAH fatty acids amides hydrolases inhibits inhibitors inhibition URB597 acyl anandamide AEA esters unsaturated carbamates arachidonoyl ethanolamides neurochemistry 8.441088397790
10266 JWH 007 Exclusive 155471-10-6 ≥98% 2011-02-23 39.806735761424 jwh-007 agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy JWHs CBs JWH-007 JWH007 JWH-7 JWH 7 JWH7 39.806735761424
10486 JWH 007-d9 - ≥99% deuterated product 2010-10-11 42.265883416430 jwh-007-d9 agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy deuterateds deuteriums mass spectrometry MS standards JWHs JWH007-d9 JWH-007-d9 cannabinoids cbs synthetic JWH7-d9 JWH 7-d9 JWH-7-d9 42.265883416430
9001058 JWH 011 Exclusive New 155471-13-9 ≥98% 2011-09-06 35.616664171055 jwh-011 JWH 004 1-methylhexyl analog JWH011 JWH-011 JWH11 JWH-11 JWH015 JWH-015 JWH15 JWH-15 JWHs analogs forensics sciences cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices synthetics central peripheral 35.616664171055
10009018 JWH 015 155471-08-2 ≥98% 2006-10-05 71.726170738024 jwh-015 agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-g IFN-.gamma. CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic JWH15 JWH-15 JWH 15 71.726170738024
10660 JWH 015-d7 Exclusive - ≥99% deuterated product 2011-02-21 49.700773480663 jwh-015-d7 agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-γ IFN-gamma CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry deuteriums deuterateds standards JWH15-d7 JWH 15-d7 JWH-15-d7 49.700773480663
10900 JWH 018 209414-07-3 ≥98% 2011-05-05 39.860919038187 jwh-018 cannabinoids CB1 CB2 agonists selective receptors WIN 55212-2 JWH-018 JWH018 cbs synthetic JWH 18 JWH-018 JWH18 JWH-18 13169 39.860919038187
9000844 JWH 018 2-hydroxyindole metabolite Exclusive - ≥98% 2010-10-26 31.132379618776 jwh-018-2-hydroxyindole-metabolite cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated cbs synthetic JWH-018 JWH018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 31.132379618776
10711 JWH 018 2-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product 2011-02-25 24.113084443524 jwh-018-2-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 24.113084443524
9001007 JWH 018 2'-naphthyl-N-(1,1-dimethylpropyl) isomer New - ≥98% 2012-01-13 129.938282085955 jwh-018-2-naphthyl-n-1-1-dimethylpropyl-isomer cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic isomers JWH018 JWH-018 JWH 18 JWH-18 JWH18 JWHs pejntyl chains indoles naphthyl moiety herbal blends central peripheral 129.938282085955
9000851 JWH 018 4-hydroxyindole metabolite Exclusive - ≥98% 2010-09-01 46.814097970685 jwh-018-4-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics JWH-018 JWH018 209414-07-3 JWH018-metabolite JWH 018-metabolite one CBs M-1 M1 smoking mixtures spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 46.814097970685
10712 JWH 018 4-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product 2011-02-25 33.195926243109 jwh-018-4-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 33.195926243109
9000852 JWH 018 5-hydroxyindole metabolite Exclusive - ≥98% 2010-09-01 69.338314927368 jwh-018-5-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBS M-2 M2 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 69.338314927368
10713 JWH 018 5-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product 2011-03-11 27.502696454894 jwh-018-5-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards M-2 M2 JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 27.502696454894
9000853 JWH 018 6-hydroxyindole metabolite Exclusive - ≥98% 2010-09-01 42.598628357426 jwh-018-6-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 42.598628357426
10714 JWH 018 6-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product 2011-03-25 47.737945073679 jwh-018-6-hydroxyindole-metabolite-d9 cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 47.737945073679
10697 JWH 018 6-methoxyindole analog Exclusive - ≥98% 2011-02-15 30.978954958867 jwh-018-6-methoxyindole-analog analogs metabolites cannabinoids receptors agonists CBs JWH-018 JWH018 JWH18 JWH-18 JWH 18 30.978954958867
9000854 JWH 018 7-hydroxyindole metabolite Exclusive - ≥98% 2010-09-01 37.179710050102 jwh-018-7-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite four 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 37.179710050102
10715 JWH 018 7-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated product 2011-07-26 29.253143271526 jwh-018-7-hydroxyindole-metabolite-d9 WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 smoking mixture spices synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 CBs cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic sciences pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 29.253143271526
9000799 JWH 018 adamantyl analog Exclusive - ≥97% 2011-07-18 40.803083811230 jwh-018-adamantyl-analog AB-001 JWH 018 JWH-018 JWHs analogs forensics sciences cannabinoids CBs receptors WIN 55,212-2 CB1 CB2 cannabimimetics 40.803083811230
13824 JWH 018-d9 (solution) - ≥99% deuterated product 2010-06-21 54.097431772776 jwh-018-d9-solution cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cbs synthetic JWH018-d9 JWH-018-d9 JWH-18-d9 JWH 18-d9 JWH18-d9 JWH18d9 10901 54.097431772776
10690 JWH 018 N-(2-methylbutyl) isomer Exclusive - ≥97% 2011-03-16 21.750250279686 jwh-018-n-2-methylbutyl-isomer JWH 073 2-methylbutyl homolog cannabinoids CBs receptors WIN 55,212-2 CB1 cannabimimetics analogs forensics standards JWH-073 JWH 73 JWH73 JWH-73 21.750250279686
10691 JWH 018 N-(3-methylbutyl) isomer Exclusive - ≥97% 2011-02-07 25.015270666904 jwh-018-n-3-methylbutyl-isomer JWH 073 3-methylbutyl homolog cannabinoids agonist selective receptors WIN55212-2 WIN552122 WIN 55212-2 WIN 55,212-2 CB1 cannabimimetics analog forensics CBs JWH-073 JWH-73 JWH 73 JWH73 25.015270666904
11075 JWH 018 N-(4,5-epoxypentyl) analog New - ≥98% 2011-10-21 29.167137472777 jwh-018-n-4-5-epoxypentyl-analog JWH 018 epoxide cannabinoids CBs cannabimimetic CB1 CB2 receptor agonists spices forensics synthetic herbal central peripheral alkyl chains 29.167137472777
10796 (±)-JWH 018 N-(4-hydroxypentyl) metabolite Exclusive - ≥97% 2011-05-31 44.595594023696 -jwh-018-n-4-hydroxypentyl-metabolite JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabinoids WIN 55,212-2 urinary metabolites forensics CBs WIN 55212-2 WIN55,212-2 WIN55212-2 monohydroxylation metabolism N-alkyl chains agonists peripheral central receptors smoking mixtures 44.595594023696
10926 (±)-JWH 018 N-(4-hydroxypentyl) metabolite-d5 Exclusive - ≥99% deuterated forms (d1-d5) 2011-06-28 51.336977083511 -jwh-018-n-4-hydroxypentyl-metabolite-d5 JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabinoids WIN 55,212-2 urinary metabolites forensics CBs WIN 55212-2 WIN55,212-2 WIN55212-2 monohydroxylation metabolism N-alkyl chains agonists peripheral central receptors smoking mixtures GC/MS deuteriums standards deuterateds LC/MS GC-MS LC-MS mass spectrometry 51.336977083511
11047 JWH 018 N-(5-bromopentyl) analog New - ≥98% 2012-01-19 136.655819724129 jwh-018-n-5-bromopentyl-analog cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic central peripheral analogs JWH-018 JWH018 JWH 18 JWH18 JWH-18 JWHs herbal blends bromine pentyl chains 136.655819724129
10521 JWH 018 N-(5-chloropentyl) analog New - ≥95% 2012-01-17 147.981840723864 jwh-018-n-5-chloropentyl-analog cannabinoids CBs cannabimimetics CB1 CB2, receptors agonists spices forensics synthetic JWH018 JWH-018 JWH 18 JWH18 JWH-18 JWHs herbal blends analogs chlorine pentyl chains 147.981840723864
9000855 JWH 018 N-(5-hydroxypentyl) metabolite Exclusive - ≥98% 2010-09-01 111.610033422934 jwh-018-n-5-hydroxypentyl-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite five 5 CBs M-5 M5 smoking mixtures spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 111.610033422934
10933 JWH 018 N-(5-hydroxypentyl) metabolite-d5 Exclusive - ≥99% deuterated product 2011-06-22 79.757840793639 jwh-018-n-5-hydroxypentyl-metabolite-d5 cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBs M-5 M5 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 bath salts LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums agonists selective M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 79.757840793639
9000856 JWH 018 N-pentanoic acid metabolite Exclusive - ≥95% 2010-09-01 110.132510405829 jwh-018-n-pentanoic-acid-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 110.132510405829
9000867 JWH 018 N-pentanoic acid metabolite-d4 Exclusive - ≥99% deuterated product 2010-09-15 280.977045593935 jwh-018-n-pentanoic-acid-metabolite-d4 JWH-018 JWH018 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 280.977045593935
13169 JWH 018 (solution) 209414-07-3 ≥98% 2009-03-12 68.923268613605 jwh-018-solution cannabinoids CB1 CB2 agonists selective receptors WIN 55212-2 JWH-018 JWH018 cbs synthetic JWH 18 JWH-018 JWH18 JWH-18 10900 68.923268613605
13633 JWH 019 209414-08-4 ≥98% 2010-01-14 50.127632658708 jwh-019 cannabinoids CB1 CB2 receptors THC JWH-019 JWH019 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinol cannabinmimetic indoles cannabinoids cbs synthetic JWH019 JWH-019 JWH19 JWH 19 JWH-19 50.127632658708
9000764 JWH 019 5-hydroxyindole metabolite Exclusive - ≥98% 2011-07-06 26.981218665814 jwh-019-5-hydroxyindole-metabolite JWH 019-M2 JWH019 JWH-019 JWH-19 JWH 19 JWH19 cannabinoids cannabimimetic metabolites CB1 CB2 receptors agonists spice forensics synthetic smoking urinary urine serum neuroscience CBs 26.981218665814
9000765 JWH 019 N-(6-hydroxyhexyl) metabolite Exclusive New - ≥98% 2011-10-13 30.547854892471 jwh-019-n-6-hydroxyhexyl-metabolite JWH019 JWH-019 JWH-19 JWH 19 JWH19 JWHs cannabinoids cannabimimetic metabolites CB1 CB2 CBs receptors agonists spices forensics synthetic smoking urinary urine serum herbal blends metabolized livers 30.547854892471
10850 JWH 020 Exclusive 209414-09-5 ≥98% 2011-06-02 43.933702363359 jwh-020 cannabinoids CBs cannabimimetic CB1 receptors agonists CB2 forensics bath salts JWH020 JWH-020 WIN55212-1 WIN55212-2 WIN-55212-1 WIN-55212-2 WIN552121 WIN552122 in vivo JWH 020 43.933702363359
9001056 JWH 022 Exclusive 209414-16-4 ≥98% 2011-08-09 84.562414988077 jwh-022 JWH022 JWH-022 JWH22 JWH-22 JWHs cannabinoids CBs synthetic standards forensics sciences 84.562414988077
10831 JWH 030 Exclusive New 162934-73-8 ≥98% 2011-10-11 59.469825443952 jwh-030 JWH-030 JWH030 JWH30 JWH-30 JWH30 cannabimimetic cannabinoids synthetics CB1 CB2 CBs receptors forensics neuroscience naphtholyl pyrrole mouse mice inhibits inhibition inhibitors electrically induced vas deferens 59.469825443952
10904 JWH 073 208987-48-8 ≥97% 2011-05-06 40.353743785596 jwh-073 cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 cannabinoids cbs synthetic JWH-073-d7 JWH073-d7 JWH73d7 10904 40.353743785596
10633 JWH 073 2-hydroxyindole metabolite - ≥98% 2011-01-11 37.668238301845 jwh-073-2-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs JWH073 JWH-073 cannabinoids cbs synthetic JWH 73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 37.668238301845
10716 JWH 073 2-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product 2011-03-10 19.228790996521 jwh-073-2-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites monohydroxylated forensics JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 glucuroconjugate JWH-073 JWH073 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 19.228790996521
10848 JWH 073 2-methylnaphthyl analog Exclusive New - ≥98% 2011-10-11 28.319358014608 jwh-073-2-methylnaphthyl-analog JWHs cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetics herbal blends JWH-073 073 JWH73 JWH-73 JWHs 73 28.319358014608
9001017 JWH 073 2'-naphthyl-N-(1,1-dimethylethyl) isomer New - ≥98% 2012-01-12 119.645204472316 jwh-073-2-naphthyl-n-1-1-dimethylethyl-isomer cannabinoids cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic CBs herbal blends research applications isomers JWH073 JWH-073 JHW 73 JWH73 JWH-73 JWHs naphthyl groups butyl chains central peripheral 119.645204472316
9000861 JWH 073 4-hydroxyindole metabolite - ≥98% 2010-09-01 43.375395282530 jwh-073-4-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic standards CBs JWH073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 43.375395282530
10717 JWH 073 4-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product 2011-02-21 19.579435563740 jwh-073-4-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 19.579435563740
9001076 JWH 073 4-methylnaphthyl analog New - ≥98% 2011-09-06 35.278436481376 jwh-073-4-methylnaphthyl-analog JWH 122 N-butyl analog; 1-butyl-3-(1-(4-methyl)naphthoyl) indole JWH073 JWH-073 JWH73 JWH-73 analogs hybrids forensics sciences cannabinoids CBs JWHs indoles cannabimimetics JWH 018 122 smoking incense spices forensics pains neuroscience 35.278436481376
9000862 JWH 073 5-hydroxyindole metabolite Exclusive - ≥98% 2010-09-01 37.173574988467 jwh-073-5-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 2 JWH-073 JWH073 CBs M-2 agonists smoking mixtures spices cbs synthetic JWH073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 37.173574988467
10718 JWH 073 5-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product 2011-03-11 21.566729128299 jwh-073-5-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics Metabolite 2 JWH-073 JWH073 M-2 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 21.566729128299
9000863 JWH 073 6-hydroxyindole metabolite Exclusive - ≥95% 2010-09-01 33.166485782090 jwh-073-6-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 33.166485782090
10719 JWH 073 6-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product 2011-03-11 19.228790996521 jwh-073-6-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 19.228790996521
9000864 JWH 073 7-hydroxyindole metabolite Exclusive - 98% 2010-09-01 30.644219555686 jwh-073-7-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 4 JWH-073 CBs JWH073 M-4 mixtures smoking spices synthetic JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 30.644219555686
10720 JWH 073 7-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated product 2011-07-25 25.409004024282 jwh-073-7-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics CBs deuterateds deuterium mass spectrometry MS LC/MS LC-MS GC-MS GC/MS WIN55212-2 WIN552122 pain neuroscience JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 25.409004024282
9000868 JWH 073-d7 (solution) Exclusive - ≥99% deuterated product 2010-08-10 35.952230308723 jwh-073-d7-solution deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-073 JWHs JWH073 JWH73 JWH-73 JWH 73 cannabinoids CB1 receptors CB2 peripheral central cbs synthetic JWH073d7 JWH-073-d7 JWH073-d7 JWH73-d7 JWH-73-d7 JWH73-d7 JWH73d7 10905 35.952230308723
9001013 JWH 073 N-(1,1-dimethylethyl) isomer New - ≥98% 2012-01-12 119.645204472316 jwh-073-n-1-1-dimethylethyl-isomer cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWHs JWH073 JWH-073 central peripheral herbal blends butyl chains isomers 119.645204472316
10795 (±)-JWH 073 N-(3-hydroxybutyl) metabolite Exclusive - ≥98% 2011-05-31 53.345126292079 -jwh-073-n-3-hydroxybutyl-metabolite JWH-073 JWH073 JWH73 JWH-73 JWH73 cannabinoids metabolites cannabimimetic aminoalkyl chains adulterant CBs metabolism in vitro smoking mixtures 53.345126292079
10927 (±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5 Exclusive - ≥99% deuterated forms (d1-d5) 2011-07-25 46.084455221335 -jwh-073-n-3-hydroxybutyl-metabolite-d5 deuterateds deuterium GC-MS GC/MS LC-MS LC/MS mass spectrometry MS JWH073 JWH73 JWH-073 JWH-73 cannabinoids metabolites cannabimimetic aminoalkyl chains adulterant CBs metabolism in vitro smoking mixtures pain neuroscience 46.084455221335
9000865 JWH 073 N-(4-hydroxybutyl) metabolite Exclusive - ≥98% 2010-09-01 85.111283486231 jwh-073-n-4-hydroxybutyl-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices M-5 synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 85.111283486231
10934 JWH 073 N-(4-hydroxybutyl) metabolite-d5 Exclusive New - ≥99% deuterated product 2011-10-14 66.724011217090 jwh-073-n-4-hydroxybutyl-metabolite-d5 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M deuterated deuterium metabolites cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices 66.724011217090
9000866 JWH 073 N-butanoic acid metabolite Exclusive - ≥98% 2010-09-01 94.707746633261 jwh-073-n-butanoic-acid-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH 073 Metabolite 6 JWH-073 CBs JWH073 M-6 smoking mixtures spices cbs synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 94.707746633261
9000870 JWH 073 N-butanoic acid metabolite-d5 Exclusive - ≥99% deuterated product 2010-09-20 88.435213297809 jwh-073-n-butanoic-acid-metabolite-d5 JWH 073 Metabolite 6-d5 JWH-073 JWH073 cannabinoids CBs receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 deuterateds deuteriums mass spec GC-MS LC-MS GC/MS LC/MS M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 88.435213297809
13170 JWH 073 (solution) 208987-48-8 ≥97% 2009-03-02 44.560786731709 jwh-073-solution cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 cannabinoids cbs synthetic JWH-073-d7 JWH073-d7 JWH73d7 10904 44.560786731709
10579 JWH 081 210179-46-7 ≥98% 2010-10-22 76.572986461864 jwh-081 cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids cbs synthetic JWH-081 JWH 81 JWH-81 JWH81 76.572986461864
9001045 JWH 081 3-methoxynaphthyl isomer New - ≥98% 2012-01-25 187.336528974017 jwh-081-3-methoxynaphthyl-isomer cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWH-081 JWH081 JWH81 JWH-81 JWH 81 central peripheral 187.336528974017
9001047 JWH 081 6-methoxynaphthyl isomer New 824961-41-3 ≥98% 2012-01-19 167.038438607436 jwh-081-6-methoxynaphthyl-isomer JWH 166 cannabinoids CBs cannabimimetics central CB1 CB2 peripheral receptors agonists spices forensics synthetic isomers methoxy groups naphthyl rings research JWH081 JWH-081 JWH 81 JWH-81 JWH81 JWH166 JWH-166 JWHs 167.038438607436
9001049 JWH 081 8-methoxynaphthyl isomer New - ≥98% 2012-01-11 148.684279342982 jwh-081-8-methoxynaphthyl-isomer cannabinoids cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic CBs ten-fold ten fold reduced reduces affinity isomers methoxy groups naphthyl rings central peripheral 148.684279342982
10511 JWH 081-d9 New - ≥99% deuterated product 2011-09-08 66.443078325278 jwh-081-d9 cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids CBs synthetic JWH-081 JWH 81 JWH-81 JWH81 standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 66.443078325278
9000768 JWH 081 N-(5-hydroxypentyl) metabolite Exclusive - ≥95% 2011-08-05 95.818200155193 jwh-081-n-5-hydroxypentyl-metabolite JWH-081 JWH081 JWH-81 JWH81 JWH 81 JWHs CBs cannabinoids forensics sciences metabolites cannabimimetics metabolites CB1 CB2 receptors agonists spices synthetics smoking urinary urine serum 95.818200155193
10680 JWH 098 Exclusive 316189-74-9 ≥98% 2011-04-20 51.161757491380 jwh-098 JWH-098 JWH98 JWH-98 JWH 98 cannabinoids cannabimimetics CBs CB1 receptors agonists CB2 pain spice forensics synthetic naphthalen-1-yl-(1-pentylindol-3-yl)methanone 1-propyl-2-methyl-3-(1-naphthoyl)indole 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC 1-pentyl-3-(1-naphthoyl)indole naphthalenes JWH 133 JWH133 JWH-133 JWH-018 JWH018 JWH 018 JWH18 JWH015 JWH15 JWH 015 JWH-015 indoles 51.161757491380
10512 JWH 122-d9 New - ≥99% deuterated product 2011-09-08 41.408151914141 jwh-122-d9 JWHs JWH-122 JWH122 cannabinoids CB1 CB2 CBs CB-1 CB-2 receptors potent synthetic forensics pain central peripheral cannabinoids CBs synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 41.408151914141
10925 JWH 122 N-(5-hydroxypentyl) metabolite Exclusive - ≥98% 2011-06-17 50.501041928730 jwh-122-n-5-hydroxypentyl-metabolite cannabinoids CBs receptors CB1 CB2 cannabimimetics analogs forensics JWH122 JWH-122 monohydroxylation N-alkyl chains naphthoylindole JWH 018 JWH018 JWH-018 JWH18 JWH-18 JWH 18 JWH073 JWH-073 JWH 073 JWH73 JWH-73 JWH 73 50.501041928730
10825 JWH 145 Exclusive New 914458-19-8 ≥95% 2011-11-10 26.667005378671 jwh-145 JWH-145 JWH145 JWHs cannabinoids CBs CB1 CB2 herbals smoking forensics receptors agonists cannabimimetic aminoalkylindole JWH018 JWH-018 JWH 018 blends 73 18 JWH073 JWH-073 JWH 073 JWH73 JWH 73 JWH-73 JWH18 JWH-18 26.667005378671
11201 JWH 175 Exclusive New 619294-35-8 ≥98% 2012-02-09 130.536276661375 jwh-175 CBs JWH-175 JWH175 JWHs CB1 CB2 cannabinoids JWH018 JWH-018 JWH 018 receptors agonist spices synthetic 130.536276661375
10643 JWH 182 Exclusive New 824960-02-3 ≥97% 2011-10-11 53.435623815085 jwh-182 JWH-182 JWHs CB1 CB2 CBs receptors agonists pains spices forensics synthetics cannabinoids cells animals 53.435623815085
10902 JWH 200 103610-04-4 ≥98% 2011-05-05 47.054774727766 jwh-200 cannabinoids receptors agonists CB1 pain antinociception cannabinoids cbs synthetic JWH200 JWH-200 10902 47.054774727766
10744 JWH 200 4-hydroxyindole metabolite Exclusive - ≥98% 2011-04-15 36.781428004611 jwh-200-4-hydroxyindole-metabolite JWH-200 JWH200 cannabinoids receptors agonists pain antinociception CBs cannabimimetic metabolites CB1 CB2 spices forensics synthetic smoking urinary urine 36.781428004611
10745 JWH 200 5-hydroxyindole metabolite Exclusive - ≥98% 2011-07-06 25.218674674828 jwh-200-5-hydroxyindole-metabolite JWH-200 JWH200 cannabinoids receptors agonists pain antinociception CBs cannabimimetic metabolites CB1 CB2 spices forensics synthetic smoking urinary urine neuroscience 25.218674674828
10903 JWH 200-d5 - ≥99% deuterated product 2011-05-06 10.563329852221 jwh-200-d5 cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-200-d5 JWH200-d5 10903 10.563329852221
10682 JWH 200-d5 (solution) - ≥99% deuterated product 2011-01-07 33.996941087390 jwh-200-d5-solution cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-200-d5 JWH200-d5 10903 33.996941087390
13171 JWH 200 (solution) 103610-04-4 ≥98% 2009-03-25 45.758690559580 jwh-200-solution cannabinoids receptors agonists CB1 pain antinociception cannabinoids cbs synthetic JWH200 JWH-200 10902 45.758690559580
10721 JWH 201 Exclusive 864445-47-6 ≥98% 2011-02-24 77.624510665918 jwh-201 cannabinoids CB1 CB2 receptors CBs JWH201 JWH-201 JWH250 JWH-250 JWH 250 77.624510665918
9000736 JWH 203 864445-54-5 ≥98% 2011-02-21 73.687547154631 jwh-203 cannabinoids receptors JWH 250 JWH203 JWH-203 CB1 CB2 cannabimimetics forensics pain CBs binding analgesic 73.687547154631
10868 JWH 203 3-chlorophenyl isomer Exclusive 864445-56-7 ≥98% 2011-06-03 31.132707182320 jwh-203-3-chlorophenyl-isomer JWH 237; JWH 203 3-chloro isomer cannabinoids receptors JWH 250 JWH203 JWH-203 CB1 CB2 CBs cannabimimetics forensics pain bath salts phenylacetylindole analog 31.132707182320
10867 JWH 203 4-chlorophenyl isomer Exclusive 864445-58-9 ≥98% 2011-06-02 36.822909760589 jwh-203-4-chlorophenyl-isomer JWH 206; JWH 203 4-chloro isomer cannabinoids CB1 CB2 receptors synthetic forensics pain bath salts CBs JWH203 JWH-203 JWH206 JWH-206 36.822909760589
10644 JWH 210 824959-81-1 ≥98% 2011-02-01 119.609337313713 jwh-210 cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 119.609337313713
9001039 JWH 210 3-ethylnaphthyl isomer New - ≥98% 2011-11-30 74.802596125547 jwh-210-3-ethylnaphthyl-isomer cannabinoids CBs cannabimimetic metabolites receptors agonists spices forensics synthetic smoking urinary urine serum JWHs JWH210 JWH-210 alkylindole herbal blends isomers ethyl chains naphthyl groups 74.802596125547
9000771 JWH 210 5-hydroxyindole metabolite Exclusive - ≥98% 2011-08-10 44.869743788179 jwh-210-5-hydroxyindole-metabolite JWH-210 JWH210 cannabinoids CBs cannabimimetic metabolites CB1 CB2 receptors agonists spices forensics synthetic smoking urinary urine serum 44.869743788179
9001041 JWH 210 6-ethylnaphthyl isomer New - ≥98% 2012-01-31 206.657795692826 jwh-210-6-ethylnaphthyl-isomer cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic smoking JWH210 JWH-210 JWHs isomers alkylindoles extracts herbal blends 206.657795692826
10510 JWH 210-d9 New - ≥99% deuterated product 2011-09-08 48.455738971633 jwh-210-d9 cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 JWHs standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS pain 48.455738971633
10940 JWH 210 N-(4-hydroxypentyl) metabolite New - ≥95% 2012-01-19 126.559825701640 jwh-210-n-4-hydroxypentyl-metabolite cannabinoids CBs cannabimimetics metabolites receptors agonists spices forensics synthetic smoking urinary urine serum JWH210 JWH-210 JWHs alkylindoles liver 126.559825701640
11153 JWH 249 New 864445-60-3 ≥98% 2012-02-10 0E-12 jwh-249 cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWH249 JWH-249 JWHs central peripheral 0E-12
13634 JWH 250 864445-43-2 ≥98% 2010-01-14 76.881878954195 jwh-250 cannabinoids CB1 CB2 receptors THC JWH-250 JWH250 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinols indoles cbs synthetic 76.881878954195
9000766 JWH 250 5-hydroxyindole metabolite Exclusive - ≥98% 2011-07-20 35.722872928177 jwh-250-5-hydroxyindole-metabolite JWH250 JWH-250 cannabinoids CBs cannabimimetics metabolite CB1 CB2 receptors agonists spices forensics synthetic smoking urinary urine serum 35.722872928177
10661 JWH 250-d5 Exclusive - ≥99% deuterated product 2011-02-14 32.813926949452 jwh-250-d5 cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-250-d5 JWH250-d5 32.813926949452
10939 JWH 250 N-(4-hydroxypentyl) metabolite Exclusive New - ≥98% 2011-10-24 46.770100893042 jwh-250-n-4-hydroxypentyl-metabolite JWHs JWH-250 JWH250 metabolites cannabinoids CB1 CB2 CBs herbal smoke smoking forensics receptors agonist cannabimimetic metabolite metabolism 46.770100893042
10938 JWH 250 N-(5-carboxypentyl) metabolite Exclusive - ≥98% 2011-07-19 77.234958111501 jwh-250-n-5-carboxypentyl-metabolite JWHs JWH-250 JWH250 metabolites forensics sciences urinary urine synthetics cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices synthetics smoking urinary urine serum 77.234958111501
9000767 JWH 250 N-(5-hydroxypentyl) metabolite Exclusive - ≥98% 2011-08-05 63.171820525698 jwh-250-n-5-hydroxypentyl-metabolite JWH250 JWH-250 forensic sciences CBs cannabinoids JWHs cannabimimetics metabolites CB1 CB2 receptors agonists spices forensics synthetics smoking urinary urine serum 63.171820525698
10578 JWH 251 864445-39-6 ≥98% 2010-08-20 53.611618745255 jwh-251 cannabinoids receptors JWHs JWH-251 JWH251 WIN55212-2 WIN 55212-2 CB1 CB2 cannabimimetics urine forensics cannabinoids cbs synthetic 53.611618745255
10722 JWH 302 Exclusive 864445-45-4 ≥95% 2011-03-04 77.296232569548 jwh-302 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine forensics CBs JWH302 JWH-302 indoles central peripheral GTPγS binding 77.296232569548
10797 JWH 307 New 914458-26-7 ≥96% 2011-12-15 96.786584949347 jwh-307 JWH307 JWH-307 cannabinoids CBs CB1 CB2 herbal smoking forensics receptors agonists JWHs cannabimimetic psychological neurological nuerology toxicological toxicology 96.786584949347
10829 JWH 368 New 914458-31-4 ≥98% 2011-12-14 77.487867180509 jwh-368 JWH368 JWH-368 cannabinoids CBs CB1 CB2 herbal smoking forensics sciences receptors agonists cannabimimetic JWHs 77.487867180509
10828 JWH 369 New 914458-27-8 ≥95% 2012-01-25 121.627138556643 jwh-369 JWH369 JWH-369 cannabinoids cannabimimetics CB1 CB2 CBs receptors agonists spices forensics synthetic central peripheral mouse research 121.627138556643
10827 JWH 370 New 914458-22-3 ≥95% 2011-11-10 31.736608786711 jwh-370 JWH370 JWH-370 JWHs cannabinoids CB1 CB2 herbal smoking forensics receptors agonists cannabimimetic aminoalkylindole JWH 018 JWH 18 JWH-018 JWH018 JWH073 JWH 73 JWH 073 JWH-073 analogs blends JWH-73 JWH73 JWH-18 JWH18 31.736608786711
13636 JWH 398 Exclusive - ≥95% 2010-10-22 73.228542786809 jwh-398 jwh398 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine forensics CBs JWH-398 cbs synthetic 73.228542786809
9001024 JWH 398 3-chloronaphthyl isomer New - ≥98% 2012-01-11 109.267221717577 jwh-398-3-chloronaphthyl-isomer cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWH398 JWH-398 JWHs isomers herbal mixtures chlorine naphthyl rings central peripheral 109.267221717577
9001028 JWH 398 8-chloronaphthyl isomer New - ≥98% 2012-01-13 112.335403648117 jwh-398-8-chloronaphthyl-isomer cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic isomers herbal mixtures JWHs JWH-398 JWH398 central peripheral 112.335403648117
13158 JZL 184 1101854-58-3 ≥97% 2009-01-26 160.348107734806 jzl-184 2-AG 2AG MAGL inhibitors inhibits inhibition endocannabinoids pains analgesia MGL inhibitor JZL184 JZL-184 cannabinoids 160.348107734806
13668 JZL 195 - ≥98% 2010-02-10 120.234751381215 jzl-195 fatty acid amide hydrolase FAAH monoacylglycerol lipase MAGL endocannabinoids arachidonoyl ethanolamide AEA 2-arachidonoylglycerol 2-AG inibitors inhibition inhibits PF-3845 PF 3845 PF3845 JZL195 JZL-195 JZL184 antinociception pain catalepsy hypomotility CB1 2AG cannabinoids inhibitors cbs sythetic Methylenedioxybenzenes 1,3-Dioxaindans 1,3 Dioxaindans 1,3-Dioxindans 1,3 Dioxindans Benzodioxoles 120.234751381215
13711 KCNQ1 Potassium Channel Monoclonal Antibody (Clone S37A-10) - 2009-12-02 0E-12 kcnq1-potassium-channel-monoclonal-antibody-clone-s37a-10 antibodies western blots WB immunoblotting blotting immunoprecipitation IP immunohistochemistry IHC KCNQ-1 IKs inner ears cardiac muscles channels Kv7.1 hyperpolarization-activated cation hyperpolarization activated activity activate 0E-12
13712 KCNQ2 Potassium Channel Monoclonal Antibody (Clone S26A-23) - 2009-12-02 0E-12 kcnq2-potassium-channel-monoclonal-antibody-clone-s26a-23 antibodies western blots WB immunoblotting blotting immunoprecipitation IP immunohistochemistry IHC KCNQ-2 IKs inner ears cardiac muscles channels Kv7.1 familial neonatal convulsions benign hyperpolarization activated 0E-12
13713 KCNQ4 Potassium Channel Monoclonal Antibody (Clone S43-6) - 2009-12-02 0E-12 kcnq4-potassium-channel-monoclonal-antibody-clone-s43-6 antibodies western blots blotting immunoblotting immunoprecipitation immunocytochemistry ICC IP KCNQ-4 proteins retigabine hyperpolarization-activated hyperpolarization activated activity activate cation antioconvuslants anti-convulsantd 0E-12
10640 KM 233 Exclusive 628263-22-9 ≥98% 2011-07-07 35.974917127071 km-233 KM233 KM-233 CBs cannabinoids CB2 agonists recptors CB1 gliomas anti tumors cancers 35.974917127071
10009280 L-759,633 174627-50-0 >98% 2007-09-13 35.046546961326 l-759-633 L759633 cannabinoids receptors agonists CB1 CB2 endocrinology neurochemistry cannabinoids cbs synthetic 35.046546961326
10008618 Lauric Acid Leelamide - >98% 2006-09-05 0.520475138122 lauric-acid-leelamide saturated fatty acids synthesized synthesis plants animals acetyl coenzymes CoA energy storage 12-carbons coconut nut oils COX-2 cyclooxygenase-2 cyclooxygenases expressions C:8-18 inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine leelamine cannabinoids cbs synthetic 0.520475138122
13248 L-DOPA 59-92-7 ≥95% 2010-02-03 3.530939226519 l-dopa 3,4-Dihydroxyphenylalanine; Pardopa; Levodopa; Syndopa dopamine neurotransmitter locomotion Parkinson's disease stroke dopaflex (-)-dopa 3,4-dihydroxyphenylalanine parda larodopa laradopa levopa veldopa weldopa dopalina dopastral doparkine dopasol 3-(3,4-dihydroxyphenyl)-alanine ledopa DOPA phenylalanines alanines 1-(-)-dopa L-3,4-Dihydroxyphenylalanine L 3,4 Dihydroxyphenylalanine Medphano Brand of Levodopa Roberts Brand of Levodopa Roche Brand of Levodopa 3-Hydroxy-L-tyrosine 3 Hydroxy L tyrosine Levodopa Larodopa Dopaflex Levopa L-Dopa L Dopa Dopar 3.530939226519
10006148 Leelamine 1446-61-3 >98% 2006-05-10 0.520865561694 leelamine Dehydroabietylamine inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine cannabinoids cbs synthetic 0.520865561694
10008614 Leelamine (hydrochloride) - ≥98% 2006-05-10 0.419208103131 leelamine-hydrochloride Dehydroabietylamine inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine cannabinoids cbs synthetic 0.419208103131
10010572 Lercanidipine-d3 (hydrochloride) - >99% deuterated product 2008-04-14 0E-12 lercanidipine-d3-hydrochloride SPI blocker calcium dihydropyrine neurochemistry 0E-12
13353 Lignoceric Acid 557-59-5 ≥98% 2009-08-04 11.580796339375 lignoceric-acid FL 88 fatty acids brains development cerebrosides sphingomyelin myelin galactoplipids peroxisome Zellweger cerebro-hepato-renal cerebrohepatorenal syndromes X chromosomes X-chromosomes chromosome-linked linked adrenoleukodystrophy lignin FL88 L 88 FL-88 L-88 11.580796339375
90155 Linoleoyl Ethanolamide 68171-52-8 >98% 7.189558011049 linoleoyl-ethanolamide cannabinoids neurotransmitter ethanolamides fatty acids neurochemistry neuroscience ethanolamines linoleyl cbs synthetic 7.189558011049
9000553 Linoleoyl Ethanolamide-d4 Exclusive - ≥99% deuterated product 2010-01-13 7.936983425414 linoleoyl-ethanolamide-d4 cannabinoids neurotransmitter ethanolamides fatty acids neurochemistry neuroscience ethanolamines linoleyl deuterateds deuteriums LC-MS GC/MS GC-MS mass spectrometry standards LC/MS MS cbs synthetic 7.936983425414
9000326 Linoleoyl Glycine 2764-03-6 ≥98% 2008-10-29 5.679337016575 linoleoyl-glycine N-Linoleoyl Glycine; LinGly; Glycine Linoleamide arachidonyl glycine fatty acids AEA FAAH inhibits inhibitor inhibition anandamide homologs 5.679337016575
700570 L-Theanine Fluorometric Assay Kit Exclusive - 2011-05-31 240.716457949662 l-theanine-fluorometric-assay-kit 5-N-ethyl-Glutamine; Glutamic Acid γ-ethyl amide; γ-ethylamino-L-Glutamic Acid; γ-Glutamylethylamide kits assays measures measurements glutamines amino acids aa Camellia sinensis C. sinensis green teas japonica sasanqua mushrooms Xerocomus badius X. badius water-solubles non-proteins plants leaves umami humans immune systems .gamma..delta. gammadelta γδ T cells T-cells infection-fighting infections antigens ethylamine renal metabolites brains .alpha.-waves alpha-waves α-waves alertness schizophrenia neuroprotective effects glutamates receptors N-methyl-D-aspartate NMDA calcium Ca Ca2+ intracellular animals anthracyclines hypertensives rats antihypertensives blood pressures dopamines norepinephrines serotonins 240.716457949662
10563 MDA 19 1048973-47-2 ≥95% 2010-09-17 51.340761641673 mda-19 agonists cannabinoids CB2 CB1 pains 1104302-26-2 tactile allodynia paclitaxel spinal nerves ligation MDA-19 MDA19 CBs peripheral central MDAs central cannabinoids cbs synthetic cannabinoids Epidermal Growth Factor Receptor Protein-Tyrosine Kinase Receptors, Epidermal Growth Factor-Urogastrone Receptor Transforming Growth Factor alpha Transforming Growth Factor alpha Receptor Epidermal Growth Factor Receptor Kinase Receptor Epidermal Growth Factor Receptor erbB 1 Proto Oncogene Protein Receptor Urogastrone Urogastrone Receptor Receptor TGF alpha TGF-alpha Receptor c-erbB-1 Protein Proto-Oncogene Receptor EGF EGF Receptor 51.340761641673
9001102 MDAI New 13274-81-2 ≥95% 2011-11-04 27.510141190915 mdai 5,6-Methylenedioxy-2-aminoindane designer drugs forensics MDA MDMA neuroscience neurotoxicity analogs amphetamine serotonin neurotoxin methamphetamine 12440-03-9 27.510141190915
10979 MDMA methylene homolog (hydrochloride) Exclusive - ≥98% 2011-06-22 34.462629087627 mdma-methylene-homolog-hydrochloride 3,4-Methylenedioxymethamphetamine methyl homolog forensic sciences cannabinoids CBs pyrovalerones pentylones designer drugs forensics neuroscience psychoactive ecstasy HCl 34.462629087627
10009518 MEK1 (Phospho-Thr292) Polyclonal Antibody - 2007-01-12 0E-12 mek1-phospho-thr292-polyclonal-antibody MAP Kinase Kinase 1; MAPKK1 antibodies WB western blot MEK 1 phosphorylation MAP kinase cell growth differentiation threonine tyrosine phospho-specific blotting immunoblotting 0E-12
10009517 MEK1 (Phospho-Thr386) Polyclonal Antibody - 2007-01-11 0E-12 mek1-phospho-thr386-polyclonal-antibody MAPK1; MAP Kinase Kinase 1 antibodies WB western blot MEK 1 phosphorylation MAP kinase cell growth differentiation threonine tyrosine phospho-specific blotting immunoblotting 0E-12
600180 Melanocortin-3 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - 2010-01-05 9.503093922652 melanocortin-3-receptor-step-reporter-assay-kit-luminescence MC3R MC-3R melanocortins petides hormones proopiomelanocortins pituitary CNS central nervous systems skin placenta tissues MCR receptors G protein-coupled GPCRs cAMP Adenosine 3',5' cyclic mononucleotides messenger signal transduction pathways melanocortin-3 hypothalmus homeostasis fat lean mass hyperphagia MC4R melanocortin-4 adiposity MC3R-knockout mice mouse murine fatty acids oxidations blood pressure hypertension obesity glucose metabolisms insulin insensitivity agonists ligands Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening a-MSH alpha-MSH α-MSH 9.503093922652
10006355 Melanocortin-4 Receptor Polyclonal Antibody - 2005-08-03 15.466270718232 melanocortin-4-receptor-polyclonal-antibody MC4R antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry melanocortins melanogenesis steroidogenesis sexual functions inflammations appetite regulations energy homeostasis G-proteins coupled receptors GPCRs MC1R MC2R MC3R MC5R transcripts brain genetic studies heteozygous mutations human obesity mammalian unglycosylated SDS-PAGE endocrinology immunoblotting 15.466270718232
600190 Melanocortin-4 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - 2010-01-05 10.453403314917 melanocortin-4-receptor-step-reporter-assay-kit-luminescence MC4R MC-4R melanocortins petides hormones proopiomelanocortins pituitary CNS central nervous systems skin placenta tissues MCR receptors G protein-coupled GPCRs cAMP Adenosine 3',5' cyclic mononucleotides messenger signal transduction pathways melanocortin-3 hypothalmus homeostasis fat lean mass hyperphagia MC4R melanocortin-4 adiposity MC3R-knockout mice mouse murine fatty acids oxidations blood pressure hypertension obesity glucose metabolisms insulin insensitivity agonists ligands sexual function antagonists fever suppression inflammatory mediators in vivo Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening a-MSH alpha-MSH α-MSH 10.453403314917
10529 Methedrone (hydrochloride) New 879665-92-6 ≥98% 2011-10-11 63.140864465314 methedrone-hydrochloride 4-Methedrone; Methoxyphedrine; PMMC; para-Methoxymethcathinone cathinone analogs MAO inhibitors PMMC mephedrone PMMA 530-54-1 inhibits inhibition phenethylamines amphetamines cathinones derivatives psychoactive MDMA hydrochloride HCl 63.140864465314
70660 Methyl Arachidonyl Fluorophosphonate 188404-10-6 >98% 48.292615101289 methyl-arachidonyl-fluorophosphonate MAFP phospholipases inhibitors cPLA2 iPLA2 MAFP fatty acids neuroscience neurochemistry 48.292615101289
13775 Methyl-CpG-Binding Protein 2 Polyclonal Antibody - 2010-04-27 0E-12 methyl-cpg-binding-protein-2-polyclonal-antibody MeCP2 antibodies domains cytosines dinucleotides methylations DNA proteins mammalian MED1 MeCP2 PCM1 MBDs MBDs MBD-1 MBD-2 MBD-3 MBD-4 MBD2 MBD3 MBD4 MBD 2/3 MBD-2/3 MBD 1 MBD 2 MBD 3 MBD 4 MBD2-3 MBD 2-3 0E-12
10624 Methylenedioxy Pyrovalerone Exclusive 687603-66-3 ≥98% 2011-01-07 41.186211080622 methylenedioxy-pyrovalerone MDPV 3,4-methylenedioxypyrovalerone inhibitors neurotransmitters dopamine norepinephrine MDMA ecstasy forensics designer drugs Hemihydrate Apomorphine Hydrochloride Anhydrous Apomorphine Hydrochloride Chloride Apomorphine Apomorphin Teclapharm Apomorphine Chloride Berberine Alkaloids Camptothecine Camptothecin Umbellatine Apomorphine Britaject Berberine Alkaloids Berbines Apokinon 41.186211080622
10679 Methylenedioxy Pyrovalerone-d8 (hydrochloride) 1246820-09-6 ≥99% deuterated product 2011-02-15 37.891464123511 methylenedioxy-pyrovalerone-d8-hydrochloride MDPV-d8 3,4-methylenedioxypyrovalerone inhibitors neurotransmitters dopamine norepinephrine MDMA ecstasy neuroscience forensics designer drugs deuterateds deuteriums GC/MS GC-MS LC/MS LC-MS mass spectrometry MS standards 37.891464123511
10684 Methylenedioxy Pyrovalerone (hydrochloride) 24622-62-6 ≥98% 2011-01-07 56.786631573859 methylenedioxy-pyrovalerone-hydrochloride MDPV 3,4-methylenedioxypyrovalerone inhibitors neurotransmitters dopamine norepinephrine MDMA ecstasy neuroscience forensics designer drugs 56.786631573859
70662 Methyl α-Linolenyl Fluorophosphonate - >98% 22.170568271507 methyl-linolenyl-fluorophosphonate MLnFP PLA2s phospholipases A2 FAAH fatty acids amides hydrolase inhibitors cannabinoids CB receptors antagonists analogs MAFP MaLnFP M.alpha.LnFP MalphaLnFP alpha-linolenyl .alpha.-linolenyl neurochemistry neuroscience 22.170568271507
70664 Methyl γ-Linolenyl Fluorophosphonate - >98% 17.508112338858 methyl-linolenyl-fluorophosphonate MγLnFP PLA2s phospholipases A2 FAAH fatty acids amides hydrolases inhibitors cannabinoids CB receptor antagonists M.gamma.LnFP MgammaLnFP analogs MAFP neurochemistry neuroscience 17.508112338858
11151 Mitragynine New 4098-40-2 ≥95% 2011-12-01 96.260735880908 mitragynine 9-methoxy Corynantheidine alkaloids forensics Mitragyna pain neuroscience opioids receptors agonists incense indoles plants noradreneric serotonergic metabolites 11047-39-5 36455-45-5 1383-32-0 6202-22-8 96.260735880908
10212 Monoacylglycerol Lipase (FL) Polyclonal Antibody - 2010-03-23 29.409715864245 monoacylglycerol-lipase-fl-polyclonal-antibody MAGL; MGL WB western blots hydrolases antibodies antiserum antisera hydrolysis immunohistochemistry IHC immunoblotting MGL monoacylglycerol neuroscience neurochemistry MAGL monoglycerol blotting 29.409715864245
10007812 Monoacylglycerol Lipase (human recombinant) - >95% 2008-04-01 53.800283149171 monoacylglycerol-lipase-human-recombinant MAGL; MGL neuroscience neurochemistry 2-AG endocannabinoids hydrolases proteins MAGLs MGLs recombinant 53.800283149171
705192 Monoacylglycerol Lipase Inhibitor Screening Assay Kit - 2009-10-22 62.555753749013 monoacylglycerol-lipase-inhibitor-screening-assay-kit MAGL; MGL neuroscience neurochemistry inhibitors inhibiting inhibition inhibits endocannabinoids serines hydrolases pain obesity monoglycerol 62.555753749013
100035 Monoacylglycerol Lipase Polyclonal Antibody - 36.053911602209 monoacylglycerol-lipase-polyclonal-antibody MAGL; MGL WB western blots hydrolases antibodies antiserum antisera hydrolysis immunohistochemistry IHC immunoblotting MGL monoacylglycerol neuroscience neurochemistry MAGL monoglycerol blotting 36.053911602209
10009566 Monoacylglycerol Lipase Western Ready Control - Whole cell lysate 2007-01-31 9.678011049723 monoacylglycerol-lipase-western-ready-control MGL; MAGL hormone-sensitive lipases HSL kidney spleen heart liver testis stomach brain lung adrenal gland keletal muscle adipose tissue neurochemistry 9.678011049723
10230 (+)-Muscarine (iodide salt) 24570-49-8 ≥95% 2010-05-06 0.790883977900 -muscarine-iodide-salt neurochemistry 300-54-9 2438-77-9 poisonous mushroom acetylcholine G proteins Alzheimer's disease signal transduction L-muscarine Amanita muscaria 0.790883977900
13667 Muscimol 2763-96-4 ≥98% 2010-05-28 6.727562154696 muscimol Pantherine; Agarin γ-aminobutyric acid GABA neurotransmitters GABAA GABAC GABAB agonists benzodiazepines memory neurochemistry neuroscience GABA-A Receptor alpha Subunit GABA Benzodiazepine Receptors GABA A Receptor gamma Subunit GABA A Receptor delta Subunit GABA A Receptor alpha Subunit GABA Benzodiazepine Receptor GABA A Receptor beta Subunit Benzodiazepine-GABA Receptor Benzodiazepine GABA Receptor GABA-A Receptor rho Subunit GABA A Receptor rho Subunit Benzodiazepine Receptors Benzodiazepine Receptor Receptors Muscimol Receptors, Diazepam Muscimol Receptor Diazepam Receptor GABA A Receptors GABA-A Receptor GABA A Receptor 6.727562154696
10007704 N-(3-hydroxyphenyl)-Arachidonoyl amide Exclusive 183718-75-4 >98% 2007-02-02 13.166132596685 n-3-hydroxyphenyl-arachidonoyl-amide 3-HPAA neurochemistry neuroscience AM404 anologs N-(4-hydroxyphenyl)-arachidonoylamides AEA ethanolamides cycloxygenase-1 cyclooxygenase-2 COX-1 COX-2 inhibits inhibitors inhibition N-(3-hydroxyphenyl)-Arachidonoylamide 3-HPA cannabinoids cbs synthetic 13.166132596685
10014 N-Ac-Tyr-Val-Ala-Asp-CMK 178603-78-6 >98% 2004-04-13 27.311325966850 n-ac-tyr-val-ala-asp-cmk Ac-YVAD-CMK inhibitors inhibits interleukins neuroprotective cerebral ischemia inhibition selective irreversible interleukin-1.beta.converting enzyme ICE Caspase-1-IL-1.beth. IL1beta neuroprotective cerebral ischemia alaninamides neurochemistry chloromethyl ketones 27.311325966850
10009737 NAPE-PLD Blocking Peptide - 2007-04-16 1.018176795580 nape-pld-blocking-peptide peptides WB western blots blotting IHC immunohistochemistry ICC immunocytochemistry N-acylethanolamines NAEs inflammatory regulations apoptosis tissues degenerations biosynthesized membranes phospholipid-dependent pathway enzymes enzymatic hydrolysiscatalyzing phospholipases D subtypes mRNA and proteins activity brain kidney testis neuroscience neurochemistry 1.018176795580
11240 Naphyrone 1-naphthyl isomer (hydrochloride) New - ≥95% 2012-01-24 169.534477911646 naphyrone-1-naphthyl-isomer-hydrochloride designer drugs forensics pyrovalerone cathinones dopamine serotonin norepinephrine bath salts isomers hydrochloride HCl analogs party pills 169.534477911646
10517 Naphyrone (hydrochloride) New 850352-11-3 ≥97% 2011-08-29 119.314385553262 naphyrone-hydrochloride O-2482; NRG-1; Naphpyrovalerone; β-Naphyrone analogs MDPV forensics sciences designer drugs 850352-53-3 pyrovalerones cathinones dopamine serotonins norepinephrines bath salts 119.314385553262
10158 N-Arachidonoyl-3-hydroxy-γ-Aminobutyric Acid - >98% 2004-03-04 8.698661755678 n-arachidonoyl-3-hydroxy-aminobutyric-acid NAG-3H-ABA amino acids bovines brains glycines congeners NAGly suppress responses pain NAG3HABA neurochemistry neuroscience 8.698661755678
90057 N-Arachidonoyl Dopamine 199875-69-9 >98% 16.907932780847 n-arachidonoyl-dopamine NADA analogs capsaicin arachidonic acids amides VR1 receptors vannilloids cannabinoids aada cb1 cb2 analgesic N-arachidonoyl-dopamine neurochemistry neuroscience 16.907932780847
10007431 N-Arachidonoyl Dopamine-d8 - ≥99% deuterated product 2005-08-10 10.737403314917 n-arachidonoyl-dopamine-d8 NADA-d8 deuterateds analogs capsaicin arachidonic acids amides VR1 receptors vannilloids cannabinoids ada cb1 cb2 analgesic arachidonoyl-dopamine neurochemistry neuroscience deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass 10007431 spectrometry cannabinoids cbs synthetic 10.737403314917
90065 N-Arachidonoyl-L-Alanine 401941-73-9 >98% 2004-04-19 12.454599447514 n-arachidonoyl-l-alanine NALA amino acids bovines brains glycines congeners NAGly suppress responses pain neurochemistry neuroscience 12.454599447514
10005455 N-Arachidonoyl-L-Serine 187224-29-9 >98% 2004-08-11 7.638297338021 n-arachidonoyl-l-serine ARA-S endocannabinoids antagonists cannabidiols neuroprotective neurotransmitters hypotensive effects antagonize antagonist neurochemistry neuroscience cannabinoids cbs synthetic 7.638297338021
10005537 N-Arachidonoyl Taurine Exclusive - >98% 2004-11-18 9.314400157852 n-arachidonoyl-taurine bovine brain NADA dopamine ARA-S ARAS N-arachidonoyl-L-serine lipidomics mass spectrometry MS rats N-fatty acyl amides amino acids neurochemistry neuroscience TRPV1 TRPV4 FAAH, cbs, cannabinoids, synthetic 9.314400157852
90067 N-Arachidonoyl-γ-Aminobutyric Acid 128201-89-8 >98% 2004-02-26 8.800143646409 n-arachidonoyl-aminobutyric-acid NAGABA amino acids bovines brains glycines congeners NAGly suppress responses pain neurochemistry neuroscience 8.800143646409
10007517 N-Arachidonyl Maleimide 876305-42-9 >98% 2006-07-31 16.884563535911 n-arachidonyl-maleimide NAM neurochemistry neuroscience 2-AG 2-arachidonoyl glycerol MGL MAGL monoacylglycerol lipase monoglycerol inhibition inhibits inhibitor pain inflammation anxiety endocannabinoids anandanides 2AG fatty acids CB1 CB2 central peripheral inhibitors cannabinoids cbs synthetic 16.884563535911
13718 Nav1.7 Sodium Channel Monoclonal Antibody (Clone S68-6) - 2009-12-04 0E-12 nav1-7-sodium-channel-monoclonal-antibody-clone-s68-6 antibodies channels ions western blots blotting immunoblotting immunoprecipitation WB IP immunocytochemistry ICC pain sensitivity insensitivity sodiums voltage-gated voltage gated 0E-12
10007739 N-Cyclohexanecarbonylpentadecylamine 702638-84-4 ≥98% 2006-08-04 10.100269337016 n-cyclohexanecarbonylpentadecylamine endocannabinoids neurons acidic PEAase palmitoyl ethanolamides amidases anandamides AEA fatty acyls inhibits inhibitors inhibition arachidonoyl neurochemistry neuroscience FAAH hydrolase cannabinoids inhibitors 10.100269337016
10008317 N-Cyclohexanecarbonyltetradecylamine - ≥98% 2006-08-16 10.008901933701 n-cyclohexanecarbonyltetradecylamine FAAH AEA anandamide PEAase inhibitors PEA palmitoylethanolamides ararchidonoyl acidic fatty acids amide hydrolases amidase inhibits inhibition cannabinoids 10.008901933701
10005851 N-Decanoyl p-Nitroaniline 72298-63-6 ≥98% 2004-12-07 7.035676795580 n-decanoyl-p-nitroaniline DepNA FAAH substrates anandamides hydrolases colorimetric cannabinoids aea para-nitroanalines fatty acids anandamide arachidonoyl ethanolamides neurochemistry neuroscience anilide 7.035676795580
10010574 N-Desmethyltrimebutine (hydrochloride) 294882-33-0 ≥99% 2008-04-14 0E-12 n-desmethyltrimebutine-hydrochloride SPI trimebutine metabolites anesthetics disorders spasmolytic gastrointestinal neurochemistry 0E-12
10007288 N-Docosanoyl Taurine - ≥98% 2005-12-29 0.906395027624 n-docosanoyl-taurine neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic 0.906395027624
10004184 NESS 0327 Exclusive 494844-07-4 >98% 2008-05-27 38.872345554997 ness-0327 neurochemistry neuroscience cannabinoids antagonist CB1 CB2 SR 141716A rimonabant WIN 55212-5 pain obesity 38.872345554997
10007286 N-Lignoceroyl Taurine 807370-75-8 >98% 2005-12-21 0.950473559589 n-lignoceroyl-taurine neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic 0.950473559589
10607 NMDA Receptor NR1 Subunit Monoclonal Antibody - 2009-10-26 0.371546961325 nmda-receptor-nr1-subunit-monoclonal-antibody inhibits inhibitors neurotransmitters WB western blots blotting receptors ion channels glutamate 0.371546961325
10608 NMDA Receptor NR2A Subunit Polyclonal Antibody - 2009-10-26 0.371546961325 nmda-receptor-nr2a-subunit-polyclonal-antibody inhibits inhibitors neurotransmitters WB western blots blotting receptors ion channels glutamate inhibition immunoprecipitation IP IHC Immunohistochemistry 0.371546961325
10009759 NMDA Receptor NR2B Subunit (Phospho-Tyr1252) Polyclonal Antibody - 2007-02-09 1.582196132596 nmda-receptor-nr2b-subunit-phospho-tyr1252-polyclonal-antibody antibodies WB western blots phospho-specific NMDA receptor NMDAR phosphorylation NR2B blotting immunoblotting 1.582196132596
10009760 NMDA Receptor NR2B Subunit (Phospho-Tyr1336) Polyclonal Antibody - 2007-02-09 1.582196132596 nmda-receptor-nr2b-subunit-phospho-tyr1336-polyclonal-antibody antibodies WB western blots phospho-specific NMDA receptor NMDAR phosphorylation NR2B blotting immunoblotting 1.582196132596
10009761 NMDA Receptor NR2B Subunit (Phospho-Tyr1472) Polyclonal Antibody - 2007-02-22 5.497941988950 nmda-receptor-nr2b-subunit-phospho-tyr1472-polyclonal-antibody antibodies WB western blots phospho-specific NMDA receptor phosphorylation NR2B blotting immunoblotting 5.497941988950
10609 NMDA Receptor NR2B Subunit Polyclonal Antibody - 2009-10-26 0.371546961325 nmda-receptor-nr2b-subunit-polyclonal-antibody N-methyl-D-aspartate Receptor inhibits inhibitors neurotransmitters WB western blots immunoblotting receptors ion channels glutamate IP IHC immunohistochemistry immunoprecipitation 0.371546961325
9001144 N,N-Dimethylcathinone (hydrochloride) New 10105-90-5 ≥98% 2011-12-12 106.814633073045 n-n-dimethylcathinone-hydrochloride Metamfepramone forensics cathinone phenylethylamine phenethylamine neuroscience dimethylpropion dimepropion rats psychotropic hydrochloride hcl 106.814633073045
10007287 N-Nervonoyl Taurine - >98% 2005-12-29 0.950473559589 n-nervonoyl-taurine neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic 0.950473559589
360871 nNOS Blocking Peptide - 7.812154696132 nnos-blocking-peptide ncNOS; Neuronal Nitric Oxide Synthase; NOS I western blots bNOS synthases immunoblotting controls peptides constitutive antibodies 7.812154696132
360870 nNOS Electrophoresis Standard - >95% 6.775395948434 nnos-electrophoresis-standard ncNOS; Neuronal Nitric Oxide Synthase; NOS I western blots immunoblotting bNOS synthases standards constitutive antibodies neurochemistry 6.775395948434
160870 nNOS Polyclonal Antibody - 11.711721915285 nnos-polyclonal-antibody ncNOS; Neuronal Nitric Oxide Synthase; NOS I synthases Western blots brain bNOS neurotransmitters memory blotting constitutive human neurons antibodies WB ICC immunocytochemistry IHC immunohistochemistry antisera antiserum immunoprecipitation IP neurochemistry immunoblotting 11.711721915285
60870 nNOS (rat recombinant) - cell lysate 100,000 x g supernatant 6.669861878453 nnos-rat-recombinant ncNOS; Neuronal Nitric Oxide Synthase; NOS I neuronal enzymes constitutive nitric oxide synthase bNOS neurochemistry 6.669861878453
60875 nNOS (rat recombinant) - Purified - >95% 18.784735595895 nnos-rat-recombinant-purified ncNOS; Neuronal Nitric Oxide Synthase; NOS I neuronal enzymes constitutive nitric oxide synthase bNOS neurochemistry 18.784735595895
10009632 nNOS Western Ready Control - 2007-05-30 7.995623081645 nnos-western-ready-control NOS I; ncNOS Western blotting WB citrulline nomenclature tissue neuronal brain N-terminus PSD-95 PSD-96 PZD neurochemistry 7.995623081645
10115 N-Oleoyl Dopamine 105955-11-1 >98% 6.968823993686 n-oleoyl-dopamine ODA VR1 agonists CB1 receptors analogs vanilloids cannabinoids analgesic amides N-oleoyldopamine inhibits inhibitors inhibition 5-lipoxygenases 5-LOs binding selective FAAH hydrolases fatty acid neurochemistry neuroscience cbs synthetic 6.968823993686
90269 N-Oleoyl Glycine 2601-90-3 >98% 2.941104972376 n-oleoyl-glycine precursor oleoylamide fatty acids neurochemistry neuroscience oleoylglycine oleoyl-glycine 2.941104972376
13058 N-Oleoyl-L-Serine - ≥98% 2008-10-17 2.381270718232 n-oleoyl-l-serine lipids bones endogenous anabolic activity activities formation resorption cannabinoids cbs synthetic 2.381270718232
10005609 N-Oleoyl Taurine Exclusive 52514-04-2 ≥98% 2005-01-05 6.681187845304 n-oleoyl-taurine endocannibinoids fatty amides oleamides taurines amino-acyls lipidomics profiling fatty acids neurochemistry neuroscience TRPV1 TRPV4 FAAH cannabinoids cbs synthetic 6.681187845304
781001 NOS Activity Assay Kit - 117.986593001841 nos-activity-assay-kit iNOS eNOS nNOS nitric oxide synthases activity radiolabeled arginine inducible neuronal endothelial citrulline kits assays 117.986593001841
10007697 N-Palmitoyl Dopamine 136181-87-8 >98% 2005-11-23 5.533591160221 n-palmitoyl-dopamine PALDA N-acyls fatty anologs N-araachidonoyl NADA N-oleoyl ODA bovine brains amides palmitic acids hybrids anandamides neurotransmitter pathways inactive vanilloid receptors 1 VR1 ligands hyperalgesics nocifensives responses in vivo entourage effects neurochemistry cannabinoids cbs synthetic 5.533591160221
10009020 N-Palmitoyl Glycine 2441-41-0 ≥98% 2009-12-01 9.929088397789 n-palmitoyl-glycine N-Hexadecanoyl-Glycine; PalGly pain inflammation AEA anandamides DRG nociception calcium influx arachidonoyl amides glycines 9.929088397789
10005611 N-Palmitoyl Taurine 83982-06-3 >98% 2005-02-16 6.632880820836 n-palmitoyl-taurine endocannabinoids fatty amides oleamides bovine brain lipidomics rat amino-acyl neurochemistry, cannabinoids cbs synthetic 6.632880820836
70590 NS-398 123653-11-2 >98% 105.368845917740 ns-398 cyclooxygenases inhibitors NSAIDs COX-2 nonsteroidal anti-inflammatory drugs cox2 pghs2 pghs-2 prostaglandins synthases synthase-2 inhibits selective ns398 selectivity neurochemistry 105.368845917740
10005610 N-Stearoyl Taurine 63155-80-6 >98% 2005-02-09 6.862715074980 n-stearoyl-taurine endocannabinoids fatty amides oleamides amino-acyl bovine brain rat lipidomics neurochemistry neuroscience TRPV1 TRPV4 FAAH cannabinoids cbs synthetic 6.862715074980
10032 N-(α-Linolenoyl) Tyrosine 259143-19-6 >98% 15.383613259668 n-linolenoyl-tyrosine NALT neurochemistry neuroscience fatty acids neurotransmitters dopamine CNS central nervous system anti-Parkinson's anti-Parkinsons diseases endocrinology 15.383613259668
80587 Nω-propyl-L-Arginine 137361-05-8 >98% 13.891208563535 n-propyl-l-arginine nNOS NOS selective inhibitors arginine nitric oxide synthase neurochemistry 13.891208563535
10006803 O-1602 317321-41-8 >98% 2005-09-12 10.751519337016 o-1602 abnormal cannabidiols CB1 CB2 receptors vasorelaxation neurochemistry neuroscience central cannabinoids peripheral selective antagonists nonendothelium-dependant vasodilation nitric oxides NOs inhibits inhibitors inhibition vasorelaxant cannabinoids cbs synthetic 10.751519337016
10006804 O-1821 35482-50-9 >97% 2005-09-12 18.792081031307 o-1821 abnormal cannabidiol central cannabinoids peripheral CB1 CB2 receptors vasorelaxation neurochemistry neuroscience antagonists synthetic regioisomer endothelium dependent vasodilation cannabinoids cbs synthetic 18.792081031307
10004914 O-1918 536697-79-7 >98% 2005-09-09 9.388121546961 o-1918 antagonists abnormal cannabinoids cannabidiols cannabidiol-mediated synthetic regioisomers CB1 CB2 responsiveness psychotropics activity induces endothelium-dependent vasodilations NO-independent nitric oxides mechanisms analogs endothelial receptors inhibits inhibition inhibitors vasorelexants in vitro blocks induced activations PI3-kinases Akt pathway umbilical vein cells neuroscience neurochemistry O1918 0-1918 cannabinoids cbs synthetic 9.388121546961
10009195 O-2545 (hydrochloride) - >98% 2007-07-12 1.533701657459 o-2545-hydrochloride cannabinoids water soluble agonists receptors CB1 CB2 lipophilic surfactants 874745-42-3 murine models intravenously IV 02545 intracerebroventricularly endocrinology neurochemistry cannabinoids cbs synthetic 1.533701657459
91050 O-Arachidonoyl Ethanolamine (hydrochloride) 443129-35-9 >98% 33.231204419889 o-arachidonoyl-ethanolamine-hydrochloride Virodhamine; O-AEA; Arachidonic Acid-(2-aminoethyl)-ester endocannabinoids anandamides tetrahydrocannabinoids THC CB1 CB2 receptors arachidonoyl ethanolamides ligand ethanolamines neurochemistry neuroscience esters antagonists cannabinoids cbs synthetic 33.231204419889
10010547 O-Arachidonoyl Glycidol Exclusive 439146-24-4 >98% 2008-03-31 18.812883977900 o-arachidonoyl-glycidol 2-AG 2-arachidonoyl glycerol 2-oleoylglycerol N-arachidonoylethanolamine anandamide AEA FAAH endocannabinoid obesity pain neurodegenerative diseases monoacylglycerol lipase inhibits inhibitors inhibitions MAGL MGL cannabinoids 18.812883977900
90265 Oleoyl Ethanolamide 111-58-0 >98% 18.113664825046 oleoyl-ethanolamide Oleic Acid Ethanolamide; OEA cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides cbs synthetic 18.113664825046
10007823 Oleoyl Ethanolamide-d2 - ≥99% deuterated product 2006-03-06 13.068480662984 oleoyl-ethanolamide-d2 OEA-d2; Oleic Acid Ethanolamide-d2 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides cbs synthetic 13.068480662984
9000552 Oleoyl Ethanolamide-d4 Exclusive - ≥99% deuterated product 2010-01-12 10.002320441988 oleoyl-ethanolamide-d4 Oleic Acid Ethanolamide-d4; OEA-d4 cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides deuterateds deuteriums MS mass spectrometry CBs LC-MS OEAs LC/MS GC/MS G-MS standards PPAR brain tissue neurochemistry neuroscience synthetic 10.002320441988
10005459 Oleoyl Ethyl Amide Exclusive 85075-82-7 >98% 2004-07-21 21.423348066299 oleoyl-ethyl-amide N-Ethyloleamide; OEtA endocannabinoids analogs FAAH fatty acid amide hydrolase analgesic inhibitors inhibitor inhibition acyl PEAase anxiolytic inhibits selective selectivity neuroscience neurochemistry cannabinoids cbs synthetic 21.423348066299
71650 Oleoyl Oxazolopyridine 288862-58-8 >98% 12.563011049724 oleoyl-oxazolopyridine CAY10400 FAAH fatty acid amide hydrolases inhibitors inhibition inhibits hydrolysis hydrolyze CAY-10400 neuroscience neurochemistry 12.563011049724
62640 Oleyl Trifluoromethyl Ketone 177987-23-4 >98% 2.979889502762 oleyl-trifluoromethyl-ketone OTK; Heptadecyl Trifluoromethyl Ketone Trifluoromethyl ketone inhibitors inhibits analogs oleic fatty acids neurochemistry neuroscience 2.979889502762
90262 Olvanil 58493-49-5 >98% 6.050239410681 olvanil NE 19550; N-Vanillyloleamide capsaicin capsicum vanilloids receptors agonists cannabinoids analgesia anandamides analgesic vanillylamines amides analogs neurochemistry neuroscience 6.050239410681
10171 OMDM-1 - >98% 2004-02-05 11.400041436463 omdm-1 (S)-N-oleoyl Tyrosinol endocannabinoids inhibitors AEA lipids anandamides analogs selective selectivity inhibits inhibition R-tyrosinol amides (R)-tyrosinol oleic acid reuptake OMDM1 neurochemistry neuroscience cannabinoids inhibitors 11.400041436463
10179 OMDM-2 - >98% 2004-02-05 9.800618784530 omdm-2 (R)-N-oleoyl Tyrosinol endocannabinoids inhibitors AEA lipids anandamides analogs selective selectivity inhibits inhibition R-tyrosinol amides (R)-tyrosinol oleic acid reuptake OMDM2 neurochemistry neuroscience cannabinoids inhibitors 9.800618784530
300000 Optineurin (C-Term) Blocking Peptide - 12.680662983425 optineurin-c-term-blocking-peptide NRP; FIP-2 western blots blotting WB peptides controls FIP2 apoptosis OPTN c-terminus 14.7k interacting protein-2 TNFalpha TNF.alpha. TNF-alpha TNF-.alpha. tumornecrosis factor neurochemistry neuroscience 12.680662983425
100000 Optineurin (C-Term) Polyclonal Antibody - 28.524309392265 optineurin-c-term-polyclonal-antibody NRP; FIP-2 apoptosis signaling transduction signalling 14.7k interacting protein-2 nemo-related proteins WB western blots blotting cell death glaucoma IOP intraocular pressure neurochemistry neuroscience CTerm ophthalmology immunoblotting 28.524309392265
300002 Optineurin (INT) Blocking Peptide - 3.162983425414 optineurin-int-blocking-peptide NRP; FIP-2 receptors controls peptides antibodies FIP2 WB western blot blotting 14.7K interacting protein-2 neurochemistry neuroscience 3.162983425414
100002 Optineurin (INT) Polyclonal Antibody - 19.006629834254 optineurin-int-polyclonal-antibody NRP; FIP-2 apoptosis signaling transduction signalling neurochemistry neuroscience fip2 tumor necrosis factors tnf glaucoma IOP intraocular pressure WB western blots blotting cell death 14.7k interacting protein-2nemo-related ophthalmology immunoblotting 19.006629834254
600240 Orexin 1 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - 2010-03-31 0.869820441989 orexin-1-receptor-step-reporter-assay-kit-luminescence OX1R hypercretins 1 orexins 2 A orexin-2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 0.869820441989
600250 Orexin 2 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - 2010-03-31 1.019337016574 orexin-2-receptor-step-reporter-assay-kit-luminescence OX2R hypercretins 1 orexin 2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 1.019337016574
10008642 oxy-Arachidonoyl Ethanolamide - >98% 2007-09-06 10.283609576427 oxy-arachidonoyl-ethanolamide oxy-Anandamide; oxy-AEA oxyanadamide arachidonylethanolamide AEA THC marijuana CB1 CB2 endocannabinoids receptors cannabinoids inhibitors 10.283609576427
90350 Palmitoyl Ethanolamide 544-31-0 ≥98% 27.096596685082 palmitoyl-ethanolamide Palmidrol; PEA endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic 27.096596685082
10007824 Palmitoyl Ethanolamide-d4 Exclusive 1159908-45-8 ≥99% deuterated product 2006-03-06 30.176906077348 palmitoyl-ethanolamide-d4 Palmidrol-d4; PEA-7,7,8,8-d4 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cyclic cAMP ethanolamides anandamides AEA fatty acids neurochemistry ethanolamines cannabinoids cbs synthetic 30.176906077348
9000551 Palmitoyl Ethanolamide-d4 Exclusive - ≥99% deuterated product 2010-01-20 8.388955538015 palmitoyl-ethanolamide-d4 Palmidrol-d4; PEA-hydroxyethyl-1,1,2,2-d4 endocannabinoids CB2 neurotransmitters receptors ligands PEAs N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines LC-MS GC-MS mass spetrometry standards deuterateds deuterium MS LC/MS GC/MS cannabinoids cbs synthetic 8.388955538015
9000573 Palmitoyl Ethanolamide-d5 Exclusive - ≥99% deuterated compound 2010-03-04 5.932974217311 palmitoyl-ethanolamide-d5 PEA-15,15,16,16,16-d5; Palmidrol-d5 endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines LC-MS GC-MS mass spetrometry standards deuterateds deuterium MS LC/MS GC/MS CBs synthetic 5.932974217311
91354 Palmitoyl N-Isopropylamide 189939-61-5 >98% 6.115548539858 palmitoyl-n-isopropylamide PIA cannabinoids FAAH fatty acid amide hydrolase inhibits inhibitors inhibition ethanolamides palmitoyl-n-isopropylamide PEA neurochemistry neuroscience synthetic analogs hydrolysis ethanolamines 6.115548539858
62175 Palmitoyl Serinol 126127-31-9 >98% 22.767748618784 palmitoyl-serinol endocannabinoids 2PG CB1 receptors synthases FAAH fatty acids amides analogs hydrolases 2-PG glycerols adenyl cyclase inhibits inhibition re-uptake reuptake neurochemistry neuroscience cannabinoids cbs synthetic 22.767748618784
62650 Palmityl Trifluoromethyl Ketone 141022-99-3 >98% 46.367403314918 palmityl-trifluoromethyl-ketone PTK; Pentadeca Trifluoromethyl Ketone ketones inhibitors analogs palmitic fatty acids inhibits inhibition lipoxygeanses LOs neurochemistry neuroscience 46.367403314918
9000746 Pentylone (hydrochloride) 17763-01-8 ≥98% 2011-04-20 50.368140286714 pentylone-hydrochloride mephedrone MDMA ecstasy neuroscience forensics designer drugs MDPV valerophenone 1-pentanone pentanone 698963-77-8 50.368140286714
13279 PF-3845 1196109-52-0 ≥98% 2010-01-27 37.992885205648 pf-3845 fatty acids hydrolase FAAH N-acyl ethanolamines NAEs endocannabinoids N-arachidonoyl ethanolamine anandamide AEA inhibitors inhibits inflammation pain PF3845 PF 3845 cannabinoids cbs synthetic Antibodies Monoclonal Monoclonal Antibodies 37.992885205648
10010907 PF-622 898235-65-9 >98% 2008-03-26 6.383455163621 pf-622 FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain fatty acids amides hydrolases neurochemistry 6.383455163621
10010908 PF-750 959151-50-9 >98% 2008-03-25 11.288732734806 pf-750 FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain neurochemistry 11.288732734806
9000849 Phenazepam 51753-57-2 ≥98% 2011-02-14 12.435635359116 phenazepam Fenazepam; BD 98 benzodiazepine agonists GABAA receptors anxiolytic sedative anticonvulsive anti-convulsive anti convulsive hypnotic tranquilizers 12.435635359116
71655 PHOP 288862-83-9 >98% 2005-02-02 10.937995264403 phop Phenyl hexanoyl oxazolopyridine; CAY10402 FAAH fatty acids amides hydrolases inhibits inhibitors inhibition cannabinoids CB1 CB2 hydrolysis hydrolyze CAY-10402 TGH triacylglycerols neurochemistry neuroscience cbs synthetic 10.937995264403
589751 Prion Protein EIA Kit - 15.008586556169 prion-protein-eia-kit Prion Protein ELISA Kit proteins mad cow diseases bovine spongiform scrapie Creutzfeldt-jakob neurodegeneration measures kits eias enzyme encephalopathy immunoassays ELISAs BSE spi-bio spibio A05201 assays 15.008586556169
10009030 Prion Protein Monoclonal Antibody (11C6) - 2006-07-11 4.900552486187 prion-protein-monoclonal-antibody-11c6 proteins antibodies antisera antiserum spi-bio spibio A03212 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry 4.900552486187
189710 Prion Protein Monoclonal Antibody (12F10) - 8.691298342541 prion-protein-monoclonal-antibody-12f10 proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob A3221 neurodegeneration antibodies antisera antiserum neurochemistry neuroscience spi-bio spibio WB western blots blotting immunoblotting IHC immunohistochemistry 8.691298342541
189750 Prion Protein Monoclonal Antibody (308) - 6.868093922651 prion-protein-monoclonal-antibody-308 proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum neurochemistry neuroscience spi-bio spibio A03200 WB western blots blotting immunoblotting IHC immunohistochemistry 6.868093922651
189760 Prion Protein Monoclonal Antibody (8G8) - 7.645027624309 prion-protein-monoclonal-antibody-8g8 proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antisera antiserum antibodies WB western blots blotting IHC immunohistochemistry neurochemistry neuroscience spi-bio spibio A03220 immunoblotting 7.645027624309
10009034 Prion Protein Monoclonal Antibody (BAR221) - 2006-07-11 5.227255985267 prion-protein-monoclonal-antibody-bar221 proteins antibodies antisera antiserum spi-bio spibio A03222 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry IHC immunohistochemistry 5.227255985267
10009035 Prion Protein Monoclonal Antibody (BAR224) - 2006-07-11 23.976427255985 prion-protein-monoclonal-antibody-bar224 proteins antibodies antisera antiserum spi-bio spibio A03211 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry IHC immunohistochemistry 23.976427255985
10009036 Prion Protein Monoclonal Antibody (BAR233) - 2006-07-11 9.393738489871 prion-protein-monoclonal-antibody-bar233 proteins antibodies antisera antiserum spi-bio spibio A03223 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry 9.393738489871
10009037 Prion Protein Monoclonal Antibody (BAR236) - 2006-07-11 5.227255985267 prion-protein-monoclonal-antibody-bar236 proteins antibodies antisera antiserum spi-bio spibio A03224 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry 5.227255985267
189720 Prion Protein Monoclonal Antibody (SAF-32) - 28.570441988950 prion-protein-monoclonal-antibody-saf-32 proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt- jakob neurodegeneration antibodies antisera antiserum saf32 neurochemistry neuroscience spi-bio spibio A03202 WB western blots blotting immunoblotting IHC immunohistochemistry Enzyme-linked immunosorbent assays FC flow cytometry 28.570441988950
189730 Prion Protein Monoclonal Antibody (SAF-53) - 5.552486187845 prion-protein-monoclonal-antibody-saf-53 proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf53 neurochemistry neuroscience spi-bio spibio A03203 Enzyme-linked immunosorbent assays FC flow cytometry 5.552486187845
189740 Prion Protein Monoclonal Antibody (SAF-54) - 5.552486187845 prion-protein-monoclonal-antibody-saf-54 proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf54 neurochemistry neuroscience spi-bio spibio A03204 IHC immunohistochemistry 5.552486187845
189755 Prion Protein Monoclonal Antibody (SAF-61) - 6.598756906077 prion-protein-monoclonal-antibody-saf-61 proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf61 neurochemistry neuroscience spi-bio spibio A03205 Enzyme-linked immunosorbent assays FC flow cytometry 6.598756906077
189770 Prion Protein Monoclonal Antibody (SAF-70) - 7.645027624309 prion-protein-monoclonal-antibody-saf-70 proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt- A03206 jakob neurodegeneration antibodies SAFTO WB western blots blotting antisera antiserum neurochemistry neuroscience spi-bio spibio immunoblotting 7.645027624309
189765 Prion Protein Monoclonal Antibody (SAF-83) - 8.691298342541 prion-protein-monoclonal-antibody-saf-83 proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf83 neurochemistry neuroscience spi-bio spibio A03207 WB western blots blotting immunoblotting Enzyme-linked immunosorbent assays FC flow cytometry 8.691298342541
189775 Prion Protein Monoclonal Antibody (SAF-84) - 19.154005524862 prion-protein-monoclonal-antibody-saf-84 proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf84 neurochemistry neuroscience spi-bio spibio A03208 WB western blots blotting immunoblotting IHC immunohistochemistry 19.154005524862
13621 Pristimerin Exclusive 1258-84-0 ≥98% 2010-03-08 42.875840568271 pristimerin Celastrol methyl ester; NSC 99281 monoacylglycerol lipases MAGLs monoglycerol MGLs cannabinoids 2-arachidonoyl glycerol 2-AG inhibitor 2-Picenecarboxylic acids cannabinoids cbs synthetic Triterpenes 42.875840568271
500940 Progranulin (human) EIA Kit - 2011-04-26 27.290078623034 progranulin-human-eia-kit PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants 27.290078623034
500950 Progranulin (mouse) EIA Kit - 2011-04-26 36.071109064866 progranulin-mouse-eia-kit murine mice PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants 36.071109064866
12010 Prostaglandin D2 41598-07-6 >99% 180.514980639373 prostaglandin-d2 PGD2 Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry 180.514980639373
12015 Prostaglandin D2-1-glyceryl ester 309260-52-4 >95% (as a 9:1 mixture of the 1- and 2-glyceryl esters) 2004-08-05 35.607513812154 prostaglandin-d2-1-glyceryl-ester PGD2-1-glyceryl ester endocannabinoids anandamides 2AG fatty acids porcine brain isomerase moiety cannabinoids cbs synthetic 35.607513812154
312010 Prostaglandin D2-d4 - ≥99% deuterated product 55.610165745856 prostaglandin-d2-d4 PGD2-d4 GC/MS deuterium isotopes PGD2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience 55.610165745856
10007272 Prostaglandin D2-d4 Lipid Maps MS Standard - ≥99% deuterated compound 2009-02-26 47.598011049723 prostaglandin-d2-d4-lipid-maps-ms-standard PGD2-d4 GC/MS deuterium isotopes PGD2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience MS mass spectrometry standards 47.598011049723
10010123 Prostaglandin D2-d9 - ≥99% deuterated product 2007-10-25 93.132005831798 prostaglandin-d2-d9 PGD2-d9 GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience allergy asthma 93.132005831798
512031 Prostaglandin D2 EIA Kit - 2010-07-19 268.101938305709 prostaglandin-d2-eia-kit PGD2 ELISA Kit PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions 268.101938305709
12012 Prostaglandin D2 Ethanolamide 398138-28-8 >96% 29.102312549329 prostaglandin-d2-ethanolamide PGD2-EA anandamides ethanolamides cannabinoids PGD2 prostaglandins AEA neurochemistry neuroscience ethanolamines prostamides 29.102312549329
10007203 Prostaglandin D2 Ethanolamide Lipid Maps MS Standard 398138-28-8 >96% 2008-10-29 28.541617995264 prostaglandin-d2-ethanolamide-lipid-maps-ms-standard PGD2-EA anandamides ethanolamides cannabinoids PGD2 prostaglandins AEA neurochemistry neuroscience ethanolamines prostamides GC LC mass spectrometry MS standards 28.541617995264
512041 Prostaglandin D2 Express EIA Kit - 2010-07-19 125.652167445813 prostaglandin-d2-express-eia-kit PGD2 Express ELISA Kit PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions 125.652167445813
10192 Prostaglandin D2 serinol amide - >98% 2004-05-13 39.763292817680 prostaglandin-d2-serinol-amide PGD2-SA PGD2 vasodilation prostaglandins brain sleep platelets aggregation anandamides serinols amides cannabinoids AEA 39.763292817680
10006593 Prostaglandin D Synthase (hematopoietic-type; human recombinant) - ≥95% 2005-02-16 34.087328334649 prostaglandin-d-synthase-hematopoietic-type-human-recombinant Hematopoietic-PGDS; H-PGDS; PGD Synthase (hematopoietic-type; human recombinant) prostaglandins synthases PGDs PGD2 HPGDS H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators 34.087328334649
10009625 Prostaglandin D Synthase (hematopoietic-type; human recombinant) Western Ready Control - 2007-07-19 24.699454419889 prostaglandin-d-synthase-hematopoietic-type-human-recombinant-western-ready-control Hematopoietic-PGDS; H-PGDS western blot WB PGH2 lipocalin-type hematopoietic peripheral tisses antigen-presenting cells mast megakaryocytes allergic HPGDS H-PGDS inflammatory diseases inhibits inhibitor inhibition E. coli 24.699454419889
10004347 Prostaglandin D Synthase (hematopoietic-type; mouse recombinant) Exclusive - ≥85% 2008-06-05 33.098225905463 prostaglandin-d-synthase-hematopoietic-type-mouse-recombinant H-PGDS; Hematopoietic-PGDS PGH2 lipocalin-type .beta.-trace prostaglandins hematopoietic enzymes PGD2 proteins recombinant inflammation activity high throughput screening inhibitors inhibits inhibition assays HPGDS H-PGDS 33.098225905463
10007684 Prostaglandin D Synthase (lipocalin-type; human) EIA Kit Exclusive - 2008-06-09 18.893540515653 prostaglandin-d-synthase-lipocalin-type-human-eia-kit Lipocalin-PGDS ELISA Kit; L-PGDS EIA Kit EIAs ELISAs Assays sandwich immunometric homodimer glycosylation catalyzes prostaglandins PGH2 PGD2 carrier proteins lipid-like molecules neurochemistry retinoids thyroid hormones body fluids cerebrospinal seminal plasma PTGDS beta-trace b-trace .beta.-trace betatrace btrace lpgds l-pgds assays 18.893540515653
10004342 Prostaglandin D Synthase (lipocalin-type; human) Monoclonal Antibody (Clone 10A5) - 2004-03-04 26.870538674033 prostaglandin-d-synthase-lipocalin-type-human-monoclonal-antibody-clone-10a5 Lipocalin-PGDS; L-PGDS prostaglandins inhibitors renal failure synthases lpgds antibodies antisera antiserum wb ihc western blots blotting immunohistochemistry b-trace beta-trace .beta.-trace l-pgds immunoblotting 26.870538674033
10006788 Prostaglandin D Synthase (lipocalin-type; human recombinant) - ≥95% 2005-03-23 39.367700605103 prostaglandin-d-synthase-lipocalin-type-human-recombinant L-PGDS; Lipocalin-PGDS prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds 39.367700605103
10009741 Prostaglandin D Synthase (lipocalin type; human) Western Ready Control - 2007-04-30 6.126104972375 prostaglandin-d-synthase-lipocalin-type-human-western-ready-control L-PGDS; Lipocalin-PGDS GST lpgds l-pgds western blot WB neurochemistry hL-PGDS hLPGDS 6.126104972375
10004344 Prostaglandin D Synthase (lipocalin-type; mouse) Polyclonal Antibody - 2004-03-10 7.867237569060 prostaglandin-d-synthase-lipocalin-type-mouse-polyclonal-antibody L-PGDS; Lipocalin-PGDS prostaglandins inhibitors renal failure synthases antibodies antisera antiserum wb ihc western blots blotting immunohistochemistry lpgds l-pgds immunoblotting 7.867237569060
10006787 Prostaglandin D Synthase (lipocalin-type; mouse recombinant) - ≥95% 2005-03-23 41.216685082873 prostaglandin-d-synthase-lipocalin-type-mouse-recombinant L-PGDS; Lipocalin-PGDS prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds 41.216685082873
160003 Prostaglandin D Synthase (lipocalin-type) Polyclonal Antibody - 29.164076120319 prostaglandin-d-synthase-lipocalin-type-polyclonal-antibody L-PGDS; Lipocalin-PGDS antibodies human pgds synthases western blots blotting prostaglandins pgd2 antisera antiserum wb lpgds l-pgds immunoblotting 29.164076120319
10010548 Prostaglandin D Synthase (lipocalin-type; rat recombinant) Exclusive - ≥95% 2008-07-01 38.236034849129 prostaglandin-d-synthase-lipocalin-type-rat-recombinant L-PGDS; Lipocalin-PGDS prostaglandins PGH2 beta-trace b-trace proteins assays neurochemistry rL-PGDS rlPGDS .beta.-trace beta-trace b-trace recombinant human cerebrospinal fluid PGs CSF GST-tags GST-tagged N-terminal lpgds l-pgds 38.236034849129
13012 Prostaglandin E1 Ethanolamide 210976-81-1 >98% 37.707145488030 prostaglandin-e1-ethanolamide PGE1-EA; Alprostadil Ethanolamide anandamides ethanolamides cannabinoids PGE1 prostaglandins AEA neurochemistry neuroscience ethanolamines prostamides 37.707145488030
10140 Prostaglandin E2-1-glyceryl ester 37497-47-5 >98% (as a 85:15 mixture of the 1- and 2-glyceryl esters) 48.040865561694 prostaglandin-e2-1-glyceryl-ester PGE2-1-glyceryl ester Prostaglandins PGE2-1-GE esters 2-AG 2-arachidonyl-glycerol metabolites COX-2 PGHS-2 cycloxygenases synthases PGE2-2-GE COX2 PGHS2 cannabinoids cbs synthetic 48.040865561694
14012 Prostaglandin E2 Ethanolamide Exclusive 194935-38-1 >98% 40.204841160221 prostaglandin-e2-ethanolamide PGE2-EA; Dinoprostone Ethanolamide; Prostamide E2 anandamides ethanolamides cannabinoids PGE2 prostaglandins AEA analogs neurochemistry neuroscience ethanolamines prostamides 40.204841160221
10007212 Prostaglandin E2 Ethanolamide Lipid Maps MS Standard 194935-38-1 >98% 2008-11-05 31.647041129527 prostaglandin-e2-ethanolamide-lipid-maps-ms-standard Dinoprostone Ethanolamide; Prostamide E2; PGE2-EA anandamides ethanolamides cannabinoids PGE2 prostaglandins AEA analogs neurochemistry neuroscience ethanolamines prostamides GC-MS GC/MS LC-MS LC/MS mass spectromatory standards 31.647041129527
10193 Prostaglandin E2 serinol amide Exclusive - ≥98% 2004-03-03 36.258397790055 prostaglandin-e2-serinol-amide PGE2-SA PGE2SA cannabinoids agonists CB1 receptors analogs 2-glyceryl neurochemistry neuroscience 36.258397790055
10139 Prostaglandin F-1-glyceryl ester 43042-79-1 >98% (as a 9:1 mixture of the 2- and 1-glyceryl esters) 16.060359116022 prostaglandin-f2-1-glyceryl-ester PGF2α-1-glyceryl ester Prostaglandins PGF2alpha-1-GE PGF2.alpha.-1-GE esters 2-AG 2-arachidonoyl-glycerol COX-2 metabolites cyclooxygenases PGHS-2 synthases PGHS2 COX2 PGF2alpha-2-GE PGF2.alpha.-2-GE PGFa-2-GE PGF2a-1-GE cannabinoids cbs synthetic 16.060359116022
10194 Prostaglandin F serinol amide - >98% 2004-02-23 13.622338858195 prostaglandin-f2-serinol-amide PGF2α-SA PGF2alphaSA PGF2.alpha.SA PGF2alpha-SA PGF2.alpha.-SA cannabinoids agonists CB1 recptors analogs 2-glyceryl esters amides neuroscience 13.622338858195
160630 Prostaglandin I Synthase Monoclonal Antibody (Clone isn-1) - Protein-A purified 5.170662983425 prostaglandin-i-synthase-monoclonal-antibody-clone-isn-1 Prostacyclin Synthase; PGIS; PGI Synthase synthases endothelium PGI2 prostaglandins antibodies antisera antiserum Bovine PGI synthase atherosclerosis neurochemistry IP immunoprecipitation IHC immunohistochemistry 5.170662983425
100023 Prostaglandin I Synthase (murine) Polyclonal Antibody - 2004-06-30 10.323301104972 prostaglandin-i-synthase-murine-polyclonal-antibody PGIS; Prostacyclin Synthase; PGI Synthase antibodies antisera antiserum western blots blotting wb IHC immunohistochemistry prostaglandins prostacyclins synthases receptors atherosclerosis immunoblotting 10.323301104972
160640 Prostaglandin I Synthase Polyclonal Antibody - 8.795432780847 prostaglandin-i-synthase-polyclonal-antibody Prostacyclin Synthase; PGIS; PGI Synthase PGIS prostacyclin synthases endothelium Western blots PGI2 prostaglandins blotting antisera antiserum immunoprecipitation IP antibodies atherosclerosis WB immunoblotting 8.795432780847
10011435 PSD95 Monoclonal Antibody (Clone 6G6) - 2008-05-07 1.906077348066 psd95-monoclonal-antibody-clone-6g6 Postsynaptic Density Protein 95 antibodies ICC WB western blots immunocytochemistry proteins neurochemistry neurons memory learning neuronal AMPA immunoblotting autism TARPs blotting 1.906077348066
10011436 PSD95 Monoclonal Antibody (Clone 7E3) - 2008-05-07 0.953038674033 psd95-monoclonal-antibody-clone-7e3 Postsynaptic Density Protein 95 antibodies WB western blots proteins neurochemistry neuronal neurons synapse memory learning PSD-95 immunoblotting receptors TARPs AMPA autism PSD 95 blotting 0.953038674033
10009506 PSD95 Polyclonal Antibody - 2007-01-03 0.347645558861 psd95-polyclonal-antibody Postsynaptic Density Protein of 95 antibodies WB western blot PDZ domain glutamate receptors signaling proteins synapse NMDAR phosphorylation proteins signalling blotting immunoblotting 0.347645558861
10008594 PSN632408 Exclusive 857652-30-3 >98% 2006-08-01 84.541160220994 psn632408 GPR119 SNORF25 agonists oleoylethanolamide OEA obesity appetite food intake GPCR G protein-coupled receptors PSN632408 weight gain pancreas gastrointestinal tract brain endocrinology neurochemistry 84.541160220994
10817 Pyrovalerone Exclusive 3563-49-3 ≥95% 2011-05-25 40.680014376032 pyrovalerone Thymergix; Centroton; Valerophenone inhibitors neurotransmitters dopamine norepinephrine controlled substances forensic analysis forensics bath salts 10836 valerophenone 40.680014376032
10836 Pyrovalerone (hydrochloride) 1147-62-2 ≥95% 2011-05-24 45.364385875727 pyrovalerone-hydrochloride Centroton; Thymergix inhibitors neurotransmitters dopamine norepinephrine controlled substances forensic analysis forensics bath salts inhibition 10817 free base inhibits 3563-49-3 45.364385875727
90070 R-1 Methanandamide 157182-49-5 >98% 20.680584056827 r-1-methanandamide (R)-(+)-Arachidonyl-1'-Hydroxy-2'-Propylamide; AM356 cannabinoids neurotransmitters ligand AEA lipids CB1 CB2 receptor anandamide analogs agonists neurochemistry neuroscience 20.680584056827
10004281 R-1 Methanandamide Phosphate - >98% 2004-08-20 17.891049723757 r-1-methanandamide-phosphate R-1MAP; (R)-(+)-Arachidonyl-1'-Hydroxy-2'-Propylamide Phosphate endocannabinoids neurotransmitters ligands AEA lipids CB1 CB2 receptors anandamides analogs agonists phosphates LPA lysophatidic acids neurochemistry neuroscience R1 cannabinoids cbs synthetic 17.891049723757
90074 R-2 Methanandamide - >98% 9.283011049724 r-2-methanandamide (R)-(-)-Arachidonyl-2'-Hydroxy-1'-Propylamide cannabinoids neurotransmitter AEA lipids CB1 CB2 receptors anandamide analogs neurochemistry neuroscience 9.283011049724
10491 (R)-AM1241 Exclusive 444912-51-0 ≥98% 2010-05-27 39.482488234090 -r-am1241 (+)-AM1241 cannabinoids CB2 receptors CB1 agonists inverse agonists antinociception pains SR144528 rimonabant CBs 39.482488234090
10645 RCS-4 - ≥98% 2010-11-24 127.480315197521 rcs-4 cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics CBs neurochemistry cannabinoids cbs synthetic 127.480315197521
10865 RCS-4 2-methoxy isomer - ≥98% 2011-06-15 54.039667490549 rcs-4-2-methoxy-isomer synthetic cannabinoids forensics receptors herbal spices incense JWH 250 JWH-250 JWH250 RCS4 RCS 4 analogs CB1 CB2 cannabimimetic indoles CBs 54.039667490549
10866 RCS-4 3-methoxy isomer Exclusive - ≥98% 2011-06-15 45.111948033066 rcs-4-3-methoxy-isomer cannabinoids receptors JWH 018 CB1 CB2 CBs cannabimimetics forensics synthetic bath salts JWH-018 JWH018 45.111948033066
10798 RCS-4-C4 homolog Exclusive - ≥98% 2011-04-21 58.428009777551 rcs-4-c4-homolog BTM-4; SR-19; OBT-199; E-4 cannabinoids cannabimimetic metabolites CB1 CB2 receptors agonists spice forensics synthetics smoking urinary urine serum JWH018 JWH 018 JWH-018 JWH18 BTM4 BTM 4 E4 E 4 OBT199 OBT 199 SR19 SR 19 58.428009777551
10513 RCS-4-d9 New - ≥99% deuterated product 2011-09-12 44.447019892911 rcs-4-d9 cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics sciences CBs neurochemistry synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 44.447019892911
10935 RCS-4 N-(5-hydroxypentyl) metabolite Exclusive - ≥98% 2011-06-17 45.618204419889 rcs-4-n-5-hydroxypentyl-metabolite cannabinoids cannabimimetic metabolites CB1 CB2 CBs receptors agonists spices forensics synthetic smoking urinary urine RCS4 RCS 4 JWHs glucuroconjugate forensics sciences neuroscience 45.618204419889
10636 RCS-8 Exclusive - ≥98% 2010-11-02 110.680693566903 rcs-8 SR-18 cannabinoids receptors JWH 250 CB1 CB2 cannabimimetics forensics cannabinoids cbs synthetic Rabbit Aorta Contracting Substance A2 Thromboxane Thromboxane A2 110.680693566903
10012554 Resolvin D1 Exclusive 872993-05-0 ≥95% 2008-06-06 256.881973164956 resolvin-d1 RvD1; 17(S)-Resolvin D1 EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins 256.881973164956
70255 (R)-Flurbiprofen 51543-40-9 ≥99% 2004-06-11 5.745256511444 -r-flurbiprofen E-7869; Tarenflurbil; Flurizan cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits inhibition neurochemistry 5.745256511444
10009411 Ribosomal S6 Kinase 2 Polyclonal Antibody - 2006-11-28 0E-12 ribosomal-s6-kinase-2-polyclonal-antibody RSK2 wb western blotting blots antibodies p90 kinases RSK1 RSK2 RSK3 RSK4 downstream members extracellular signal-regulated ERK/MAPK cascade humans Coffin-Lowry syndrome mental retardation growth deficits defects tonic regulation GPCRs G protein-coupled signalling immunoblotting 0E-12
9000484 Rimonabant 168273-06-1 ≥98% 2009-06-17 70.164019337016 rimonabant SR141716 SR 141716A SR141716A CB1 inverse agonists anti-obesity immunomodulation anti-proliferation appetite suppressants receptors weight control medication cannabinoids anti-proliferative immunodulatory cbs sythetic 70.164019337016
10011132 Rolipram 61413-54-5 ≥98% 2008-12-16 11.821048563680 rolipram ZK 62711; SB 95952 inhibits inhibitor inhibition phosphodiesterase PDE4 cAMP inflammation leukocyte LPS TNF monocytes C5a LTC4 eosinophil neurons bones loss 11.821048563680
90353 R-Palmitoyl-(1-methyl) Ethanolamide 142128-47-0 >98% 5.706824829379 r-palmitoyl-1-methyl-ethanolamide R-1 PMA PEA AEA ethanolamides R-1-PMA cannabinoids analogs (R)-methyl ethanolamines inhibitors inhibits CB2 receptors neurochemistry neuroscience 5.706824829379
90357 R-Palmitoyl-(2-methyl) Ethanolamide 179951-56-5 >98% 5.360389809699 r-palmitoyl-2-methyl-ethanolamide RP-2ME PEA cannabinoids analogs anandamides methanandamides CB2 receptors ethanolamides inhibits inhibitors (R)-N-(2-hydroxypropyl)-hexadecanamide FAAH fatty acids hydrolases agonists neurochemistry neuroscience ethanolamines 5.360389809699
10009227 (R)-SLV 319 656827-86-0 >98% 2007-09-05 0.216408839779 -r-slv-319 CB1 CB2 receptors cannabinoids antagonists inflammation 0.216408839779
90072 S-1 Methanandamide - >98% 9.503867403315 s-1-methanandamide (S)-(-)-Arachidonyl-1'-Hydroxy-2'-Propylamide cannabinoids neurotransmitters ligand AEA lipids CB1 CB2 receptors anandamides analogs agonists neurochemistry neuroscience 9.503867403315
90076 S-2 Methanandamide - >98% 18.562338858195 s-2-methanandamide (S)-(+)-Arachidonyl-2'-Hydroxy-1'-Propylamide cannabinoids neurotransmitter ligand AEA lipid CB1 CB2 receptors anandamide analogs agonists neurochemistry neuroscience 18.562338858195
13603 S-Adenosylhomocysteine 979-92-0 ≥98% 2010-04-22 9.582690607734 s-adenosylhomocysteine SAH; AdoHcy amino acids derivatives cysteine methyl cycle biosynthesis risk factors metabolic pathways cancers by-products by products neurodegenerative diseases Adenosylhomocysteine, S S-Adenosylhomocysteine S Adenosylhomocysteine 9.582690607734
10490 (S)-AM1241 Exclusive 444912-53-2 ≥98% 2010-05-27 44.391381093392 -s-am1241 (-)-AM1241 cannabinoids CB2 receptors CB1 agonists inverse agonist antinociception pains SR144528 rimonabant CBs 44.391381093392
10096 SB 242084 (hydrochloride) 1049747-87-6 ≥98% 2010-06-29 4.652028413575 sb-242084-hydrochloride 181632-25-7 serotonins 5-hydroxytryptamines 5-HT neurotransmitters neuroscience receptors gut central nervous system antagonists 5-HT2C dopamine adrenergic receptors brain anxiolytic neurochemistry CNS Antigens HLA-SB Antigens HLA-PL Antigens HLA-DP HLA-SB Antigens HLA-PL Antigens HLA-DP Antigens HLA SB Antigens HLA PL Antigens HLA DP Antigens HLA-SB HLA-PL HLA-DP 4.652028413575
11019 SB 366791 New 472981-92-3 ≥98% 2011-10-13 5.295556823889 sb-366791 pain TRPV1 antagonists hyperalgesia receptors neurons central peripheral nerves terminals thermal mechanical hyperalgesia bone cancers ganglion SB366791 SB-366791 5.295556823889
14060 SC-19220 19395-87-0 >96% 62.085182320441 sc-19220 PGE2 antagonists antinociceptives EP1 receptors selective prostaglandins SC19220 SC 19220 62.085182320441
10767 SETD2 (human recombinant) New - ≥95% 2012-01-19 81.098823852129 setd2-human-recombinant p231HBP; Huntington Interacting Protein B; HYPB; KMT3A epigenetics histones methyltransferases SET-domains containing SETD-2 SETD 2 huntingtin interacting proteins b HYBP trimethylation H3K36me3 mouse fibroblasts cells mono-methylation di-methylation WW hyperphosphorylation RNA polymerase II regulation diseases 81.098823852129
13332 (S)-Glycyl-H-1152 (hydrochloride) Exclusive 913844-45-8 ≥98% 2010-01-27 51.846950276243 -s-glycyl-h-1152-hydrochloride Rho Kinase Inhibitor IV Rho kinases ROCK-I p160ROCK ROCK-II G protein Rho cytoskeletons adhesions proliferation smooth muscles contraction stem cells inhibitors inhibition inhibited Fasudil hydrochloride ROCK IV h1152 h-1152 h 1152 51.846950276243
10009312 SKF-96365 (hydrochloride) 130495-35-1 >98% 2007-01-19 49.686806629834 skf-96365-hydrochloride calcium antagonists voltage-gated inhibits inhibitors inhibition acetylcholine-induced depolarization smooth muscles platelets neutrophils SFK9635 Ach-induced HCl neurochemistry 49.686806629834
10009226 (±)-SLV 319 Exclusive 362519-49-1 >98% 2007-01-16 21.822596685082 -slv-319 CB1 CB2 Receptors Cannabinoids Antagonists Inflammations inflammatory neurochemistry lipophilic ligands cannabinoids cbs synthetic 21.822596685082
10006518 S-Nitrosylated Protein Detection Kit - 2005-11-29 169.887066707591 s-nitrosylated-protein-detection-kit SNO Detection NOs nitric oxides synthases oxidation oxidative reactive nitrogen species RNS thiol SH groups signalling proteins kits measures measurements S-nitrosation nitrosation S-nitrosylation nitrosylation assays 169.887066707591
700330 Sphingomyelinase Inhibitor Screening Assay Kit - 2010-02-09 37.411236516705 sphingomyelinase-inhibitor-screening-assay-kit SMase assays kits measures measuring measurementsphingomyelinases SMases hydrolases enzymes sphingolipids metabolisms DNase I superfamily phosphocholines ceramides cellular cells stress pathophysiological lysosomal digestion ceramide-mediated signal transductions cytokine-induced apoptosis differentiation immune inflammatory lipoproteins aggregation vessels atherogenesis intracellular trafficking acidic neutral proliferation depressive disorders neurodegenerative disorders strokes Alzheimer's dementia diseases therapeutics cleavage conjugates free thiols 37.411236516705
9000491 SR 144528 192703-06-3 ≥98% 2009-08-05 71.692483118478 sr-144528 antagonist CB1 CB2 cannabinoids receptors inverse agonist inflammation leukocytes CP 55940 CP55940 55,940 CP55,940 pain initiation suppression immune activation sr144528 CBs synthetic 71.692483118478
10683 SR 16584 New 1150153-86-8 ≥95% 2011-11-17 47.778732351136 sr-16584 antagonists receptors nicotinic acetylcholine receptors neuroscience nAChRs ligands ion channels central peripheral nerves nervous system subtypes SR-16584 SR16584 α3β4 α4β2 α7 47.778732351136
10009022 (S)-SLV 319 Exclusive 464213-10-3 >98% 2007-08-16 0.216408839779 -s-slv-319 CB1 CB2 receptors cannabinoids antagonists inflammation obesity neurochemistry inflammatory neuro-inflammatory neuroinflammatory (S)-SLV319 disorders ligands 0.216408839779
90245 Stearoyl Ethanolamide 111-57-9 >98% 12.535421270718 stearoyl-ethanolamide Stearic Acid Ethanolamide; Ceramid anandamides N-acyl ethanolamines PLD fatty acids neurochemistry neuroscience ethanolamides 12.535421270718
583751 Substance P EIA Kit - 243.551643646408 substance-p-eia-kit Substance P ELISA Kit solid plates Substance-P Sub-P neurokinin measures kits eias enzyme immunoassays ELISAs pain endocrinology neurochemistry neuroscience assays 243.551643646408
10606 Synapsin I Polyclonal Antibody - 2009-10-23 3.504143646408 synapsin-i-polyclonal-antibody gamma inhibits inhibitors neurotransmitters WB western blots blotting enzymes synthesis plasticity brain IHC IF IP immunohistochemistry immunoprecipitation immunofluorescence 3.504143646408
10605 Synapsin I Polyclonal Antibody (neat serum) - 2009-10-23 0.386740331491 synapsin-i-polyclonal-antibody-neat-serum gamma inhibits inhibitors neurotransmitters WB western blots blotting enzymes synthesis plasticity brain 0.386740331491
13830 Synthetic Cannabinoid HPLC Mixture I - ≥95% for each compound 2010-05-13 39.243082614455 synthetic-cannabinoid-hplc-mixture-i cannabinoids CBs endocannabinoids cannabidiols CP-47,497 cp 47,497 47,497-c8-homolog CP-47,497-C8 homolog analog CP-55,940 cp47,497 cp55,940 cp 55,940 HU-331 HU331 HU 331 HU308 HU 308 HU-308 JWH-015 jwh015 jwh 015 jwh 018 jwh018JWH-018 JWH-200 jwh200 jwh 200 jwh 250 jwh250 JWH-019 Win-55212-2 Jwh-250 win 55212-2 win55212 2 synthetic spices mixes synthetic 39.243082614455
13850 Synthetic Cannabinoid HPLC Mixture II - ≥95% for each compound 2010-12-21 39.551017802333 synthetic-cannabinoid-hplc-mixture-ii cannabinoids CBs synthetics mixtures receptors agonists synthetic 39.551017802333
11337 Synthetic Cannabinoid HPLC Mixture V (AM Series) New - ≥95% for each compound 2012-02-02 101.640890116636 synthetic-cannabinoid-hplc-mixture-v-am-series AM series AM-2201 AM-1220 AM-630 AM-1241 AM-694 AM-2233 AM2201 AM1220 AM630 AM1241 AM694 CBs cannbinoids mixtures AM2233 101.640890116636
70240 Tacrine (hydrochloride) 1684-40-8 >98% 7.605985267035 tacrine-hydrochloride Romotal; Cognex acetylcholinesterase inhibitors Alzheimer's disease serotonin noradrenalin AChE enzyme immunoassay reagents neurochemistry neuroscience 7.605985267035
10009911 Tangeritin 481-53-8 ≥98% 2008-12-16 11.958232044199 tangeritin Ponkanetin; NSC 618905; NSC 53909 flavone cancers tumors cholesterol atherosclerosis ERKs p38 MAPKs JNKs AKTs LDLs triacylglycerol estradiol MDR1 pregnane X receptors IL-1 IL1 IL 1 melanoma insulinoma 11.958232044199
11190 Termitomycamide B New 1254277-89-8 ≥97% 2012-01-31 173.333333333333 termitomycamide-b mushrooms extracts ER stress apoptosis endoplasmic reticulum neuroscience proteins misfolding Parkinson’s diseases Alzheimer’s prions fatty acids cells death termites termitomycamides Termitomyces titanicus Neuro2a 173.333333333333
11191 Termitomycamide E New 1177258-62-6 ≥98% 2012-01-27 173.333333333333 termitomycamide-e 2'-Deoxotermitomycamide A mushrooms extracts ER stress apoptosis endoplasmic reticulum neuroscience proteins misfolding Parkinson’s diseases Alzheimer’s prions neuronal calcium homeostasis Termitomyces titanicus termites 173.333333333333
10011127 Thioperamide Maleate 148440-81-7 ≥98% 2009-03-26 0.960497237569 thioperamide-maleate histamines H3 receptors antagonists seizures GABA 110-16-7 106243-16-7 selective croses blood-brain barrier 0.960497237569
13623 Topiramate 97240-79-4 ≥98% 2010-08-17 1.118121546961 topiramate TPM; Topamax®; RWJ 17021; McN 4853; Epitomax anticonvulsants seizures epilepsy migraines headaches McN-4853 McN4853 RWJ-17021 RWJ17021 epitoma topamac topimax topina topomax 1103510-60-6 administered orally sulfamates anti-convulsants prevention Instituto Farmacologico Brand of Fructose Fresenius Kabi Brand of Fructose Grifols Brand of Fructose Plast Apyr Levulosa Mein Bieffe Brand of Fructose Baxter Brand of Fructose Levulosado Bieffe Medit Braun Brand of Fructose Ern Brand of Fructose Levulosa Fleboplast Fleboplast Levulosa Levulosado Vitulia Levulosado Braun Levulosa Grifols Levulosa Baxter Levulosa, Apir Levulosa Braun Levulosa Mein Levulosa Ibys Apir Levulosa Levulosa Ife Levulose Levulosa Fructose 1.118121546961
11120 TPPU Exclusive New 1222780-33-7 ≥98% 2011-10-26 6.444971864129 tppu soluble epoxide hydrolase sEH inflammation hypertension cardiovascular disease neuroscience inhibitors inhibits inhibition pharmacokinetics 6.444971864129
10011659 Trolox 53188-07-1 ≥98% 2008-12-02 295.447856353591 trolox 6-hydroxy-2,5,7,8-tetramethylchroman-2-Carboxylic Acid antioxidants vitamins E oxidative injury injuries neurodegeneration aging cancers adjunctive 295.447856353591
10009398 Tryptophan Hydroxylase (Phospho-Ser260) Polyclonal Antibody - 2006-12-18 0.948077348066 tryptophan-hydroxylase-phospho-ser260-polyclonal-antibody TPH TPH260 hydroxylases catalyzes 5-hydroxylation biosynthesis indoleamines serotonin melatonin brain mammals neurons Raphe nuclei pineal gland neurotransmitter phosphorylation cyclic AMP cAMP-dependent kinases PKA Ca2+/calmodulin kinase II CaM K II phosphorylates antibodies antisera antiserum WB western blots blotting proteins diseases phospho-specific immunoblotting 0.948077348066
10009397 Tryptophan Hydroxylase (Phospho-Ser58) Polyclonal Antibody - 2006-12-18 0.790064456721 tryptophan-hydroxylase-phospho-ser58-polyclonal-antibody TPH TPH58 hydroxylases catalyzes 5-hydroxylation biosynthesis indoleamines serotonin melatonin brain mammals neurons Raphe nuclei pineal gland neurotransmitter phosphorylation cyclic AMP cAMP-dependent kinases PKA Ca2+/calmodulin kinase II CaM K II phosphorylates antibodies antisera antiserum WB western blots blotting proteins diseases phospho-specific immunoblotting 0.790064456721
10009396 Tryptophan Hydroxylase Polyclonal Antibody - 2006-12-13 0.948077348066 tryptophan-hydroxylase-polyclonal-antibody TPH hydroxylases catalyzes biosynthesis serotonin melatonin brain mammals neurons Raphe nuclei pineal gland antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry frozen sections proteins diseases immunoblotting 0.948077348066
10559 Tubastatin A (trifluoroacetate salt) Exclusive - ≥95% 2011-02-08 60.463449585635 tubastatin-a-trifluoroacetate-salt HDAC6 inhibitors histones deacetylases neuroprotection neurons epigenetics TFA inhibition inhibited neuronal protection α-tubulin alpha tubulin .alpha.tubulin a-tubulin tubastatin-A Acids Hydroxamic Hydroxamic Acids Acid Hydroxamic Hydroxamic Acid 60.463449585635
10009412 Tyrosine Hydroxylase (Phospho-Ser19) Polyclonal Antibody - 2006-11-28 1.740331491713 tyrosine-hydroxylase-phospho-ser19-polyclonal-antibody TH wb western blotting blots if immunofluorescence ihc immunohistochemistry antibodies rate-limiting enzymes synthesis catecholamines dopamine norepinephrine markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's diseases drug abuse signaling phosphorylation phospho-specific regulation cells identification immunoblotting 1.740331491713
10009413 Tyrosine Hydroxylase (Phospho-Ser31) Polyclonal Antibody - 2006-11-28 0.580110497237 tyrosine-hydroxylase-phospho-ser31-polyclonal-antibody TH wb western blotting blots if immunofluorescence ihc immunohistochemistry antibodies rate-limiting enzymes synthesis catecholamines dopamine norepinephrine markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's diseases drug abuse signaling phosphorylation phospho-specific regulation cells identification phospho-specific immunoblotting 0.580110497237
10009414 Tyrosine Hydroxylase (Phospho-Ser40) Polyclonal Antibody - 2008-07-07 0.870165745856 tyrosine-hydroxylase-phospho-ser40-polyclonal-antibody TH wb western blotting blots if immunofluorescence ihc immunohistochemistry antibodies rate-limiting enzymes synthesis catecholamines dopamine norepinephrine markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's diseases drug abuse signaling phosphorylation phospho-specific regulation cells identification immunoblotting 0.870165745856
10604 Tyrosine Hydroxylase Polyclonal Antibody - 2009-10-23 0.386740331491 tyrosine-hydroxylase-polyclonal-antibody TH gamma inhibits inhibitors neurotransmitters WB western blots blotting enzymes synthesis dopamine norepinephrine immunoblotting IHC immunohistochemistry IF immunofluorescence 0.386740331491
10010245 U-83836E 137018-55-4 ≥98% 2008-07-08 0.160220994475 u-83836e antioxidant anti-oxidant oxidative injury stress free radicals ischemia diabetes a-tocopherol .alpha.-tocopherol 122003-11-6 PNU-83836E PNU83836E 0.160220994475
10045 UCM707 390824-20-1 >98% 2004-01-30 22.976160220994 ucm707 cannabinoids neurotransmitter inhibitors AEA lipids CB1 UR1 receptors anandamide hydrolysis fatty acids neurochemistry neuroscience 22.976160220994
13261 URB447 Exclusive 1132922-57-6 ≥98% 2009-06-18 32.550309392265 urb447 CB1 CB2 cannabinoids antagonists obesity SR 141716A SR141716A rimonabant blood brains barrier URB appetite suppressant receptors URB-447 URB blocking peptides 447 cannabinoids cbs synthetic 32.550309392265
10046 URB597 546141-08-6 >98% 54.148442993470 urb597 FAAH fatty acid amide hydrolases inhibitors URB-597 anandamides lipids inhibition selective selectivity AEA inhibits hydrolysis hydrolyze arachidonoyl cannabinoids ethanolamides neuroscience neurochemistry 54.148442993470
10007457 URB602 565460-15-3 >98% 2005-09-06 40.770787292817 urb602 monoglycerol lipase MGL inhibition inhibits inhibitors rat brain enzymes enhanced stress-induced analgesia novel drugs pain stress management CNS central nervous system monoacylglycerol neuroscience neurochemistry cannabinoids cbs synthetic 40.770787292817
10007691 URB754 86672-58-4 >98% 2005-11-04 24.893955801105 urb754 neurochemistry neuroscience 2-AG 2-archidonoyl glyerol MGL monoacylglycerol lipase monoglyceride lipase endocannabinoids FAAH fatty acid amide hydrolase inhibitors inhibition inhibits monoglycerol MAGL neurochemistry cannabinoids 24.893955801105
10674 URB937 Exclusive - ≥98% 2011-03-08 17.586224677716 urb937 FAAH anandamide AEA inhibitors peripheral pain Cannabinoids 17.586224677716
700620 Urea Fluorometric Assay Kit New - 2011-08-31 95.065620018036 urea-fluorometric-assay-kit kits assays measures measurements carbamide cycle protein amino acids aa metabolisms catabolism deaminated ammonia livers N-acetylglutamate blood kidneys urine nitrogen countercurrent exchange systems nephrons kidneys creatinine prerenal hperuremia cardiac decompensation water depletion renal glomerulonephritis chronic nephritis polycystic nephrosclerosis tubular necrosis urinary tract toxic metabolites ammonium hyperammonemia plasma detoxification neurological brain neuroprotection serum urease hydrolysis carbon dioxide CO2 detector fluorescence fluorescent 95.065620018036
10006731 VDM11 313998-81-1 >98% 2005-07-13 7.874125230202 vdm11 analogs arachidonoyls ethanolamides AEA anadamides potentiates activity inhibits inhibition reuptake neurons FAAH fatty amides acyls hydrolases transport CB1 CB2 cannabinoids VR1 vanilloid receptors AM404 glutamergic synaptic transmission hippocampal mechanisms sodium channels neurochemistry neuroscience 7.874125230202
9000976 Vigabatrin 68506-86-5 ≥95% 2011-05-04 16.287348066298 vigabatrin γ-Vinyl GABA; Sabril™ 60643-86-9 neurotransmitters γ-aminobutyric acids GABA inhibitors seizures epilepsy neuroscience gamma-vinyl-gamma-aminobutyric gamma vinyl aminobutyric gamma-vinyl-GABA Sabrilex Sabril 16.287348066298
10009023 (+)WIN 55212-2 (mesylate) 131543-23-2 >98% 2006-10-05 47.709641060716 -win-55212-2-mesylate WIN-2 agonists cannabinoids CB1 CB2 neurons rat glutamates SR141716A IP3 Xestospongin C 55212-3 WIN-3 inflammatory neuropeptides CGRP trigeminal neurochemistry ganglions TG exocytosis WIN55,212-2 endocrinology WIN55212-2 cannabinoids cbs synthetic 47.709641060716
10736 (±)WIN 55212 (mesylate) New 137795-17-6 ≥98% 2012-01-11 110.382203395478 -win-55212-mesylate cannabinoids CB1 CB2 receptors pain neuroscience agonists antagonists aminoalkylindole CBs enantiomers (+)WIN 55212-2 (-)WIN 55215-3 SR144528 SR-144528 SR 144528 racemic mesylate central peripheral 110.382203395478
10011213 WWL70 Exclusive 947669-91-2 >97% 2008-04-15 9.642836095764 wwl70 serine hydrolase ABHD6 inhibitors inhibits inhibition 2-AG endocannabinoids .alpha./.beta. a/b alpha/beta neurochemistry cannabinoids inhibitors 9.642836095764
10790 Xanomeline oxalate 141064-23-5 ≥98% 2011-06-14 0.382872928177 xanomeline-oxalate Lumeron; Memcor; LY246708 agonists muscarinic receptors acetylcholine psychosis antipsychotic memory neurotransmitters neurological Alzheimer’s diseases M1-preferring 0.382872928177
80340 α-Guanidinoglutaric Acid 73477-53-9 ≥98% 2.612246777163 -guanidinoglutaric-acid GGA nitric oxide synthase inhibitors nNOS NO seizure brain neurochemistry 2.612246777163
78050 (−)-(α)-Kainic Acid 487-79-6 >98% 2004-04-08 65.327900552486 -kainic-acid neuroexcitatory seizures neuroexcitotoxics epileptogenics alga algae neurochemistry neuroscience 65.327900552486
90215 α-Linolenoyl Ethanolamide Exclusive 57086-93-8 >98% 10.168516179952 -linolenoyl-ethanolamide cannabinoids neurotransmitters ethanolamides fatty acids CB alpha-linolenoyl .alpha.-linolenoyl cannabinergic neurochemistry neuroscience ethanolamines, cbs, synthetic 10.168516179952
9001195 α-Pyrrolidinobutiophenone (hydrochloride) New 13415-54-8 ≥95% 2012-01-27 142.495838792477 -pyrrolidinobutiophenone-hydrochloride α-PBP 13415-82-2 hydrochloride HCl forensics phenethylamines amphetamines cathinones designer drugs butyrophenones ketones MPBP party pills synthetic anti-psychotic anti-emetic antipsychotic antiemetic anti psychtic anti emetic α-pyrrolidinobutyrophenone 142.495838792477
9001083 α-Pyrrolidinopentiphenone (hydrochloride) Exclusive New 5485-65-4 ≥98% 2011-10-11 60.351186131782 -pyrrolidinopentiphenone-hydrochloride α-PVP; 2-(1-pyrrolidinyl)-Valerophenone; O-2387 14530-33-7 designer drugs forensics pyrovalerone bath salts inhibits inhibitors inhibition transporters neurotransmitters dopamine norepinephrine uptake monoamine analogs alpha PVP APVP hydrochloride HCl psychoactive stimulant 60.351186131782
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?